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Thesis Summary 
In the modern materials science, functional inorganic nanoparticles have 
become the spotlight especially in various biomedical applications for theranostic 
purposes. The unique size-dependent physical (e.g. optical and magnetic) properties 
allow such nanoparticles to be employed as imaging contrast agents, hyperthermia 
agents, drug/gene delivery agents and etc. Up to date, the major challenge in the 
related field is the precise-controlled fabrication approach to obtain high quality 
water-soluble functional inorganic nanocrystals with excellent colloidal stability, 
biocompatibility and appropriate surface chemistry for biofunctionalization. Of 
various current strategies to prepare these nanoparticles, thermal decomposition 
method in non-polar solvent is favored due to the monodisperse characteristics of the 
resultant hydrophobic nanoparticles. However, for biomedical applications, additional 
step to render these hydrophobic nanoparticles water soluble is essentially required. 
Several strategies, such as ligand exchange or modification, polymer encapsulation, 
inorganic coating, have been employed to functionalize and water solubilize inorganic 
nanoparticles. These processes often yield water-soluble nanoparticles with many 
inherent problems such as: (i) lack of colloidal stability which causes the 
nanoparticles to be prone to aggregation, compromising the long-term stability, (ii) 
surface sensitive process that compromises nanoparticles physical properties, (iii) lack 
of coating control which results in the undesirable nanoparticles architectural system 
and (iv) biocompatibility issue, especially in physiological solution. Such drawbacks 
call for development of a better controlled water-solubilization process.  
This thesis was organized into four independent sections to investigate various 
possibilities of using organic-based materials as functional coating during water 
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solubilization processes. The first part focused on the direct surface modification of 
the hydrophobic nanoparticles during the thermolysis process by incorporating a 
classic maleinization reaction in order to obtain water soluble nanoparticles 
straightforwardly. The second part focused on the use of dodecylamine-grafted poly 
(isobutylene-alt-maleic anhydride) amphiphilic brush copolymer to obtain water 
soluble nanoparticles with single (thin) layer surface polymer coating over each 
individual nanoparticles. In the third part, PEG-grafted poly (maleic anhydride-alt-1-
octadecene) amphiphilic brush copolymer was used to collectively encapsulate 
hydrophobic nanocrystals. This method was potentially used to form multifunctional 
nanoclusters. The last part was dedicated on the development of new water 
solubilization method using ultra-small graphene oxide sheets host. Despite the water 
solubility, it was revealed that the nanoparticles were only simply decorated on the 
surface of the graphene oxide layer without any encapsulation. In each section, the 
study was dedicated specially to water solubilize monodisperse and uniform 
hydrophobic superparamagnetic nanoparticles. However, the overall investigations 
aimed at designing optimized and universal phase-transfer methods for any 
hydrophobic nanoparticles system onto the aqueous phase, forming water-soluble 
nanocomposites. For each approach, the synthesized hydrophilic nanocomposites 
colloidal stability (pH- or time-dependent) and its biocompatibility (with NIH/3T3 
fibroblast or MCF-7 breast cancer cells) were assessed. The –COOH functional 
groups on the organic coating surface allowed easy biofunctionalization. Lastly, the 
hydrophilic nanocomposites would be demonstrated for various biomedical 
applications (i.e. MRI, MFH and cellular labelling).   
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Chapter 1. Introduction 
 
1.1 Overview of Inorganic Nanoparticles for Biomedical 
Applications 
In recent years, cancer has been one of the leading causes of death worldwide, 
claiming 8.2 million deaths as recorded in 2012. [1] In 2012, it was estimated that 
there were 14.1 million cancer cases around the world. The annual cancer cases are 
expected to reach 24 millions by 2035. [2] Regardless of its types, cancer diseases 
have becoming one of the most-feared and fatal diseases that often resulted in 
mortality. Due to the annual steady increase in the mortality rate, early cancer 
diagnosis, prevention and treatment have gained significant attention world-widely 
and become a great scientific challenge. [3] Although there are many existing cancer 
diagnosis and treatment methods, the worldwide emerging cancer issue still remained 
un-resolved. For instance, the current conventional cancer imaging methods only 
allow the cancerous tissues differentiation from healthy tissues when there are visible 
marks indicating the on-going proliferation or metastasis process. In addition to this, 
conventional cancer therapies would involve physical surgery, radio-therapy, chemo-
therapy and lately whole body hyperthermia therapy, which limit the efficacy and 
complicate the treatment procedures. These methods are also associated with high risk 
of deleterious effect to the surrounding healthy tissues as well as low efficiency in 
destroying cancerous tissues due to its non-specific treatment characteristic. [4] 
To cater for advanced cancer diagnosis and treatment needs, colloidal 
inorganic nanoparticles systems have gained enormous interest because of its 
biomedical-related applications. [3-7] These nanoparticles are extremely small with 
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average dimensions of several up-to few hundred nanometers, two to three orders of 
magnitude smaller than biological cells. Because of its comparable size with many 
macromolecules (e.g. lipid and protein), nanoparticles can act as nano-probes to 
interact with various biological systems. Nanoparticles are also capable to improve 
the efficacy of cancer treatment due to their inherent ‘passive targetting’ effect which 
allows the nanoparticles to preferentially accumulate in the tumor locations due to 
leaky tumor vasculature and high fluid flow. This enhanced permeation and retention 
(EPR) effect is also accompanied by lower reticularendothelial system (RES) uptake 
of the nanoparticles by liver, spleen and bone marrow which then produced long-
circulating nanoparticles. [6, 8-10] Basically, nanoparticles with average dimensions 
of 30–200 nm are favored to enhance the EPR effect and to suppress the RES uptake. 
[11] Moreover, due to their nano-size, inorganic nanoparticles have also demonstrated 
significant deviation in terms of physical, chemical and biological properties as 
compared to its bulk counterpart. [6,12-13] 
Currently, there are various types of inorganic nanoparticles formulations, 
designed through tremendous biomedical research efforts. These functional 
nanoparticles include (i) semiconductor quantum dots (QDs), (ii) up-/down- 
converting nanoparticles, (iii) noble metallic nanoparticles and (iv) magnetic 
nanoparticles (MNPs). [14-34] Among these nanoparticles, magnetic nanoparticles 
are useful as nano-tools for various advanced applications due to their unique 
behaviors and quick responsiveness towards externally applied magnetic field. [34] 
As summarized in Figure 1-1, magnetic nanoparticles applications include (i) 
magnetic bioseparation/detection, (ii) magnetically guided drug delivery, (iii) targeted 
magnetofection, (iv) magnetic resonance imaging (MRI) contrast agent, (v) magnetic 
fluid hyperthermia (MFH), as well as the recent (vi) cell-/tissue-fate control. [35-70] 
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This wide range of applications is enabled, owing to the superparamagnetism 
behaviors and high penetrability of magnetic field to human tissue without any 
significant attenuation. Upon magnetic field application, functionalized magnetic 
nanoparticles with specific surface receptor (to bind with cancerous cells) can be 
attracted and separated for further characterization. [35-41] By using similar strategy, 
magnetic nanoparticles loaded with drugs or silencing-gene can be steered in-vivo 
upon injection, enabling targeted delivery and higher treatment efficacy due to 
potential nanoparticles accumulation in the target site [42-45]. The payload also can 
be released through alternative pathways such as heat-triggered release. [46-53] With 
proper nanostructures design, payload controlled release can be easily achieved. 
 
Figure 1 - 1: Examples of cancer diagnosis and treatment using superparamagnetic 
nanoparticles. 
Under the influence of strong external magnetic field, magnetic nanoparticles 
enable surrounding water molecules proton (
1
H) relaxation enhancement through 
induced-magnetic perturbation. As such, magnetic nanoparticles can be used as 
contrast agent to improve magnetic resonance (MR) imaging signal-to-noise ratio. 
[54-59] Meanwhile, under alternating magnetic field, magnetic nanoparticles repeated 
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relaxation enables energy transfer from the applied field to heat release, allowing such 
system to be used for cancer hyperthermia. [60-65] On top of this, deep penetrability 
of magnetic field and magnetic translational force exerted on magnetic nanoparticles 
upon the application of external magnetic field, allow a close interaction between 
magnetic nanoparticles with the cellular receptors. For example, functionalized 
magnetic nanoparticles that bind specifically to surface receptor can induce receptors 
aggregations (mimicking the natural signaling pathway) under applied static magnetic 
field, allowing artificial cellular signaling activation such as enhanced angiogenesis, 
ion-channel activation and cellular apoptosis. [66-70] 
Based on the aforementioned applications, magnetic nanoparticles can be 
functionally exploited for the combined cancer diagnostic and therapeutic 
(theranostics) applications. [71-72] Ideally, this advanced preventive medicine 
requires the development of non-invasive theranostics agent which relies on the 
combination between multimodality imaging, detection and high treatment efficacy. 
At present, only superparamagnetic nanoparticles (SPM) that offer suitable functional 
behavior for such theranostics applications due to the non-invasiveness and high 
penetrability of magnetic field to human body, i.e. MRI and MFH. [32,34] 
1.2 Magnetic Resonance Imaging (MRI) 
1.2.1 Basic 
Briefly, magnetic resonance imaging (MRI) is a non-invasive imaging and 
diagnostic technique involving externally applied magnetic field and few radio-wave 
energy pulses to obtain images from human body and organs. As one of the most 
powerful imaging tools, MRI is preferred to detect various diseases that are associated 
with brain, central nervous system, spine, cardiovascular system, musculoskeletal 
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system and recently for tumor detection. [73-78] In comparison with x-ray imaging, 
ultrasound imaging, computed tomography (CT) scan, positron emission tomography 
(PET) scan, MRI diagnostic method is more advantageous due to the non-
invasiveness  and high penetrability of the magnetic field to human body as well as its 
high spatial resolution. [54,79-81] The basic principle of MRI is based on the nuclear 
magnetic resonance (NMR) signal of hydrogen protons (
1
H). Hence, MRI relies on 
the abundance of
 1
H nuclei (99.9%) in human body (biological tissues), mainly in the 
form of water molecules. Because it probes water molecules, MRI is able to provide 
high resolution soft tissues anatomic images which are beneficial in detecting tumors.  
 
Figure 1 - 2: Principle of MRI: (a). Hydrogen proton nuclei with and without the 
influence of external magnetic field. (b). Nuclear spin aligns and precesses at Larmor 
frequency (ω0) under the influence of strong external magnetic field. (c). When a 
short 90
o
 RF pulse was introduced, the spin directions flip 90
o
 and the nuclear spins 
precess on xy–plane. The nuclear spin then undergoes relaxation process. (d) The 
longitudinal magnetization or spin–lattice (T1) relaxation. (e) The tranverse 
magnetization or spin–spin (T2) relaxation (adapted from ref [75]). 
  - 6 - 
 
Hydrogen protons nuclei, or commonly called nuclear spins, are tiny-like 
magnets that are sensitive to the external magnetic field. As illustrated in Figure 1-2a, 
without the external magnetic field, the nuclear spin will be randomly oriented and the 
system possesses zero net magnetization macroscopically. Under the influence of 
external magnetic field (B0), the nuclear spins align with the direction of the applied 
field. There are two possible nuclear spins orientations, parallel (aligned with the 
field) and anti-parallel configurations. With more spins (slight excess) aligned 
parallelly to the applied field than the anti-parallel spins, the net macroscopic 
magnetization is no longer zero. This implies that there is a net magnetization along 
the applied field direction (longitudinal direction). Under the influence of B0 field (in 
Z-direction), the nuclear spins precess along the axis of the applied field as shown in 
Figure 1-2b. These spinning protons precessions proceed by Larmor frequency (ω0): 
ω0 = – γB0     …(1) 
where ω0 is the angular frequency, γ is the hydrogen proton nuclei gyromagnetic ratio 
and B0 is the local magnetic field. Since there will be no influence from the applied 
field on the transverse direction, the nuclear spins rotate randomly and the sum of the 
transverse magnetizations is zero. 
As shown in Figure 1-2c, when an oscillating RF pulse (90
o
) at Larmor 
resonant frequency is applied perpendicularly to the longitudinal axis (applied B0 
field) to perturb the system, all nuclear spins absorb electromagnetic energy, tilt away 
by 90
o
 from the longitudinal axis and start to precess on the transverse-plane. 
Therefore, the longitudinal magnetization (Mz) decreases and the transverse 
magnetization (Mxy) is generated due to the coherent alignment of the nuclear spins to 
the RF pulse. When the RF pulse is removed, the excited nuclei return to its lower 
energy level state (i.e. paralel alignment along longitudinal axis). The recovery of the 
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magnetization to the original condition (relaxation process) involves the exponential 
free induction decay (FID) of the precessing nuclear spins. Overall, the relaxation 
processes can be divided into two independent processes, mainly (i) longitudinal T1 
relaxation process whereby the longitudinal magnetization (Mz) is recovered through 
spin-lattice energy transfer and (ii) transverse T2 relaxation process whereby the 
transverse magnetization (Mxy) decays because of the spin–spin interaction. During 
this relaxation process, the change in magnetization generates voltage that is 
registered by external RF receiver coil as signal. From Figure 1-2d, T1 is the 
relaxation time required for longitudinal magnetization to recover 63.2% of its 
original equilibrium value. This recovery is caused by nuclear spins interaction with 
the surrounding lattice, leading to the loss of excited spin energy to the surrounding 
lattice. In T1-weighted images, the shorter the T1 relaxation time, the stronger the 
signal intensity measured. Hence, the T1-weighted MRI images appear bright against 
the background which produced positive contrast for area with fast T1 relaxation. 
Meanwhile, T2 is the relaxation time required for the transverse magnetization to 
decay 36.8% from its original transient value (Figure 1-2e) due to the excited nuclear 
spins de-phasing in the transverse direction. This coherency loss is attributed to the 
local magnetic field inhomogeneity nearby the nuclear spins. The T2-weighted images 
appear dark against the background which produced negative contrast.  
1.2.2 MRI Contrast Agent 
MRI contrast agent can be simply defined as the exogenous substance that 
enhances the natural contrast of the MRI signal intensity between two adjoining 
tissues. Collectively, the MRI contrast agent enhances the signals from human vessels 
or organs. In the early stage of MRI contrast agent development, gadolinium-chelates 
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agent was developed to the resolve the low imaging contrast problem. Later on, more 
contrast agents have been developed and commercialized. [55,56]  Generally, MRI 
contrast agent is not visually visible and usually works by altering the relaxation time 
T1 and/or T2 of the local hydrogen nuclei. Based on the relaxation mechanism, MRI 
contrast agent can be classified into: (i) positive contrast agent with T1 relaxation 
enhancement (hypersignal) and (ii) negative contrast agent with T2 relaxation 
(hyposignal). Some of the earlier positive contrast agent include gadolinium chelates 
(Gadolite
®
), manganese chelates (Lumenhance
®
) and ferric ammonium citrate 
(Ferriseltz
®






Table 1 - 1: T1 and T2 contrast enhancement agents [56, 83-84, 88-89]. 
Description T1 Contrast Agent T2 Contrast Agent 
Enhancement Positive contrast agent Negative contrast agent 
Relaxation Spin – lattice relaxation Spin – spin relaxation 
Effect Shortens T1 more significantly than T2 Shortens T2 more significantly than T1 
Relaxivity 
Ratio (r) 
r2/r1 < 10 r2/r1 >> 10 
Mechanism 
Agent induces fluctuating local magnetic 
field. When the fluctuation frequency 
matches ω0, energy transfer occurred. 
Induced local magnetic field leads to local field 






Paramagnetic nanoparticles. For instance, 
manganese- and gadolinium-based oxides. 
(MnO, Mn3O4, GdO, Gd2O3) 
Ferromagnetic and superparamagnetic 
nanoparticles. For instance, iron-based oxides 
and ferrites. (Fe3O4, MnFe2O4 and etc) 
In recent years, MRI contrast agent development has focused on more stable 
inorganic nanostructured-probes with tunable properties, e.g. transition metal oxides 
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and lanthanide-based oxide. [82-89] Based on years of development efforts, MRI 
contrast agent requirements are summarized in Table 1-1. Usually MRI T1 contrast 
agent involves materials with paramagnetic behavior to induce local magnetic 
fluctuation. If the contrast agent frequency matches the Larmor frequency, T1 
relaxation time will be reduced significantly. To become an effective MRI contrast 
agent, the transverse and longitudinal relaxivities ratio (r2/r1 ratio) is very critical. 
Positive enhancement is obtained when r2/r1 ratio is less than 10 while negative 
enhancement is obtained when r2/r1 ratio is more than 10. Typically, T1 contrast agent 
involves the use of paramagnetic property (high r1) while minimizing the magnetic 
anisotropy (low r2). Various transition and lanthanide metal oxides (e.g. Mn- and Gd-
based oxides and paramagnetic ultrasmall iron oxides) are suitable as MRI T1 contrast 
agent due to large amount of metal ions with high magnetic moments. [84, 86, 90-92] 
For T2 contrast agent, significant perturbation to local field inhomogeneity is required 
to accelerate the spin de-phasing process which can be achieved by using 
ferromagnetic and superparamagnetic nanoparticles. For SPM, in the absence of 
externally applied magnetic field, the net magnetization is zero. However, under 
applied external magnetic field, SPM exhibit strong magnetization that enhances local 
field inhomogeneity. This local perturbation will therefore accelerate nuclear spins 
de-phasing process and shortens the nearby protons T2 relaxation time. [53-58, 93] 
1.3 Magnetic Fluidic Hyperthermia (MFH) 
1.3.1  Basic 
The working principle of magnetic fluidic hyperthermia (MFH) is based on 
the interaction behavior between magnetic nanoparticles with externally applied 
alternating magnetic field (AMF) in which heat will be generated and released to the 
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surrounding environment. [34, 94-97] This interaction is well known as induction 
heating and is normally caused by the major hysteresis losses when magnetic 
nanoparticles undergo repeated magnetic spins re-alignment with the applied AMF. 
For multi-domain magnetic nanoparticles, the heating mechanism involves the 
hysteresis losses due to magnetic domain walls movement. In contrary, for single 
domain magnetic nanoparticles (as illustrated in Figure 1-3) Neel and/or Brownian 
relaxation dominate the interaction. Neel relaxation is the random magnetic moment 
flipping/rotation of the nanoparticles. The Neel relaxation characteristic time (τN) is 
dependent on the temperature and can be described as [96]: 
τN = τ0 exp (EB/kBT)    …(2) 
where kB is the Boltzmann constant and EB refers to the anisotropy energy barrier. τ0 
defines the attempt time for the magnetic moment flipping to occur. On the other 
hand, Brownian relaxation refers to the nanoparticles’ physical rotation in viscous 
medium. The Brownian relaxation characteristic time (τB) associated with such 
rotation can be described as [97]:  
τB = 3Vh η/kBT    …(3) 
where Vh is the hydrodynamic volume (obtained commonly by dynamic light 
scattering experiment) and η refers to the viscosity of the medium where the 
nanoparticles are dispersed. Based on equations (2) and (3), both Neel and Brownian 
relaxation processes are highly dependent on various factors of the MFH agents itself. 
These include nanoparticles’ core sizes (related to the core magnetism behavior, e.g. 
superparamagnetism), actual hydrodynamic size in the medium and the viscosity of 
the surrounding medium where the nanoparticles are dispersed [98]. For nanoparticles 
with smaller core size, Neel relaxation dominates the entire relaxation process (fast 
process). Meanwhile, for larger nanoparticles, Brownian relaxation dominates the 
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relaxation process. Since Brownian relaxation requires nanoparticles’ physical 
rotation, the surrounding medium viscosity is critical. If the MFH agents are attached, 
for example to any cancerous cells surface receptors, the Brownian relaxation 
weakens significantly. [99] Overall, specific absorption rate (SAR) parameter is used 
to define the heating capabilities of the magnetic nanoparticles under influence of 
external AMF. SAR values of various MFH agents are highly dependent on the 
measurement frequency as well as the field amplitude. 
 
Figure 1 - 3: Magnetic fluidic hyperthermia (MFH) illustration. Under the applied 
external alternating magnetic field: (i) Neel and (ii) Brownian relaxation processes. 
1.3.2 Magnetic Hyperthermia Agent 
MFH is currently considered as physical treatment for cancer therapy because 
it possesses less significant side effect as compared to the current conventional 
chemotherapy or radiotherapy. [100-101] However, to obtain effective and good MFH 
agent, there are requirements to be fulfilled. Firstly, the MFH agents have to be 
colloidally and chemically stable at various aqueous solvent (inclusive of body fluid). 
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It should not aggregate with or without the presence of magnetic field. Therefore, 
SPM are highly demanded. Besides, MFH agents have to be biocompatible (minimum 
cytotoxicity) towards biological cells. Lastly, since MFH is dependent on the 
hysteresis loss, MFH agents must possess good magnetic properties (e.g. high 
saturation magnetization (MS) value and magnetic susceptibility) and good 
monodispersity for efficient energy-conversion. [62, 65, 98, 102]  
1.4 Basic Properties and Synthesis of Magnetic Nanoparticles 
1.4.1 Magnetism and Nanomagnetism Behavior 
 
Figure 1 - 4: (a) Plot of coercivity (HC) against magnetic nanoparticles size.  
Hysteresis loops: (b) pseudo-paramagnetic (ultra-small SPM), (c) superparamagnetic, 
(d) ferromagnetic and (e) paramagnetic nanoparticles (adapted from ref [31, 55]). 
Based on their magnetic behavior, bulk magnetic materials can be categorized 
into paramagnetic, diamagnetic, ferromagnetic, ferrimagnetic and anti-ferromagnetic 
materials. While paramagnetic material behavior is rather size-independent, 
ferromagnetic material and ferrimagnetic material behavior is highly size-dependent. 
Typical ferromagnetic nanoparticles include Fe3O4, MFe2O4 (where M = Mn, Co), 
FePt, CoPt, SmCO5 and etc. [103] In ferromagnetism and ferrimagnetism, the concept 
of magnetic domains is important because both samples are sub-divided onto various 
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small regions called magnetic domains. Such domain formation reduces the system 
magnetostatic energy, which gives rise to the unique hysteresis loop shape. As 
mentioned earlier, the nanoparticles behaviors are different from its bulk counterpart 
due to the size-effect. From Figure 1-4a, as ferromagnetic nanoparticles size 
decreases, multi-domain nanoparticles will become single domain nanoparticles due 
to the rising of total energy of the system required to maintain the domain wall 
(competition between the demagnetizing field and exchange interaction energy). This 
upper critical size limit is marked by the maximum coercivity field (HC). For single 
domain nanoparticles, the magnetization procedure is determined by the magnetic 
spins coherent rotations. As single domain nanoparticles’ size decreases, the thermal 
energy fluctuations will attempt to randomize the magnetic spins. [104-105] 
 
Figure 1 - 5: (Left) Magnetic nanoparticles moment orientation, under the influence 
of surrounding thermal energy (kT). (Right) Plot of energy against the magnetic 
moment orientation for large and small nanoparticles (adopted from ref [94]). 
As illustrated in Figure 1-5, when nanoparticles size decreases, the thermal 
energy overcomes the magnetic anisotropy energy. This lower critical size limit 
determines the formation of nanoparticles with superparamagnetic behavior. Below 
this limit, HC is negligible because the thermal energy fluctuation prevents stable 
magnetization. Therefore, there is no residual magnetization upon removal of external 
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magnetic field because of the magnetic spins randomization. Only under applied 
external magnetic field, the magnetic spins can re-align. The transition temperature 
for superparamagnetism to occur is defined by the blocking temperature (TB) [106]:  
K = 25kBTB/V     …(4) 
where K is the magnetic anisotropy constant, kB is the Boltzmann constant and V is 
the blocking temperature. Based on equation (4), at room temperature (300K), the 
lower limit critical size to obtain SPM are estimated to be 14, 25 and 50 nm for 
CoFe2O4, FeFe2O4 and MnFe2O4 ferrites materials. [107] 
Recently, various reports revealed that when SPM size was extremely small 
(below 2–3 nm), the surface spin canting effects (core-shell model; enhanced high 
surface-to-volume ratio) was enhanced, resulting in linear relationship between 
magnetization and magnetic field. [108-109] Such behavior resembles the typical 
naturally occurring paramagnetic materials behavior. It is important to distinguish the 
naturally occurring paramagnetic materials with the superparamagnetic materials 
(Figure 1-6). While decreasing temperature or increasing applied magnetic field 
might allow SPM to behave ferromagnetically, paramagnetic materials behavior is 
only dependent on the net magnetic moment or number of contributing atoms. 
 
Figure 1 - 6: Paramagnetic nanoparticles (left) and superparamagnetic nanoparticles 
system (right) under the influence of externally applied field (adopted from ref [94]). 
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SPM system is essential for various biomedical applications. Its lack of 
coercivity and negligible residual magnetization prevent unnecessary aggregation and 
coagulation which can bring adverse effect to human body. Its responsiveness towards 
the externally applied magnetic field, as well as the high penetrability characteristic of 
magnetic field to human body without attenuation make SPM an interesting tool for 
cancer theranostics applications, especially in terms of MRI and MFH applications. 
1.4.2 Synthesis of Magnetic Nanoparticles 
Several methods for preparing magnetic nanoparticles can be classified into 
two major approaches: (1) top-down and (2) bottom-up approach. [110-112] Here, the 
term ‘magnetic nanoparticles’ refers to mainly, but not limited to SPM. The top-down 
synthesis involves physical or chemical attenuation and disintegration of bulk 
materials into nanomaterials. In contrary, the bottom-up synthesis refers to the 
assembly of basic building block (e.g. atoms or molecules) to produce nanomaterials. 
(1) Top-Down approach 
The top-down approach includes vapor deposition, spray/laser pyrolysis, ball-milling, 
chemical etching and sonication method. [113-118] The top-down fabrication process 
resulted in high purity nanoparticles and was suitable for large-scale production. 
However, lack of size and morphological control as well as inherent aggregation 
problems (e.g. lack of capping agent) detered this approach to be used in synthesizing 
particles for biomedical applications. 
(2) Bottom-Up Approach (Chemical Synthetic Route) 
The bottom-up approach, which involves solution-phase colloidal synthetic route, is 
commonly used to fabricate magnetic nanoparticles. Based on the types of solvent 
used, the bottom-up approach can be categorized into: (a) hydrolytic and (b) non-
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hydrolytic synthetic routes. Hydrolytic synthetic routes are carried out in water, 
mostly based on the hydrolysis of metal ions precursors. These include co-
precipitation, micro-emulsion, hydrothermal, microwave-assisted synthesis method. 
[78] Meanwhile, non-hydrolytic synthetic routes include solvothermal, reverse micro-
emulsion, poly-ol and thermal decomposition method that are carried in other organic 
solvent. [103, 111] These methods will be described in more details as follows: 
Co-Precipitation Method. Co-precipitation was one of the simplest and the earliest 
method used in preparing magnetic nanoparticles. Many of the early iron-oxide based 
MRI contrast agent were synthesized through co-precipitation route. [119-120] In a 
typical synthesis, mixture of ferrous and ferric salts was reacted with alkaline solution 
under vigorous stirring in order to precipitate the magnetic nanoparticles. [121] In 
order to obtain nano-size particles, nuclei seeds growth must be inhibited through the 
use of hydrophilic polymers or small molecules (e.g. polyvinyl alcohol (PVA), 
dextran, alkanolamines and etc) that serve as both precipitating agents and surface 
capping agent. [78, 121-125] The magnetic nanoparticles synthesized using this 
method have insufficient size and shape control and were highly dependent on the 
precursors used, temperature, pH and ionic strength. Such high-polydispersity and 
non-uniformity were disadvantageous for theranostic applications. 
Reverse Micro-emulsion Method. Reverse micro-emulsion method was based on the 
formation of water-in-oil emulsion (W/O) droplets, coupled with the co-precpitation 
method. The spontaneous nanodroplets formation due to the addition of surfactant 
molecules as well as the tunable W/O droplet size and shape, enabled such droplets to 
behave as nanoreactors. [126-127] The aqueous metal–salt solutions inside the W/O 
droplet were separated by the oil phase, and  the resulting nanoparticles synthesized in 
these confined nano-reactors can be controlled in terms of its size distribution due to 
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the spatial restrictions in both nucleation and growth. [78, 112, 128] Unfortunately, 
reverse-microemulsion method has few drawbacks such as low yield, complex 
purifying/recovery process and morphological non-uniformity of the resultant 
nanoparticles. [31, 108]  
Hydrothermal Synthesis. Alternatively, hydrolytic reactions can be carried out at high 
temperature (up to 200
o
C) and pressure (up to 2000psi) to fabricate magnetic 
nanoparticles. This method is commonly referred as hydrothermal synthesis. The 
synthesis generally proceeded through hydrolysis, chemical reduction and 
decomposition of the metal-precursors with competing nucleation and growth 
process.[112] By controlling the precursors ratio, the synthesis temperature and the 
synthesis duration, nanoparticles with tunable size can be synthesized and capped 
with various hydrophilic capping agent, e.g. polyvinyl alcohol, citric acid, ascorbic 
acid, polyvinyl pyrollidone, glucose and etc. [31, 112, 129-134] Various shapes 
including nanorings, nanotubes and hollow nano-beads can be fabricated. [135-136] 
Although the resultant nanoparticles have high yield and good size distribution 
control, they were prone to aggregation in aqueous solvent.  
Microwave Synthesis. The conventional hydrothermal synthesis process also can be 
accelerated by replacing the conventional heating-up process with high power 
microwave irradiation. Because of the high-energy and fast-heating process, rapid 
synthesis can be attained. [137-140] Microwave-assisted synthesis can also be 
extended to other synthesis method such as ball-milling. [141-142] However, such 
method also shared similar problem with the conventional hydrothermal synthesis. 
Solvothermal Synthesis. Solvothermal synthesis was similar to hydrothermal, except 
for the use of non-hydrolytic solvent to replace water. Polyol compounds, which 
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contain multiple hydroxyl functional groups (e.g. ethylene glycol derivatives) can be 
used as solvent. Solvothermal synthesis allows high degree of size and morphology 
control over the synthesized nanoparticles. [143-154] Various experimental 
parameters such as synthesis temperature, reaction duration, precursors amount, types 
of solvent and surfactant were reported to influence the resultant nanoparticles’ size 
and morphology. Interestingly, various unique shapes such as hollow nanostructures, 
nanoplates and nanowires can be fabricated. [148, 150-152] Solvothermal synthesis 
often yields nanoparticles with lack of surface functional groups that are prone to 
aggregation. 
Micro-emulsion Synthesis. In contrary to the common hydrolytic reverse-micro-
emulsion technique (based on W/O emulsion), it is also possible for the synthesis 
reaction to occur in oil-in-water (O/W) droplet. [155-159] Within the nano-size O/W 
droplet (2–100nm), the addition of reducing, oxidizing or precipitating agents resulted 
in the formation of the nano-size nanoparticles. [160] Although this method is capable 
of producing fairly uniform nanoparticles, due to the nature of the solvent used, this 
method is not suitable to prepare nanoparticles for biomedical application. 
Thermal Decomposition. Thermal decomposition refers to the thermolysis process of 
metal-organic precursors in high-boiling point non-hydrolytic solvent. Due to the use 
of non-polar solvent, the synthesis is usually mediated by the presence of surface 
capping agent. [78, 83, 111-112] Thermal decomposition process can be further 
divided into ‘hot-injection’ and ‘heating-up’ method, depending on the metal-organic 
precursor addition sequences. While ‘hot-injection’ process is commonly carried out 
in high boiling point non-polar solvent, the ‘heating-up’ process can be either carried 
out in both high boiling point polar-solvent (commonly referred as poly-ol mehod) 
and non-polar solvent. For poly-ol method, the synthesis was typically carried out by 
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a simple decomposition or reduction process of metal precursors in poly-ol solvent. 
[161-169] Various solvent bearing the hydroxyl functional groups (to promote the 
solvent/metal-ions binding), including diols and glycols, were used not only as the 
synthesis medium to dissolve the inorganic compound, but also act as the reduction 
agent and surface capping agent. As capping agent, the poly-ol solvent is expected to 
control size and shape of the resultant nanoparticles and to prevent interparticle 
agglomeration. Its high temperature condition ensures the crystallinity of the 
synthesized nanoparticles. Hu et al. demonstrated the synthesis of ultra-small iron 
oxide nanoparticles (3, 4, 5 and 6 nm) in diethylene glycol at 200
o
C. The size control 
was simply achieved by the tuning of the iron precursors amount and the dwelling 
time at 200
o
C. [161] Similarly, Dipak et al. also reported controlled synthesis of 5, 9 
and 11 nm iron oxide SPM in triethylene glycol for MRI and MFH applications. [165] 
Due to the nature of poly-ol solvent, these fabricated nanoparticles can be directly 
dispersed onto various aqueous medium. Unfortunately, the simultaneous roles of the 
poly-ol compound as both surface capping agent and solvent causes the as-
synthesized sample to have insufficient useful functional groups. Thus, additional 
tedious surface modification process is still required. [161] In addition, for most 
cases, mild aggregation was not observed from the microscopy analysis. However, 
from the hydrodynamic size analysis, few nanoparticles were bonded collectively due 
to the nature of the poly-ol ligand (multiple hydroxyls group). [165, 167] 
From literatures, non-polar synthetic routes received great interest due to their 
advantages. [28-34, 56, 78, 83, 103, 111-112, 169] High temperature reaction was 
enabled due to use of organic solvents with high boiling point characteristic (e.g. 
trioctylamine, 1-octadecene and etc) to ensure the formation of nanoparticles with 
high crystallinity and monodispersity. [111] The non-polar characteristic of the 
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synthesis condition also enabled the use of various organic hydrophobic surfactants 
(e.g. oleic acid, linoleic acid, decanoid acid, oleylamine, 1,2-hexadecanediol, benzyl 
alcohol) to restrict and control the nanoparticles’ size and shape during the synthesis 
process. From thorough investigations work by various researches (e.g. Hyeon’s, 
Sun’s and Cheon’s group) on decomposition process, the key ideas to obtain high 
degree of size, monodispersity, shape and uniformity controls relied on the (i) 
successful nucleation and growth process separation, (ii) controlled heating rate, (iii) 
surfactant nature and its amount, (iv) dwelling temperatures. [83, 111, 169-172]  
 
Figure 1 - 7: Schematic diagram of inorganic nanoparticles formation via thermal–
decomposition (‘heating up’) method and its corresponding supersaturation curve 
(LaMer diagram) against the heating time (adapted from [111, 172-174]). 
The basic model for nucleation and (delayed) growth process separation was 
proposed by LaMer and Dinegar (1950) and inherently has become the basis of the 
‘heating-up’ decomposition process mechanism. [172-174] As depicted in Figure 1-7, 
the ‘heating-up’ decomposition process can be separated into three major stages. In 
the first stage, the metal-organic precursors slowly decomposed into small monomers 
and the monomers quickly accumulated. For most synthesis, intermediate dwelling 
temperature (ca.140–200oC) was used to allow complete monomers formation from 
the metal-organic precursors. In stage two, burst nucleation occurred when monomers 
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increases beyond the critical supersaturation (nucleation threshold). Stage two 
happened within a short period of time and consumed majority of the monomers, 
suppressing possible nucleation in the later stage. In stage three, the nuclei formed in 
stage two simultaneously grow at similar growth rate. Size focusing also happened 
during the dwelling period and therefore monodisperse magnetic nanocrystals can be 
formed. In ‘hot-injection’ decomposition process, burst nucleation was achieved when 
the metal-organic precursors were injected at elevated temperature. For instance, Woo 
et al. and Hyeon et al. reported high temperature iron pentacarbonyl (Fe(CO)5) 
precursor injection to synthesized monodisperse γ-Fe2O3 and Fe3O4 nanoparticles 
without the need of size-sorting process [175-177] When mixture of dimanganese 
decacarbonyl (Mn2(CO)10) was combined with Fe(CO)5 precursor, manganese ferrite 
nanoparticles can be formed. [178] By varying the metal precursor to surfactant ratio, 
the nanoparticle sizes can be tuned accordingly. 
The ‘heating-up’ process involved simultaneous heating of the metal-organic 
precursors dispersed in the hydrophobic surfactant and non-polar solvent. This 
method offered a better heating rate control as well as more accurate control of 
surfactant/precursors ratio. A wider range of metal-organic precursors were also 
available. In 2002, Sun’s group investigated the formation of Fe3O4 SPM based on the 
thermal decomposition of iron acetylacetonate precursors. [179] The synthesis was 
then further developed to synthesize MFe2O4 ferrite nanoparticles (where M = Fe, Co 
and Mn). By changing the solvent (inherently varying the boiling point limit), the 
resultant nanoparticles’ sizes can be tuned conveniently. [180] Separately, Hyeon et 
al. devised a large scale Fe3O4 synthesis method in 2004 based on the decomposition 
of iron-oleate complex. [181] This method was later developed to accommodate 
various spinel ferrites MFe2O4 nanoparticles (where M = Fe, Ni, Co and Mn). [182] 
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Interestingly, ‘heating-up’ decomposition method was so versatile that later on, 
Hyeon’s group demonstrated one nanometer resolution growth control of the Fe3O4 
nanoparticles, simply by varying the iron-oleate precursors amount. [183] 
Different hydrophobic capping agent such as sodium oleate, decanoid acid and 
some other ligands, were also heavily investigated to produce magnetic nanoparticles 
with distinctive shapes. [183-191] For instance, Guardia et al. obtained cubic 
nanoparticles with the use of decanoid acid ligand. [65,184,186] Cubic nanoparticles 
can also be obtained with the use of sodium-oleate as surfactant to promote the 
growth of {111} plane. [190] Octahedral-shaped magnetic nanoparticles can also be 
obtained by modifying the synthesis formulation. [189] Besides morphological 
tuning, fine composition tuning beyond the exact stoichiometry ratio can be achieved 
by simply adjusting the mixed-metal precursors. This was later demonstrated by 
Cheon’s group to control the doped-ferrites SPM dopants amount. [154, 159, 162] 
Lastly, thermal decomposition can be extended for other types of metal oxides (MnO, 
MnO2, Mn3O4, Gd2O3) and other types of SPM (e.g. FePt, CoPt). [111, 192-195]. 
1.5 Current Review on Water Solubilization Techniques 
From section 1.4, organic-phase synthesis was beneficial because of the 
absence of water molecules (capable of binding strongly with metal-ions) which 
complicate the reaction and particle growth process. [78] The use of organic non-
polar solvent eliminated the metal-precursors/solvent interaction, resulting in a 
controlled synthesis condition. Both ‘hot-injection’ and ‘heating-up’  thermal 
decomposition methods in high boiling point solvent (with the presence of surface 
capping agent) were well-known to produce nanoparticles with extremely high 
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monodispersity with well define and controlled size, shape and composition. These 
methods therefore eliminate the need for post-synthetic size-sorting process.  
 
Figure 1 - 8: Water solubilization techniques. From top-left corner clockwise: (a) 
ligand exchange, (b) surface–ligand modification, (c) micelle formation, (d) 
polymeric encapsulation and (e) inorganic silica coating. 
In terms of surface chemistry, nanoparticles fabricated from the organic-phase 
decomposition process were highly unsuitable for biomedical applications due to their 
hydrophobicity (dispersible in various non-polar solvent: hexane, cyclohexane, 
toluene and chloroform). Despite the drawbacks, thermal decomposition method was 
still preferred to fabricate magnetic nanoparticles due to its excellent physical 
properties (compositional tuning) and crystallinity of the resultant nanoparticles that 
cannot be reproduced by any other synthesis process. Therefore, to prepare these 
nanoparticles for biomedical applications, appropriate post-synthetic surface 
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modification was required. This surface modification process engineers the 
nanoparticles surface to improve its hydrophilicity. Figure 1-8 summarized various 
approaches to render the aforementioned hydrophobic nanoparticles soluble in 
aqueous phase and at the same time improve its colloidal stability, biocompatibility 
and biofunctionalibity with small functional molecules or targeting ligand. [196] 
These major approaches include: (i) ligand exchange, (ii) ligand modification, (iii) 
micelle formation, (iv) polymer encapsulation and (v) inorganic silica coating. 
1.5.1 Ligand Exchange 
As depicted in Figure 1-8a, a simple ligand exchange method enables direct 
replacement of the hydrophobic ligand with another ligand bearing hydrophilic 
functional groups to render hydrophobic nanoparticles water soluble. For such 
purpose, phase transfer agent with high affinity towards the nanoparticles’ surface on 
one end and suitable hydrophilicity on the other end is required during ligand 
exchange to displace the existing ligands. There are few types of ligand exchange 
phase-transfer agents: (i) cationic surfactant, (ii) catechol and its derivatives and (iii) 
other small hydrophilic molecules. [197-208] Cationic surfactants including 
tetramethylammonium hydroxide (TMAOH) [197-198] and nitrosonium 
tetrafluoroborate (NOBF4) [199] have been used to quickly displace alkenoic ligands 
from nanoparticles’ surface. Inopportunely, the resultant hydrophilic nanoparticles 
were capped with negatively charged ions and thus not dispersible in ionic solution 
(e.g. PBS solution) due to the interaction with various positively charged metal ions. 
This interaction normally leaded to aggregation. Because of this, additional surface 
modification to improve the colloidal stability was still required. [198-199] Catechol-
based surfactant such as dopamine and its derivatives [200-205] and hydrophilic 
ligands bearing single functional group such as dimercaptosuccinic acid (DMSA) and 
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various alkanethiols or mercaptoalkanoic acids [205-208] were also demonstrated to 
successfully displace hydrophobic alkenoic ligands. Such hydrophilic ligands carried 
carboxylic acid (–COOH) which has good affinity towards the surface of iron oxide. 
Unfortunately, for other types of nanoparticles such as Au metallic nanoparticles or 
quantum dots, thiol (–SH) functional group has higher affinity towards the 
nanoparticles’ surface as compared to carboxylic acid. [207] In short, ligand exchange 
can only be applied to specific type of nanoparticles due to the agents’ surface 
specificity.In addition, the exchanged-ligand bonding to nanoparticles’ surface was 
often weak which increased the risk of detachment and aggregates formation. 
Regardless of the agents, ligand exchange process involves the nanoparticles’ surface 
which in some cases causes nanoparticles’ physical properties impairment. 
1.5.2 Ligand Modification 
Besides replacing the hydrophobic alkenoic ligands, direct surface chemical 
modification has also been employed to convert hydrophobic to hydrophilic ligand. 
During the process, the current hydrophobic ligand was not displaced but 
fragmentized, for examples through oxidation. Generally, hydrophobic synthesis 
requires the use of alkenoic acid ligands which bear unsaturated double bond (–
CH2=CH2–). Several post-treatment concepts adopted from various classical chemical 
reactions that involve alkenyl groups have been proposed to convert the hydrophobic 
nanocrystal to its hydrophilic analogue. One of the common examples was the use of 
Lemieux-von Rudloff reagent. [209] This reagent oxidized double bond on oleic acid 
onto hydrophilic azelaic acid which stabilized the nanoparticles in aqueous phase. 
[210-211] Moreover, strong oxidant such as ozone can be used to oxidatively cleaves 
the alkenyl functional groups (Figure 1-8b). [212] The products from this ozonolysis 
process were the carboxylic acid (from azelaic acid) and carbonyl (from 1-nonanal) 
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functional groups. Other strong oxidizing agents including potassium permanganate 
[213] and sodium periodate [214] have been used to achieve similar objective. 
Alternatively, hydrophobic ligand was not modified but underwent grafting 
process to introduce hydrophilic functional group. For instance, the alkenyl functional 
group from oleic acid can undergo epoxidation reaction by using peroxide reagents. 
[215] After epoxidation, epoxide functional group was grafted onto the oleic acid 
backbone. Amine-reactive epoxide group will form amide linkage through ring-
opening process when it is reacted with any amine-functional group. [216] Oleic-acid 
capped nanoparticles also can be reacted with yeast and glucose to convert oleic acid 
into hydrophilic sophorolipids. [217] Although interesting, these ligand modification 
techniques were not recommended due to the risk of damaging the nanoparticles’ 
physical properties after prolonged treatment with strong oxidizing agent. Moreover, 
lengthy reaction time and low reaction yield hindered such techniques to be useful for 
preparing large quantity of water-dispersible nanoparticles. [214] 
1.5.3 Micelle Formation 
Recent advances in surfactant technology allow the use of various amphiphilic 
surfactant molecules to render hydrophobic nanoparticles onto aqueous phase [218]. 
As illustrated in Figure 1-8c, the formation of interdigitated bilayer between the 
hydrophobic capping agent (nanoparticles) and the hydrophobic tail (amphiphilic 
surfactant) stabilizes the hydrophobic nanoparticles in aqueous phase. The polar 
segment of the bipolar surfactant improves the hydrophilicity of the nanoparticles. 
Meanwhile, the hydrophobic–hydrophobic interaction between the non-polar groups 
of the surfactant molecules helped to maintain the micelle integrity. Non-anionic 
bipolar surfactants, including amphiphilic block copolymers: pluronic F127 (PEO–
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PPO–PEO) [219-222] and polysaccharides: α-cyclodextrin [223-224], have been 
employed for water solubilization process. Likewise, anionic bipolar surfactants such 
as tetramethylammonium 11-aminoundecanoate [180], n-lauroyl sarcosine sodium 
(NLSS) [225] and cetyltrimethylammonium bromide (CTAB) [226-227] have been 
employed to stabilize hydrophobic nanoparticles in aqueous solution. The main 
drawbacks in forming micelle to stabilize hydrophobic nanoparticles were: (i) 
inavailability of the functional group for bio-functionalization (for non-anionic 
surfactant) and (ii) poor colloidal stability in physiological solution. In the case of 
anionic bipolar surfactant, the anionic polar head could interact with positively 
charged metal ions which normally leaded to aggregation. In short, further surface 
modification to improve the colloidal stability was still required. 
1.5.4 Polymeric Coating 
The use of polymeric materials, especially amphiphilic block and brush 
copolymers, has been investigated in the literatures for hydrophobic nanoparticles 
water solubilization purposes. [228] From Figure 1-8d, hydrophobic–hydrophobic 
interaction between the hydrophobic segments of the polymer coating and 
nanoparticles’ surfactant causes intercalation which locks and retains the 
nanoparticles inside the polymeric coating. In addition to the the steric repulsion that 
is provided by the polymeric backbone, the hydrophilic segment of the polymer 
backbone that contains various hydrophilic functional groups (e.g. carboxylic acid, 
amine or hydroxyl) also helps to stabilize the overall nanocomposite system by 
electrostatic repulsion. Ideally, water-dispersible polymer coated nanoparticles should 
have core/shell structure in its morphology. Because of the non-specific interaction, 
polymeric coating technique can be applicable to different hydrophobic nanoparticles 
systems obtained from thermal decomposition. This technique is also preferred as it 
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will not impair the physical properties of the nanoparticles. The colloidal and physical 
stability of the resultant nanoparticles in aqueous solution are also expected to be 
higher than the nanoparticles obtained from any other water-solubilization technique. 
The presence of functional groups on the polymeric shell allows the resultant 
hydrophilic nanoparticles to be conveniently functionalizable. In addition, the organic 
coating is also expected to be biocompatible. 
To date, many polymeric systems have been engineered for water-solubilizing 
and hosting hydrophobic nanoparticles. For examples, polyacrylic acid [229], poly (2-
hydroxyethyl aspartamide) graft copolymers [230], poly (acrylic acid) and 
polystyrene block copolymer [231], poly (isobutylene-alt-maleic anhydride) modified 
with alkylamine [232-233], poly (maleic anhydride-alt-1-tetradecene) [234], poly 
(maleic anhydride-alt-1-octadecene) or PMAO [235-237], poly (N-
isopropylacrylamide) modified PMAO [238-239], polyethylene glycol modified 
PMAO [240-243], poly(styrene-co-maleic anhydride) [244] and other types of 
amphiphilic polymers [245-251]. Overall, amphiphilic polymer containing amine-
reactive anhydride backbone is more preferred as it offers ease of functionalization 
[228]. [232-243] Although polymeric coating is considered as an ideal platform to 
water-solubilize hydrophobic nanoparticles, the nanoparticles’ spatial distribution on 
the polymer matrix can be hardly controlled. Without proper control, multiple 
encapsulations that are indicated by abrupt hydrodynamic size increment as well as 
size distribution broadening can occur. 
1.5.5 Inorganic Silica Coating 
Another type of coating using silica materials usually carried out through 
controlled sol-gel reaction (Stöber method) or reverse microemulsion technique to 
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render hydrophobic nanoparticles onto aqueous solution. [226-227, 252-256] Ideally, 
inert and amorphous silica shell encases the hydrophobic nanoparticles as illustrated 
in Figure 1-8e. Several silica precursors such as tetramethoxysilane [220] and 
tetraethylorthosilicate [226-227] were commonly used. The resultant core/shell 
structure gained its hydrophilicity due to the presence of hydrophilic functional group 
on silica surface (i.e. hydroxyls) which provided electrostatic repulsion. Together with 
the steric hindrance from the overall silica shell, silica coating was able to isolate 
individual nanoparticles. The functionalizability of silica coated nanoparticles also 
can be improved by further modification. For instance, reaction with 3-
aminopropyltriethoxysilane provides amine functional groups [227]. In most cases, 
silica coating required the nanoparticles to be hydrophobic surfactant-free for the thin 
layer of silane to be attached. Therefore, hydrophobic nanoparticles need to firstly 
undergo additional phase transfer step prior to silanization. Ligand exchange (e.g. 
with TMAOH) [257] and micelle formation (e.g. with CTAB) were commonly used 
in literatures. [227] Although it is advantageous that the nanoparticles’ spatial 
distribution can be controlled [252], formation of thin layer of silica coating can 
hardly be achieved. As a result, 10–50 nm thick silica shell was usually obtained 
which were disadvantageous for biomedical applications, compromising the physical 
properties of the encased nanoparticles. [258-259]. 
1.5.6 Other Coating 
The aforementioned approaches to water-solubilize hydrophobic nanocrystals 
were summarized briefly in Table 1-2, highlighting its advantages and disadvantages. 
Besides the extensive development of polymeric and inorganic silica coating, there 
were also some other approaches to water-solubilize and functionalize hydrophobic 
nanoparticles. One of the approaches was using noble metallic coating (e.g. Ag or 
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Au), forming a thin layer of inert and biocompatible shell on the hydrophobic 
nanoparticles’ surface. [260] Such noble metallic shell can be readily functionalized 
with hydrophilic surfactant bearing thiol functional group due to its high affinity 
towards the noble metal surface. [207] These approaches however, are beyond the 
scope of this thesis. 
Table 1 - 2: Summary of the advantages and disadvantages of commonly used surface 
modification techniques to water-solubilize hydrophobic nanocrystals. 
Approach Advantages Disadvantages 
Ligand 
Exchange 
- Direct method 
- Good to assess bare-particles properties 
- Functionalizable 
- Poor colloidal stability 
- Surface-sensitive 
- Impair physical properties 
Ligand 
Modification 
- Direct method 
- Functionalizable 
- Poor colloidal stability 
- Ligand-sensitive 
- Harsh reaction condition (oxidative) 
Micelle 
Formation 
- Direct method 
- Non-surface specific 





- Good colloidal stability 
- Non-surface specific 
- Biocompatible and functionalizable 
- Hard to obtain single encapsulation 






- Non-surface specific 
- Easy functionalizable 
- Thick silica coating layer 
- Hard to control coating thickness 
- Harsh reaction condition 
- Tedious process 
1.6 Bioconjugate Techniques 
Surface modification generally is not only limited to improving the 
hydrophilicity of the system but also includes bio-functionalization aspect. Due to the 
nano-size effect, nanoparticles with high surface-to-volume ratio offer a great 
potential to be decorated in order to reduce its surface energy. To improve 
biocompatibility and to enable higher specific targeting, various small biomolecules 
such as polyethylene glycol (PEG), protein and active targeting agent (e.g. folic acid) 
can be conjugated to the nanoparticles’ surface [261]. In general, there are various 
types of hydrophilic functional groups that can be presence on either the 
nanomaterials surface or biological molecules. These groups would then define the 
  - 31 - 
 
surface properties of the materials, such as solubility and reactivity. As illustrated in 
Figure 1-9a, these functional groups include: (i) primary amine (–NH2), (ii) carboxyls 
(–COOH), (iii) sulfhydryls (–SH), (iv) hydroxyls (–OH) and (v) carbonyls (–CHO).  
 
Figure 1 - 9: (a) Common functional groups. Examples on: (b) functional group 
conversion reaction and (c) crosslinking reaction involving two functional groups. 
Regardless of the water-solubilization approach used, in most cases, these 
functional groups can be easily converted to other types of functional groups. Of 
various conversion reactions, the reactions that involve amine- and carboxyl-
functional groups are important in biomedical field due to the abundance of these 
groups in naturally occurring biomolecules (e.g. DNA or protein). Figure 1-9b 
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illustrated the conversion of amine group to carboxylic functional group (using 
succinic/maleic anhydride) and vice versa (using di-amine linker). Other types of 
conversion include (i) glutaraldehyde (converting amine- to carbonyl groups) [263] or 
(ii) thiol-disulfide interaction (converting thiol- to other functional groups) [264].  
Meanwhile, the process of linking two or more molecules through covalent 
bond is commonly referred as crosslinking. If such crosslinking involves any proteins 
or biomolecules, it is often defined as bio-conjugation. Up to date, various versatile 
bio-conjugation techniques have been developed to cater the need for quick and 
efficient crosslinking process. [228] Few popular crosslinking agents such as Sulfo-
SMCC and EDC/NHS emerged due to the ease and specific chemical reaction. Sulfo-
SMCC is commonly used to bridge amine- to sulfhydryl-functional group due to the 
presence of maleimide-reactive group. The NHS-ester on Sulfo-SMCC end reacts 
with primary amine-functional group. Meanwhile, carbodiimide chemistry based on 
EDC/NHS is commonly used to bridge carboxylic acid with amine functional groups 
in hydrolytic environment. When non-polar solvent is used, EDC/NHS can be 
replaced by DCC/NHS. The resultant of the crosslinking is the formation of amide-
linkage. Since, biomolecules such as protein or DNA oftan contain both carboxyl and 
primary amine functional group, non-specific crosslinking between these 
biomolecules is inevitable. Hence, extra precaution needs to be exercised when 
choosing suitable crosslinking agents. Besides the two commonly used crosslinking 
agents, the amine-reactive functional group (e.g. epoxy, succinic anhydride and 
maleic anhydride) are also popular. The detailed chemical reactions are summarized 
in Figure 1-9c. These anhydrides are attractive due to its high reactivity to either 
water molecules or strong bases (e.g. sodium hydroxide) to form loose carboxylic 
acids or hydroxyls group [265] as well as its high reactivity towards primary amine to 
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form amide linkage [266-268]. In addition, several specific binding chemistries such 
as avidin-biotin [269] and gold-thiol [207] were also popular for bio-conjugation. A 
more detailed explanation can be found from ‘Bioconjugate Technique’ book and the 
comprehensive review of functionalization techniques [196, 262]. 
1.7 Motivation and Objectives 
1.7.1 Project Motivation and Design 
For advanced biomedical research area, especially for cancer diagnostic and 
therapeutic applications, magnetic nanomaterials offered most promising functional 
properties as compared to other types of inorganic nanomaterials. In the past few 
decades, there has been a growing of interest in developing magnetic nanomaterials, 
for biology and medicine. [270] Below are the requirements in designing suitable 
magnetic nanoparticles for biomedical application: 
1. High quality nanoparticles with excellent physical properties 
(high crystallinity and superparamagnetic with high MS value) 
2. Controllable size and morphology with monodisperse size distribution 
3. Hydrophilic with good colloidal stability (pH, temperature, ionic solution) 
4. Suitable biocompatibility (low cytotoxicity) 
5. Biofunctionalizable (availability of surface functional group) 
If the requirements are fulfilled, the potential and performance of the synthesized 
magnetic nanoparticles can be well utilized. To fulfill the first two pre-requisites, it is 
essential to have facile synthetic route to yield high quality magnetic nanoparticles 
with good physical properties and excellent monodispersity. In section 1.4.2, 
hydrolytic bottom up synthesis through co-precipitation, hydrothermal and polyol 
route as well as non-hydrolytic route through thermal decomposition method have 
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been elaborated. The inherent problems of the hydrolytic synthesis such as low 
quality nanocrystals, lack of size morphology control, broad size distribution and 
uncontrolled aggregation limits its use in biomedical field. Various essential 
biomedical applications of magnetic nanoparticles (e.g. MRI, magnetic hyperthermia, 
bioseparation, advanced cellular control and etc) require the nanoparticles not only to 
be well suspended in aqueous solvent, but also to have better magnetic properties. 
[35-70] Poor magnetic properties from hydrolytic synthetic route, will lead to poor 
physical performance. High crystallinity, uniform size distribution, superior physical 
and magnetic properties, controllable size and morphology can only be achieved by 
‘heating-up’ thermal decomposition process in non-polar solvent. Such synthetic 
method has become an active research field after various research groups (Hyeon’s, 
Sun’s, Alivisatos’s, and Peng’s group) pioneered its development. [83, 111] 
 
Figure 1 - 10: Nanomaterials development process flow for biomedical field. The red 
dotted-line box indicated the development area to be investigated in this thesis. 
Figure 1-10 summarized common nanomaterials development process flow. 
Because thermal decomposition yields hydrophobic nanocrystals capped with various 
hydrophobic ligand, additional step involving water-solubilization of the hydrophobic 
nanoparticles has becoming active research field in the past decades. In lieu with this 
need, the solubility is not limited to only water, but also simulated physiological 
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solution, such as phosphate buffer saline solution. In terms of stability, the obtained 
water soluble magnetic ferrofluids must also be chemically and colloidally stable 
without significant aggregation, even in harsh condition such as extreme pH. These 
magnetic nanoparticles also have to be biocompatible, possessing negligible 
cytotoxicity effect against surrounding cells/tissues. Lastly, the availability of 
hydrophilic and conjugable functional groups is essential as a platform for further 
functionalization with small biomolecules or other biocompatible agents.  
From the literature survey of the water solubilization techniques (section 1.5), 
ideally, water-solubilization technique that results in water dispersible nanocompsites 
with high degree of hydrodynamic size control, compact structure, high colloidal 
stability, good biocompatibility and easy functionalization is favored. Inter-particle 
aggregation must therefore be minimized either by electrostatic or steric repulsion. 
Ligand exchange, ligand modification and micelle formation are direct methods to 
obtain water-dispersible nanocrystals at the expenses of the colloidal and physical 
properties. Polymeric and inorganic silica encapsulation offer better colloidal and 
chemical stability while compromising the overall hydrodynamic size. As there are 
many types of hydrophobic nanoparticles that can be synthesized and terminated by 
alkyl-chains ligand [14-34], a robust and general platform to water-solubilize is 
necessitated. Due to its non-surface specific characteristic, organic polymeric and 
inorganic silica coating provide a universal route to obtain water-dispersible 
nanoparticles. These methods were demonstrated to be able to control the 
hydrophobic nanoparticles’ spatial distribution in the coating matrix and therefore the 
magnetic properties and performance of the nanocomposites can be tuned. [271] It is 
also important to highlight that the separation of nanoparticles’ synthesis and water-
solubilization process gives higher degree of the resultant nanostructures control. 
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Unfortunately, to date, it still remains a challenge to develop water-solubilization 
technique to fulfill all the aforementioned requirements. With the purpose to develop 
universal pathway to water-solubilize hydrophobic nanoparticles (obtained from 
thermolysis process) onto aqueous solution with proper hydrodynamic size control 
and without compromising their integrity and physical properties, three major 
strategies will be considered in this thesis: 
1. Incorporating non-destructive ligand modification technique 
Despite the drawbacks, the idea of direct surface chemical modification to convert 
hydrophobic to hydrophilic ligand was promising only if the physical properties of 
nanoparticles was not compromised. Hence, developing a new non-destructive 
ligand modification method to be synergistically coupled with thermolysis process 
will be advantageous. This will eliminate tedious post-synthetic water-
solubilization process that compromised the nanoparticles’ physical properties. 
2. Optimizing amphiphilic polymeric coating method 
Amphiphilic polymer provides biocompatible and low toxicity characteristic as 
surface coating agent when it interacts with biological systems [272]. Thinner 
polymeric coating layer is also more beneficial as compared to silica coating. The 
current challenges of using polymeric coating in preparing water-dispersible 
magnetic nanoparticles are: (i) the hydrodynamic size optimization and (ii) the 
hydrophobic nanoparticles’ loading control onto the polymer matrix. By 
addressing these challenges, universal polymeric coating method can be beneficial 
for biomedical applications. 
3. Development of new water-solubilization method 
In addition to the conventional amphiphilic polymer, one-atom thick organic 
materials graphene oxide (GO) nanosheets can be potentially used for water-
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solubilizing hydrophobic nanoparticle. Because of the oxidizing chemical 
synthetic route, GO fundamentally is regarded as the thinnest surfactant, 
possessing segregated hydrophobic and hydrophilic regions [273]. The GO 
hydrophilicity was due to the oxygen-containing functional group such as –
COOH, –OH on the edges and epoxide on the basal plane. The hydrophobicity of 
GO was due to the presence of alkenyl group (–CH2=CH2–) and carbon-carbon 
bonds (6-member carbon ring). The presence of numerous hydrophilic functional 
groups enable GO to be highly water soluble with various bio-functionalization 
possibility. Due to its surfactant-like behavior [274], GO are potentially explored 
as a new phase-transfer host, replacing the commonly used polymeric host. 
1.7.2 Objectives 
This thesis aims specifically to investigate various water solubilization 
strategies, specially developed and tailored to water solubilize hydrophobic alkyl 
terminated nanoparticles obtained from the ‘heating-up’ thermal decomposition 
method. Although the demonstration will focus on magnetic nanoparticles, the 
techniques are intended to be applicable universally to various types of inorganic 
nanoparticles. For the resultant water-dispersible nanocrystals, the physical properties 
as well as its biomedical properties will be investigated (e.g. MRI, MFH and cellular 
imaging demonstration). The research objectives are outlined as follows: 
 To directly synthesize monodisperse hydrophilic magnetic nanocrystals with 
comparable properties to the commonly synthesized hydrophobic nanocrystals 
from thermal decomposition. 
 To synthesize high quality and monodisperse hydrophobic magnetic nanocrystals 
with excellent magnetic properties (high MS value). 
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 To synthesize different types of amphiphilic brush co-polymers as the coating 
materials to host and water-solubilize the hydrophobic nanocrystals 
 To synthesize amphiphilic graphene oxide as the coating materials to host and 
water-solubilize the hydrophobic nanocrystals 
 To obtain proper control over the hydrodynamic size of the water-dispersible 
nanocomposites regardless of the water-solubilization techniques 
 To investigate on the magnetic properties and biocompatibility of the obtained 
water-dispersible nanocomposites 
 To assess the obtained water-dispersible nanocomposites for various in-vitro 
demonstrations, e.g. cellular imaging, MRI and MFH. 
1.7.3 Thesis Outline 
Based on the outlined objectives, the thesis will be organized in the following 
manner. Chapter 3 investigates in-situ chemical modification of oleic acid with maleic 
anhydride during the thermolysis process to directly obtain high quality hydrophilic 
nanoparticles. Chapter 4 describes the use of amphiphilic brush copolymers poly 
(isobutylene-alt-maleic anhydride) grafted with 1-dodecylamine as surface coating 
and its optimization to obtain monodisperse dispersion of hydrophobic nanocrystals in 
aqueous solution. Chapter 5 focuses on the use of polyethylene glycol (PEG) grafted 
poly (maleic anhydride-alt-1-octadecene) amphiphilic brush copolymers to form 
water soluble nanocomposites based on the controlled collective aggregation of 
several hydrophobic nanoparticles. Chapter 6 explores the use of amphiphilic 
oleylamine-modified nano-graphene oxide as a universal tool to host hydrophobic 
nanoparticles. Lastly, in Chapter 7, the summary of various water solubilization 
techniques, characterizations and the key findings from various in-vitro testings as 
well as several recommendations for future work will be provided.  
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Chapter 2. Methods and Materials Characterization 
 
2.1 Summary 
Materials synthesis methods will be described separately in the corresponding 
individual chapters. Below is the list of the equipments and tools used to investigate 
structural and physical properties of the synthesized samples: 
Table 2 - 1: Summary of characterization techniques 
Characterization Equipment Model/Supplier 
Structural Characterization 
Atomic Force Microscopy (AFM) Veeco NanoScope IV 
Dynamic Light Scattering (DLS) Malvern Zetasizer Nano-ZS 
Energy Dispersive X-Ray Spectroscopy (EDX) Oxford-Instruments 
Fourier Transform Infrared Spectroscopy (FTIR) Varian 3100 FT-IR 
Indutively Coupled Plasma/Optical Emission 
Spectroscopy (ICP-OES) 
PerkinElmer Dualview Optima 
5300 DV ICP-OES system 
1H- Nuclear Magnetic Resonance Spectroscopy  
(1H-NMR) 
Bruker NMR Spectrometer 
Scanning Electron Microscope (SEM) Zeiss Supra 40 FESEM 
Thermogravimetric Analysis (TGA) New Castle SDT Q600 
Transmission Electron Microscope (TEM) JEOL 2010 and JEOL 3010 
X-Ray Photon Spectroscopy (XPS) Kratos AXIS Ultra DLD 
X-Ray Diffractometry (XRD) Bruker D8 Advance 
Physical Properties Characterization 
Vibrating Sample Magnetometry (VSM) LakeShore Model 7407 
Magnetic Relaxivity (MR) Measurement 
9.4T (Varian,Agilent) and 7T (Bruker Clinscan) 
MRI Scanner 
Magnetic Hyperthermia 
RF generator (Easyheat-5060, Ameritherm) and 
Optical fiber probe (Fluotep Series FTP-LN2). 
Cellular Imaging Demonstration 
Fluorescence Confocal Microscopy (CLSM) 
Olympus Ix2–DSU Disk Scanning Confocal 
Microscopy 
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2.2 Structural Characterization 
2.2.1  Atomic Force Microscopy (AFM) 
AFM was performed for various high resolution surface topography 
characterization in the nanometer-resolution. The AFM images in this thesis were 
obtained by using Veeco NanoScope IV Multi-Mode AFM, operated with tapping 
mode. The AFM sample was prepared by spin-coating process of the sample solution 
in water (diluted) onto Si-substrate, followed by air-drying for few hours. Large 
aggregates must be avoided to prevent damage to the AFM cantilever tip. [1] 
2.2.2 Dynamic Light Scattering Spectrometry (DLS) 
All hydrodynamic size measurement for either hydrophobic nanoparticles in 
CHCl3 or hydrophilic nanocomposites in water, sodium hydroxide and PBS 1x were 
carried out by using Malvern Zetasizer Nano-ZS (Worcestershire, UK) equipped with 
633nm He-Ne laser light source.  The nanoparticles/nanocomposites samples were 
dispersed in its respective medium (volume: 1 mL) and added onto the Kartell
®
 
disposable capillary cuvettes (10mm, 4 clear faces, PMMA). 
2.2.3 Energy Dispersive X-Ray Spectroscopy (EDX) 
Energy dispersive X-ray spectroscopy (EDX) equipment from INCA, Oxford 
Instruments, attached to the transmission electron microscope, was used to analyze 
the elemental composition of the functional inorganic nanoparticles sample. 
2.2.4  Fourier Transform Infrared Spectroscopy (FTIR) 
The FT-IR spectra of the various powder samples were recorded on Varian 
3100 FT-IR spectrophotometer (Excalibur Series, USA). The FT-IR samples were 
prepared by grinding the sample of interest with KBr and casting the mixture into 
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pellets. The sample chamber was purged for 10 minutes with dried air in order to 
remove excess moisture that interferes with the FT-IR spectra. The measurement was 
performed at room temperature with spectral range of 400 to 4000cm
-1 
(64 scans). 
2.2.5 Indutively Coupled Plasma/Optical Emission Spectroscopy (ICP-OES) 
The elemental analysis (for Fe and Mn elements) was performed with 
PerkinElmer Dualview Optima 5300 DV ICP-OES system. The sample for the 
analysis was prepared by mixing 0.1–0.5 mL of nanoparticles samples in water with 
1–2 mL of concentrated HCl (10M) to dissolve the nanoparticles. The resultant 
dispersion of metal ions in water was diluted to 10 mL before the elemental analysis. 
2.2.6 
1
H- Nuclear Magnetic Resonance Spectroscopy (
1
H-NMR) 
Proton NMR or 
1
H-NMR was performed either with Bruker DPX300 NMR 
(300MHz), Bruker DPX400NMR (400MHz), or Bruker AV500 (500MHz) 
spectrometer (Bruker, MA). The chemical shifts were analyzed by referencing to the 
respective solvent peaks (δ = 7.24 ppm for CDCl3 and δ = 4.8 ppm for D2O). 
2.2.7 Scanning Electron Microscopy (SEM) 
Field emission scanning electron microscope Zeiss Supra 40 FESEM was used 
for the morphological characterization of the synthesized samples. SEM sample was 
simply prepared by dripping the sample solution onto silicon substrate. To improve 
the conductivity, a thin gold layer (ca. 1–5nm) was sputtered onto the samples. The 
working distance was below 8mm and the acceleration voltage used was 5 kV. [2] 
2.2.8 Thermogravimetric Analysis (TGA) 
Thermogravimetric analysis (TGA) was performed by using New Castle SDT 
Q600. During the experiment, the sample was equilibrated at 100
o
C for 10 minutes to 
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 followed by air cooling to room temperature. The heating was conducted 
under inert atmosphere of Nitrogen (N2) gas flow (100 mL.min
-1
). The samples used 
for TGA analysis usually were in dry powder forms (2–10 mg). For hydrophobic 
samples, conventional oven drying was used to prepare the powder samples. For 
hydrophilic samples, freeze-drying was used to recover the powder samples. 
2.2.9 Transmission Electron Microscopy (TEM) 
The samples size, shape and morphological characterization were probed by 
transmission electron microscope (TEM). The TEM and high resolution TEM images 
were recorded by using either JEOL 2010 (at 200 kV) or JEOL 3010F (300 kV). The 
TEM sample was prepared simply dripping one drop of the sample solution (usually 
dispersed in ethanol/water for hydrophilic samples and dispersed in hexane or CHCl3 
for hydrophobic samples) onto carbon-coated TEM copper grid. The sample was then 
dried at room temperature overnight. During the analysis, selected area diffraction 
(SAED) pattern of the crystalline inorganic sample was also recorded. [2-3] 
2.2.10 X-Ray Photon Spectroscopy (XPS) 
The X-ray photoelectron spectroscopy (XPS) spectra were taken by using an 
Axis Ultra DLD X-ray photoelectron spectrophotometer equipped with an Al Kα X-
ray source (1486.69 eV). The energy step size of the XPS was 1000.0 meV for the 
survey scans and 100.0 meV for the fine scans. The substraction of the Shirley 
background, composition analysis as well as deconvolution of the XPS peaks were 
carried out by Casa XPS (2.3.14 version). The XPS spectra deconvoluted peak of sp
2
 
hybridized carbon was calibrated at 284.6 eV. For the chemical bonding analysis, 
dried samples (freeze-dried) in powder form of around 1–2 mg was used. [4] 
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2.2.11 X-Ray Diffractometry (XRD) 
The crystalline phase of various functional inorganic nanoparticle samples 
were characterized by using X-ray powder diffractions obtained from Bruker AXS D8 
Advance Diffractometer System (Germany). [5] During the experiment, Cu Kα 
(1.5418 Ǻ) source was used. The XRD sample was prepared simply dripping few 
drops of concentrated sample solution (dispersed in ethanol or water for hydrophilic 
samples and dispersed in hexane or chloroform for hydrophobic samples) onto glass 
substrate (1cm x 1cm). The sample was then dried either at room temperature 
overnight or using drying oven at elevated 70
o
C for few minutes. The nanoparticles 
average crystallite sizes were determined by using Scherrer equation: [6-7] 
t = 0.9λ/(Bcosθ)    …(5) 
where t is the crystallite average size, λ is the x-ray source wavelength (1.5418Ǻ) and 
B is the full width half-maximum of the most intense diffraction peak.  
2.3 Physical Properties Characterization 
2.3.1 Vibrating Sample Magnetometry (VSM) 
The magnetic properties of the magnetic nanoparticles presented in this thesis, 
regardless of its hydrophilicity, were analyzed by LakeShore Model 7407 
(Westerville, OH) vibrating sample magnetometer (VSM). The hysteresis loop and 
the magnetic moments of the samples were measured at room temperature. For the 
measurement, approximately ~3–8 mg of magnetic samples was weighted in 1cm x 
1cm non-magnetic aluminum foil. The foil was then folded into 3mm x 3mm size. 
The sample was placed in between two electromagnets. The sample was first 
magnetized by uniform magnetic field and subsequently vibrated sinusoidally. The 
basic measurement relies on the sample oscillation near the detection coil whereby the 
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voltage induced due to the magnetic flux change will generate signals. The voltage 
signal picked-up by the detection coil was proportional to the sample’s magnetic 
moment and independent on the applied field. The continuous measurement by 
changing the applied field results in the hysteresis loop of the sample of interest. 
Typically, up to 20 kOe applied field was used during the measurement at room 
temperature. The loaded magnetic sample was initially ramped to 20kOe magnetic 
field and then cycled to –20kOe and finally back to 20kOe again to obtain a full cycle 
of hysteresis loop. Calibration was performed before each magnetic measurement. [8] 
2.3.2 Magnetic Relaxivity (MR) Measurement 
 
Figure 2 - 1: Illustration of Bruker Clinscan 7T scanner. 
The longitudinal relaxation time T1 and transverse relaxation time T2 of water 
soluble magnetic samples at different iron concentrations was measured using either 
Varian (Agilent Inc, USA) 9.4T MRI Scanner with birdcage coil or Clinscan (Bruker) 
7T MRI scanner with shim coil (Figure 2-1). The measurement was conducted at 
room temperature. The T2-weighted images were obtained by a multi-echo spin-echo 
pulse sequence (6 echoes; TE: 9.1 – 160ms, TR: 1600ms). Finally, the T2 relaxation 
rate of the samples was computed using MATLAB v7.1 (Mathwork Inc, USA) by 
non-linear least squares fitting of an exponential function. The r1 and r2 relaxivity 
values were calculated using the linear regression analysis (Microsoft Excel) between 
relaxation rates and molar iron concentrations. [9-13] 
  - 57 - 
 
2.3.3 Magnetic Fluid Hyperthermia: Induction Heating 
 
Figure 2 - 2: Schematic diagram of induction heating experiment. 
The heating capability of water-soluble magnetic samples represented by the 
specific absorption rate (SAR values) were assessed by using RF generator (Easyheat-
5060, 4.2 – 10 kW) with a computer-attached optical fiber based temperature probe 





) in 15 mL centrifuge tube was positioned into the middle of 
the copper coil (see Figure 2-2). The time-dependent calorimetric measurements of 
each magnetic sample were performed to obtain the temperature changes against the 
AMF exposure duration. [14] The amplitude used during the experiment varied from 
41.98 – 59.99 kA.m-1, the frequency was 240 kHz with measurement time up to 900 








    …(6) 
where C is specific heat of the medium (Cwater = 4.18 J.g
-1o
C
-1), ΔT/Δt is the initial 
slope of the time-dependent temperature curve (in our calculation, ΔT/Δt was 
computed from the first 100 seconds data) and mFe+Mn is the weight fraction of the 
magnetic element (i.e. Fe and Mn) in the sample. 
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2.4 Cell Cytotoxicity and Cellular Labelling 
2.4.1 Cell Cytotoxocity Assay 
CCK-8 (cell counting kit-8) assays were carried out to evaluate the cell 
viability in the presence of the samples. NIH/3T3 fibroblast cells or MCF-7 breast 
cancer cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) culture 
growth medium supplemented with either 10% BCS (bovine calf serum) for NIH/3T3 
cells or 10% FCS (fetal calf serum) for MCF-7 cells. The cells were placed at 
incubator set to 37
o
C with 5% CO2 humidified environment. Prior to the viability test, 
the cells were trypsinized, washed (by centrifugation) and re-suspended back into the 
growth medium (DMEM with 10% BCS or FCS). The cell stock solution 




. 0.1 mL of NIH/3T3 or MCF-7 cells 
stock solutions were seeded into the 96-well cell culture plate (TPP-96), 
approximately 7500 cells per well. The cells were allowed to grow for 12 hours (or 
overnight) at 37
o
C (5% CO2 environment). Subsequently, 20 µL of sample with 
various iron concentrations were added into the growth medium. Following the 
sample addition, the mixture of cells/samples was incubated further at 37
o
C (5% CO2 
environment) for another 24 hours. For the cell viability, CCK-8 (10 µL) was added 
to each well, followed by another 4 hours incubation. Absorbance readings were 
analyzed spectrophotometrically at 450 nm using FluoStar Optima microplate reader. 
2.4.2 Fluorescence Confocal Microscopy 





were initially seeded into an 8-well plate (0.4 mL per well) and incubated at 37
o
C in a 
5% CO2 environment for 24 hours. The final concentration was 1.0 x 10
4
 cells per 
well. Subsequently the fluoresceinamine-tagged PIMA-g-C12 coated MFNPs sample 
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or A-MFNPs sample (10μL; approximately 0.5 mM Fe) was injected into each well 
and the incubated for another 24 hours. The NIH/3T3 cell samples were then washed 
by using DMEM/10% BCS to remove excess particles. This process was repeated 3 
times carefully in order not to detach the cells. The NIH/3T3 cells were then observed 
using Olympus Ix2-DSU disk scanning confocal microscope. 
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Chapter 3. Synthesis of Hydrophilic Nanocrystals Using 
Succinic Anhydride-functionalized Alkenoic Ligands 
 
3.1 Introduction 
From Chapter 1 section 1.4.2, there have been many strategies developed to 
synthesize and water solubilize hydrophobic functional inorganic nanocyrstals. A 
great interest has been devoted to directly synthesizing hydrophilic functional 
nanocrystals through the thermal decomposition of metal–organics precursors in polar 
solvents such as ethylene glycol (and its derivatives), poly (vinyl alcohol) and 
polypyrollidone. [1-3] In most cases, such solvents also acted as surface capping 
agents. These approaches resulted in hydrophilic nanocrystals without proper size and 
morphological control, as well as the inavailability of surface functional groups. 
Hence such nanocrystals were unsuitable biomedical applications and required 
additional surface modification process. From literatures, several noteworthy attempts 
have also been developed to fabricate amphibious nanocrystals (i.e. soluble in both 
non-polar and aqueous solvents), ranging from the use of dendron ligands to the use 
of amphiphilic surfactants. [4-8] These synthetic routes also share similar problems to 
those encountered by the thermolysis in polar solvent routes. To date, thermal 
decomposition of metal-organic precursors in a non-polar solvent in the presence of 
hydrophobic ligands has been demonstrated as the most promising approach to 
achieve the desired size and shape control with suitable physical properties. [9-19] 
Oleic acid (OA), the most commonly used hydrophobic ligand for 
synthesizing functional nanocrystals through thermolysis in non-polar solvent [9-19], 
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belongs to the mono-unsaturated fatty acid group which contains alkenyl (–
CH2=CH2–) functional group. Based on the roles of the alkenoic acid ligand, several 
post-treatment concepts adopted from various classical chemical reactions involving 
alkenyl functional groups have been proposed to convert the hydrophobic nanocrystal 
to its hydrophilic analogue. These methods include the direct oxidative cutting or 
fragmentation of the alkenyl functional group using Lemieux-von Rudloff [20-22], 
potassium permanganate [23], sodium periodate [24] or ozonization [25] reagents as 
well as the grafting process such as epoxidation of the alkenyl functional groups using 
perbenzoic acid reagents [26-27]. The direct oxidative method oxidizes double bond 
on oleic acid ligands onto hydrophilic azelaic acid which then stabilized the 
nanoparticles in aqueous phase. Meanwhile, epoxidation results in the formation of 
epoxide, an amine-reactive functional group. All these post-synthetic processes 
usually involve very harsh reaction conditions and long reaction times which 
compromised the physical properties of the functional inorganic nanocrystals. In 
addition, these methods were often reported with low nanocrystals yield. [22] 
 
Figure 3 - 1: Oleic acid maleinization reaction and its corresponding succinic 
anhydride hydrolysis to yield its hydrophilic analogue.  
Up until now, it still remains a challenge to synthesize high quality water 
dispersible nanocrystals which can be successfully used in various biomedical and 
bionanotechnology applications. A versatile and efficient approach to synthesize high 
quality water dispersible nanocrystals without jeopardizing their inherent physical 
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properties is highly demanded. To address this challenge, a well-established 
maleinization process involving the grafting of maleic anhydride onto the 
hydrophobic ligands bearing alkenyl functional groups (e.g. unsaturated oleic acid 
hydrophobic capping agents) to yield succinic anhydride functional groups was 
considered. [28-37] More importantly, the maleinized oleic acid (MOA) can be 
readily converted to its hydrophilic analogue (hydrolyzed MOA or hMOA) once the 
anhydride rings have been hydrolyzed into their corresponding acids upon mild 
hydrolysis with sodium hydroxide or warm water. The illustration of the oleic acid 
maleinization reaction and its hydrolysis process were presented in Figure 1-1. 
 
Figure 3 - 2: Oleic acid maleinization (200–220oC, 3–5 hours): (a) allylic addition 
and (b) ene-reaction to yield succinic anhydride functionalized alkenoic ligands. 
Adopted from Ref [28, 37]. 
The schematic diagram in Figure 3-2 depicted the classical unsaturated fatty 
acid maleinization reaction. The reaction was adopted from the well-documented 
procedures of synthesizing alkenyl succinic anhydride (ASA) that were often used in 
industry (i.e. for paper sizing agents and cutting fluids lubricants). [28,30,31,33] For 
mono-unsaturated fatty acid such as oleic acid, 1–3 times maleic anhydride to oleic 
acid molar ratio are recommended to obtain high yield of maleinized oleic acid 
adducts. [35] Typical oleic acid maleinization reaction was carried out under inert 
static N2 gas condition without the presence of any solvent or catalyst. There were 
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several reported reaction conditions whereby xylenes solvent [30] and transition metal 
catalyst [32] were used to improve the maleinization reaction yield. In this chapter, 
the presence of solvent and catalyst were not considered to avoid any complication to 
the overall synthesis reactions. Even though the maleinization of oleic acid reaction 
and its subsequent application have been widely reported, there was inadequate 
information regarding the exact reaction mechanism. As illustrated in Figure 3-2, 
currently there are two commonly proposed reaction pathways which can possibly 
occur during the maleinization process, namely: (1) ene-reaction and (2) the addition 
reaction in allylic position.  Both reaction mechanisms favor the attachment of 
succinic anhydride functional groups on either side of the alkenyl functional groups. 
[28,37] Regardless of the reaction pathway, all MOA product should bear succinic 
anhydride functional groups and therefore it can be dispersed into aqueous phase once 
hydrolyzed. To avoid confusion, succinic anhydride terminology will be used to 
denote the maleic anhydride functional groups grafted onto oleic acid. 
Based on this chemistry, herein, a new mechanism for synthesizing high 
quality water dispersible functional nanocrystals was proposed. The maleinization 
process, which is carried out at 210
o
C, can be directly combined with the typical 
nanocrystals synthesis process. As illustrated in Figure 3-3, nanocrystals capped with 
oleic acid are initially synthesized via a well-established thermolysis route at elevated 
temperature. When the reaction solution is naturally cooled to 210
o
C, maleic 
anhydride precursors is injected, forming adducts with the oleic acid capping agents 
which has already been attached onto the nanocrystals’ surface. The resulting MOA-
capped nanocrystals are still hydrophobic in nature due to the presence of 
hydrophobic succinic anhydride functional groups and alkane/alkene chain. A simple 
hydrolysis treatment of these succinic anhydride functionalized nanocrystals with 
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dilute NaOH solution is expected to render the nanocrystals hydrophilic and to be 
soluble in aqueous solvent through the anhydride ring opening process. 
 
Figure 3 - 3: Hydrophobic nanocrystals synthesis, incorporating in-situ maleinization 
process and its subsequent hydrolysis process to yield water dispersible nanocrystals. 
There are few advantages of this proposed strategy: (1) the monodisperse and 
high quality nanocrystalline characteristics of the well-established thermolysis process 
in non-polar solvents can be retained; (2) the nanocrystals can be directly dispersed 
into an aqueous phase through a simple hydrolysis treatment, minimizing the need for 
any cumbersome post-synthetic phase transfer or surface modification processes; (3) 
the maleinization of oleic acid is carried out without any harsh oxidative reaction 
conditions, as compared to the previously mentioned oleic acid post-treatment 
modifications (Chapter 1 section 1.5.2). Therefore, the physical properties, as well as 
the morphology of the nanocrystals will not be compromised; (4) lastly, a simple 
hydrolysis would yield carboxylic acid functional groups which provide good anchors 
for further bio-functionalization of these water-dispersible nanocrystals. 
To demonstrate this strategy, magnetite (Fe3O4) nanocrystals were synthesized 
through the thermal decomposition of iron carboxylate salts [13], coupled with in-situ 
maleinization process. The experimental data made it evident that the synergistic 
coupling process had little adverse effect on the size, morphology and crystallinity as 
well as the physical properties of the synthesized nanocrystals. Further investigation 
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revealed that the magnetite nanocrystals coated with such unique functional ligands 
(hMOA) were low intoxicity and inherently biocompatible. A simple MR relaxivity 
assessment revealed that hMIONPs sample was promising as MRI T2 contrast agent. 
This strategy is also readily extendable to other functional inorganic nanocrystal 
system. 
3.2 Experimental Procedures 
3.2.1 Materials 
Iron (III) oxide (FeOOH, 30 – 50 mesh), 1-octadecene (technical grade, 90%), 
1,10-phenanthroline (≥99.0%), hydroxylamine hydrochloride (99.0%), oleic acid 
(OA, ≥99.0%), maleic anhydride (≥99.0%), ammonium iron (II) sulphate hexahydrate 
(Mohr’s salt, ≥99%) were obtained from Sigma Aldrich. Sodium hydroxide (NaOH, 
97%) was obtained from Resource. Chloroform (CHCl3, 99.99%) and hexane (99.0%) 
were used as received. Minisart
®
 0.22µm syringe filter was used as purchased. Except 
for FeOOH, all chemicals were used directly without any further purification. FeOOH 
were ground into finer powder for the nanocrystal synthesis. Cell counting kit-8 
(CCK-8) was purchased from Dojindo Molecular Technologies, Inc. 
3.2.2 Synthesis of Hydrophobic IONPs 
Typical spherical iron oxide nanocrystals (magnetite, Fe3O4) were synthesized 
through the iron carboxylate salts (iron (III) oleate) thermal decomposition procedures 
reported by Colvin et al. [13] To synthesize monodisperse spherical oleic-acid capped 
nanocrystals (IONPs), dried FeOOH fine powder (8 mmol, 0.712 g) was mixed with 
oleic acid (32 mmol, 9.04 g) and 1-octadecene (20 g) in a three neck round bottom 
flask equipped with a magnetic stirrer, thermocouple and heating mantle. The reaction 
flask was purged under N2 gas flow for 30 minutes prior to the reaction to remove the 
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presence of air. The mixture was subsequently heated up to 180
o
C for 1 hour. The 
temperature was then increased to 320
o
C and held isothermally for 1 hour. The 
solution was cooled down to room temperature and IONPs were purified by a series 
of precipitation/dispersion using a mixture of hexane/isopropanol. The final product 
was dispersed in CHCl3 (~50 mg.mL
-1
) and the black ferrofluid was stored at 4
o
C. 
3.2.3 Synthesis of Hydrophobic MIONPs 
To synthesize maleinized oleic acid capped iron oxide nanoparticles 
(MIONPs), FeOOH fine powder (8 mmol, 0.712 g) was mixed with oleic acid (32 
mmol, 9.04 g) and 1-octadecene (20 g) in a three neck round bottom flask equipped 
with a magnetic stirrer, thermocouple and heating mantle. The reaction flask was 
purged under N2 gas flow for 30 minutes prior to the reaction. The mixture was 
subsequently heated up to 180
o
C for 1 hour. The solution temperature was then 
increased to 320
o
C and held isothermally for 1 hour. The black solution was cooled 
down to 210
o
C and maleic anhydride (64 mmol, 6.28 g) was injected to the mixture. 
The mixture was allowed further held isothermally for 3 hours at 210
o
C to allow the 
maleinization reaction to occur under static N2 environment. Finally, the solution was 
cooled down to room temperature and MIONPs was purified by a series of 
precipitation/dispersion using a mixture of hexane/isopropanol. The final product was 
dispersed in CHCl3 (~50 mg.mL
-1
) and the black ferrofluid was stored at 4
o
C.  
3.2.4 Hydrolysis of MIONPs into hMIONPs 
To disperse MIONPs nanoparticles into aqueous solution, MIONPs in 
chloroform was simply precipitated by the addition of isopropanol and extracted with 
centrifugation (8000 rpm, 10 minutes). To this dry precipitate, dilute sodium 
hydroxide (0.1 M) was added in order to hydrolyze the succinic anhydride functional. 
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The resulting mixture was sonicated in an ultrasonic bath for 10-15 minutes at 60
o
C. 
To obtain a better dispersion and to ensure that all succinic anhydride is fully 
hydrolyzed, the sonication time can be extended to 30-60 minutes. Finally, the 
resulting water dispersible nanoparticles (hMIONPs) were purified through 
precipitation by methanol, centrifugation and subsequent re-dispersion into water. The 
hMIONPs aqueous solution was filtered by using 0.22 µm syringe filter to remove 
large aggregates (from the secondary reaction of maleinization, e.g. copolymerization, 
oligomerization and polymerization). [29-30]  
3.2.5 Iron Content Determination (ICD) 
To quantify the hMIONPs stock solution iron concentration, 1,10-
phenanthroline colorimetric method was employed instead of inductively coupled 
plasma mass spectrometry (ICP-MS) measurements. [38]  
3.2.7 Materials Preparation for Characterization 
The IONPs and MIONPs XRD samples were simply air-dried on a glass 
substrate, while the hMIONPs XRD sample was oven-dried for 3 days. To prepare 
VSM samples, IONPs sample was washed few times using a mixture of 
hexane/isopropanol, while MIONPs sample was washed once using a mixture of 
hexane/isopropanol before drying (to avoid the loss of the MOA surfactant needed for 
the water solubilization process). For the hMIONPs sample, the sample was washed a 
few times using a mixture of water and methanol before drying in an oven for 3 days. 
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3.3 Results and Discussions 
3.3.1 Oleic Acid Maleinization Reaction 
In order to assess the potential of the conversion of the hydrophobic ligand 
adduct to its hydrophilic analogue (Figure 3-1), the maleinization of alkenyl 
functional group in oleic acid ligands was investigated. In brief, maleic anhydride was 
simply reacted with oleic acid at 210
o
C for 4 hours (solvent-less) under a static inert 
nitrogen environment. The resultant maleinized oleic acid was highly soluble in non-
polar solvent and insoluble in polar solvent. When treated with diluted sodium 
hydroxide (0.1M), the maleinized oleic acid was successfully dispersed in water. 
Besides bases, warm water was also effectively used to accelerate the hydrolysis of 
the succinic anhydride functional rings to two carboxylic acids functional groups. The 





H-NMR spectra (and its chemical structures) was given in 
Figure 1-1. The chemical shifts were analyzed with reference to the solvent CDCl3 
peak (δ = 7.27 ppm). All the main hydrogen proton peaks were successfully identified 
against their corresponding predicted peaks (the chemical shift estimation was done 
by ChemBioOffice 2008). According to literature, there was limited information on 
the exact location of succinic anhydride functional group after grafting on MOA 
adducts was unknown. Overall, there were 4 different possible configurations 
involving alkenyl functional groups and the adjacent succinic anhydride functional 
groups (few carbons away). The presence of the alkenyl functional group (–HC=CH–
) was simply indicated from the characteristic resonance peak at δ = 5.25 – 5.35 ppm 
for all three samples (pure OA, MOA and hMOA). The succinic anhydride functional 
group that appeared after the maleinization process was indicated by the characteristic 
resonance at δ = 3.05 – 3.15 ppm (–R–O–C(=O)–CH2–CH–). The hydrolysis of the 
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succinic anhydride functional group caused the chemical shifts of the ester hydrogen 
proton to disappear. The remaining characteristic peaks such as allylic protons (–
HC=CH–CH2–), vinylic protons (–HC=CH–) and the acids from carboxylic acids of 
the main fatty acid chain (–CH2–CH2–COOH) were at similar position for OA, MOA 
and hMOA samples which indicated that the chemical structure of unsaturated fatty 
acid was still intact after the maleinization and hydrolysis process.  
 
Figure 3 - 4: Oleic acid maleinization at 200–220oC for 3–5 hours at inert condition: 
(a) allylic addition and (b) ene-reaction to yield succinic anhydride functionalized 
alkenoic ligands. 
The success of the maleinization reaction was further evaluated by considering 
the integrated proton signal intensity of the OA, MOA and hMOA 
1
H-NMR signal. 
Since the integrated intensity is proportional to the number of protons that contribute 
to the signal, such information can be used to compare the relative amount of the 
presence of certain carbon on the structure. In the case of maleinization, such 
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comparison was particularly useful especially for the chemical shift at 1.96 ppm (peak 
label: ‘d’). This chemical shift was due to the protons of the carbons adjacent to the 
alkenyl functional groups where the succinic anhydride was predicted to be grafted. 
The proton signal from ‘d’ carbon (1.96ppm) was normalized against the integrated 
intensity of the proton signals from the ‘a’ carbon (2.30 ppm) of each respective 1H-
NMR spectrum, since both ‘a’ and ‘d’ carbon carry one proton each. The normalized 
integrated intensity of the proton signals from ‘d’ carbon (at 1.96 ppm) were 
calculated to be 1.72, 0.99 and 0.97 for OA, MOA and hMOA respectively. Since the 
normalized intensity of the ‘d’ proton signals from MOA and hMOA was around 50% 
of the ‘d’ proton signals from OA, it can be postulated that approximately ~50% of 
the ‘d’ carbon protons had disappeared. This indicated that the maleinization reaction 
has occurred (incomplete) and the maleic anhydride was very likely to be grafted with 
one of the ‘d’ carbons leaving the other side of alkenyl functional groups remained 
pristine. However, the information on the exact location/preferred position where the 
grafting occurred can’t be obtained precisely. 




Chemical Shift ‘a’ 
(2.30 ppm) 
Chemical Shift ‘d’ 
(1.96 ppm) 
Ratio of maleinized OA 
over OA  ‘d’ carbon 
OA 1.00 1.72 - 
MOA 1.00 0.99 56.25% 
hMOA 1.00 0.97 55.11% 
The chemical shifts for pure oleic acid (OA).
1
H-NMR (400 MHz, CDCl3) δ: 5.25–5.5 (–HC=CH–), 
2.25–2.5 (–CH2–COOH), 1.9–2.25 (–HC=CH–CH2–CH2–), 1.57–1.8 (–CH2–CH2–COOH), 1.2–1.55 
(–CH2–CH2–), 0.8–1.05 (–CH2–CH3). 
The chemical shifts for maleinized oleic acid (MOA).
1
H-NMR (400 MHz, CDCl3) δ: 5.25–5.35 (–
HC=CH–),3.05–3.15 (–O–C(=O)–CH2–CH–) 2.5–3.0 (–O–C(=O)–CH2–CH–), 2.15–2.45 (–CH2–
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COOH), 1.9–2.05 (–HC=CH–CH2–CH2–), 1.5–1.75 (–CH2–CH2–COOH), 1.1–1.5 (–CH2–CH2–), 0.8–
1.0 (–CH2–CH3). 
The chemical shifts for hydrolyzed MOA (hMOA).
1
H-NMR (400 MHz, CDCl3) δ: 5.25–5.3 (–HC=CH–
), 2.55–2.85 (HOOC–CH2–CH–COOH), 2.2–2.4 (–CH2–COOH), 1.85–2.05 (–HC=CH–CH2–CH2–), 
1.5–1.7 (–CH2–CH2–COOH), 1.1–1.5 (–CH2–CH2–), 0.8–0.95 (–CH2–CH3). 
3.3.2 Synthesis of Hydrophobic IONPs and MIONPs Nanocrystals 
 
Figure 3 - 5: TEM images of (a) IONPs and (b) MIONPs dispersed in CHCl3 (insets: 
graphical illustrations of the respective hydrophobic ligand-capped nanocrystals). 
HRTEM images of (c) IONPs and (d) MIONPs) (insets, clockwise: SAED patterns of 
both IONPs and MIONPs and digital photograph showing the dispersion of IONPs 
and MIONPs in CHCl3). 
Iron oxide (magnetite, Fe3O4) synthesized through the thermolysis of iron 
carboxylate salt precursors process was coupled with in–situ maleinization process 
and the resultant as-synthesized nanocrystals were stabilized by maleinized oleic acid 
ligands (MIONPs). Prior to hydrolysis, MIONPs were highly dispersible in non-polar 
solvent due to the nature of hydrophobic oleic acid ligand with long carbon chain. In a 
control experiment, hydrophobic oleic acid capped magnetite nanocrystals were 
synthesized under exactly similar conditions without the maleinization process 
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(IONPs). From Figure 1–2, the TEM images suggested that there was no significant 
size difference between IONPs and MIONPs samples dispersed in CHCl3. The 
isothermal maleinization reaction at 210
o
C for 3 hours apparently has no substantial 
effect on the overall resultant nanocrystals morphology and its size distribution. 
The HRTEM images of the IONPs and MIONPs (Figure 1–2 c,d) revealed the 
crystallinity of the nanocrystal samples. The calculated lattice fringe distances of 
approximately 2.94 Ǻ for IO Ps and 2.97 Ǻ for MFNPs corresponded closely to the 
magnetite (220) lattice plane d-spacing. The SAED patterns of IONPs and MIONPs 
clearly showed identical diffraction rings of (220), (311), (400), (511) and (440) 
lattice planes respectively which indicated the presence of magnetite (insets of Figure 
1–2 a,b). The digital photographs of IONPs and MIONPs showed that both samples 
were well-dispersed and stable up to more than 8 months in room temperature in non-
polar solvent CHCl3. 
3.3.3 Hydrolysis of MIONPs onto hMIONPs 
To obtain the hydrophilic counterpart of MIONPs, the hydrophobic MIONPs 
dispersed in CHCl3 were recovered by centrifugation and re-dispersed into warm 
sodium hydroxide solution (~60
o
C, 0.1M). With the aid of ultrasonic sonication bath 
(10-15 minutes), hydrophobic MOA ligand was then converted in its hydrophilic 
counterpart, hMOA. The modified ligands would stabilize nanocrystals in aqueous 
solution through both steric and electrostatic repulsions. Figure 3-6a,b showed the 
TEM and HRTEM image of MIONPs after hydrolysis (denoted as hMIONPs). From 
the TEM analysis, hMIONPs were observed to be well-dispersed without significant 
aggregation. As compared with the original hydrophobic MIONPs there was no 
significant individual size, morphology and size distribution changes. This was 
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reflected from the TEM size distributions (calculated from approximately 150 – 200 
nanocparticles, given in Figure 3-7) whereby the average diameters for IONPs (14.2 
± 1.5 nm), MIONPs (12.6 ± 1.3 nm) and hMIONPs (12.7 ± 1.6 nm) were quite close 
with each other. The average diameters indicated that the succinic anhydride rings 
opening process during the hydrolysis did not have any significant influence on the 
individual size and observable size distribution.  
 
Figure 3 - 6: (a) TEM image of hMIONPs after hydrolysis (inset: graphical 
illustration of hMIONPs). (b) HRTEM image of hMIONPs (insets: the SAED pattern 
and digital photograph showing the dispersion of hMIONPs in water). (c) 
Hydrodynamic size distribution of hMIONPs. (d) Colloidal stability of water 
dispersible hMIONPs even after prolonged exposure to magnetic field. 
To further study the size distribution of the nanocrystals, the hydrodynamic 
size of the hMIONPs in Millipore
®
 water was measured by DLS experiments. From 
Figure 3-6c, the average hydrodynamic size of hMIONPs was measured to be 38.8 ± 
2.1 nm. There was no secondary peak, typically ascribed to the presence of 
undesirable aggregates, observed from the size distribution plot. The increase of 
hydrodynamic size as compared to the TEM average size could be attributed to two 
reasons: (i) since the DLS measurements carried out in water, the presence of 
extended hydrophilic carboxylic acid functional group would increase the hMIONPs 
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hydrodynamic size and (ii) ‘dimerization’ or ‘trimerization’ of the nanocrystals 
occurred due to secondary reaction of maleinization at elevated temperature. Both 
conditions would cause the widening of DLS size distribution and the increase in 
hydrodynamic size. The secondary reaction that would occur as a result from 
maleinization reaction were inclusive of enophile polymerization, alkenyl functional 
group oligomerization, copolymerization of enophile with alkene as well as the 
thermal decomposition of MOA adducts. [29-30] Based on the TEM average size and 
DLS hydrodynamic size as well as taking into account the oleic acid length, the 
aggregation number was estimated to be 6–15 nanoparticles per aggregate. 
 
Figure 3 - 7: Nanoparticles size distributions of: (a) IONPs, (b) MIONPs and (c) 
hMIONPs calculated from the statistical analysis of the low resolution TEM images. 
In a separate attempt, maleinizaiton and thermolysis combinatorial process 
was optimized by adjusting the maleinization reaction time to obtain appropriate 
condition. Basically, three different maleinization reaction durations were employed: 
2 hours, 3 hours and 4.5 hours. The TEM of the as-synthesized MIONPs and after 
hydrolysis were given in Figure 3-8. From TEM analysis, prolonged reaction time 
has no significant effect on individual MIONPs crystal size, but large aggregates or 
nanoclusters was observed due to severe side reactions of maleinization. Due to 
aggregations, the MIONPs synthesized with 4.5 hours reaction time precipitated 
quickly (< 30 minutes) after hydrolysis and were unable to be stabilized in water. On 
the other hand, when maleinization reaction was kept short at 2 hours, no aggregation 
was observed from hydrophobic MIONPs dispersed in CHCl3. Due to the short 
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maleinization time, the grafting yield of succinic anhydride functional groups onto 
OA was insufficient to stabilize the MIONPs in water after hydrolysis due to lack of 
hydrophilic functional groups. From the comparison, the intermediate reaction time (3 
hours) was the optimal condition as it maximized the maleinization yield while 
preventing side reactions from occurring severely. 
 
Figure 3 - 8: TEM images of MIONPs in CHCl3 synthesized under different 
maleinization reaction time: (a) 2hours, (b) 3 hours and (c) 4.5 hours at 210
o
C (inert 
atmosphere). The corresponding hMIONPs in water from the hydrolysis of MIONPs 
synthesized at different maleinization time: (d) 2 hours, (e) 3 hours and (f) 4.5 hours. 
The inset in Figure 3-6b demonstrated that hMIONps were dispersed well in 
water phase (not in CHCl3 phase) and there was a clear separation between the CHCl3 
– water interphase. After hydrolysis, hMIONPs was unable to be re-dispersed back 
into CHCl3. As illustrated in Figure 3-9, this phenomenon was attributed to the need 
of maximizing the distance between the two carboxylic acids formed during the 
anhydride hydrolysis which would cause the rearrangement of the chain conformation 
that hid the hydrophobic segments of the hMOA ligands. Dispersing back hMIONPs 
into a non-polar solvent would simply imply a rearrangement of the hMOA chain 
conformation which is thermodynamically unfavourable. 
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Figure 3 - 9: Possible chemical structures of MOA and hydrolyzed MOA. 
As shown in Figure 3-6c, only after prolonged and continuous exposure to 
magnetic field, hMIONPs was fully attracted by magnet. A gentle shake to this 
precipitate would immediately re-disperse the nanocrystals back to its original 
condition without any significant precipitate residue. Overall, hMIONPs sample 
exhibited high colloidal stability in aqueous phase that was comparable with the 
colloidal stability of amphiphilic brush copolymers-stabilized nanocrystals. [39-40]  
 
Figure 3 - 10: Schematic diagram illustrating the steric repulsion between hMIONPs. 
Besides water, hMIONPs sample was also stable in PBS 1x (pH 7.4) solution. 
Unlike the nanocrystals stabilized by pure electrostatic charges (e.g. 
tetramethylammonium hydroxide or hexadecyl-trimethylammonium bromide coated 
nanocrystals) that would precipitate upon the addition of PBS solution, hMIONPs 
were unaffected by the presence of the ionic solution. [41] Such stability was 
attributed to the presence of the carboxylic acid functional group which not only 
provided electrostatic repulsion but also steric repulsion stabilization (see Figure 3-10 
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illustration). The stability hMIONPs in water and PBS 1x were excellent for more 
than 6 months under ambient conditions (Figure 3-11). 
 As a control experiment, IONPs were also dispersed into NaOH solution with 
the aid of ultrasonic bath sonication for more than 15 hours at 60
o
C. Regardless of the 
amount of NaOH and concentration used, no dispersion of IONPs into aqueous phase 
was observed. The presence of succinic anhydride and the subsequent conversion to 
the hydrophilic succinic acid analogue through ring opening process was indeed 
critical for stabilizing IONPs in aqueous phase. 
 
Figure 3 - 11: Colloidal stability of hMIONPs. Digital photograph showing the 
dispersion of hMIONPs in (a) water and (b) PBS 1x, both with and without the 
presence of magnetic field (1 day incubation). (c) Digital photograph showing the 
same samples in water and PBS 1x, taken after 3 months storage at room temperature. 
3.3.4 FT-IR Analysis of IONPs, MIONPs and hMIONPs 
To verify the grafting of succinic anhydride functional group onto oleic acid as 
well as the anhydride ring opening process, FT-IR spectroscopy was performed on 
IONPs, MIONPs and hMIONPs dried powder samples. In Figure 3-12, the presence 
of succinic anhydride functional groups was indicated by two characteristic peaks at 
1777 cm
-1
 and 1857 cm
-1
 that corresponded to the symmetric and asymmetric 
stretching vibrations of the C=O bonds from anhydride. The esters C=O stretching 
peak at 1719 cm
-1
 and the anhydrides C–O stretching vibration at 1202 cm-1 were also 
presence. After hydrolysis, these succinic anhydride rings opened up and the 
characteristic peaks of anhydrides diminished. Instead, a new peak at 1707 cm
-1
 from 
C=O stretching and at 1372 cm
-1
 from C–O stretching vibrations of carboxylic acids 
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were observed. The O–H stretch of carboxylic acid was indistinguishable from the C–
H stretch in the range of 2400-3400 cm
-1
 (data is not shown).  
 
Figure 3 - 12: FT-IR spectra of (a) IONPs, (b) MIONPs and (c) hMIONPs samples. 
3.3.5 Structural and Magnetic Properties Characterizations of IONPs, 
MIONPs and hMIONPs 
In addition to the SAED results presented earlier, the crystalline phase of 
IONPs, MIONPs and hMIONPs were analyzed using XRD. The XRD patterns given 
in Figure 3-13 showed that all peaks for the three samples were indexed against the 
crystalline phase of magnetite (Fe3O4; JCPDS 65-3107, dotted line). The XRD 
patterns indicated that there was no drastic change in the relative peak intensity and 
the peak locations, confirming that the coupling of maleinization reaction to 
thermolysis synthetic route had no significant effect on the nanocrystals phase.  
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Figure 3 - 13: X-Ray diffraction patterns of IONPs, MIONPs and hMIONPs. The 
dotted line refers to the Fe3O4 reference peak (JCPDS PDF 65-3107). 
The magnetic properties of the magnetite nanocrystals IONPs, MIONPs and 
hMIONPs were also measured to investigate the influence of coupling of 
maleinization reaction towards the physical properties of nanocrystals. The saturation 
magnetization (MS) value of IONPs, MIONPs and hMIONPs were analyzed by VSM 
experiment at room temperature (~300K). As shown in Figure 3-14a, the as-







 respectively.  
To take into account the surfactant effects, TGA was performed to determine 
the relative amount of organic surfactants on Fe3O4 surface. The relative inorganic 
Fe3O4 percentage was 77.85%, 45.06% and 64.96% for IONPs, MIONPs and 
hMIONPs samples respectively. As MIONPs has more than 50% organic coating, the 
low MS value was attributed to the presence of excessive surface coating. After 
normalization with the actual Fe3O4 weight percentage, the normalized MS values 




 and 67.73 emu.g
-1
 respectively. The 
magnitude of the normalized MIONPs and hMIONPs MS value were about the same 
and comparable to each other, suggesting the hydrolysis process to convert the 
hydrophobic MIONPs sample into water dispersible hMIONPs did not affect the 
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nanocrystals’ physical properties considerably. In addition, the actual MIO Ps MS 
value was also increase significantly as compared to the IONPs. Such increment was 
ascribed to the prolonged maleinization reaction time which enhanced the 
nanocrystals’ crystallinity. 
 
Figure 3 - 14: (a) As-measured IONPs, MIONPs and hMIONPs hysteresis loop 
profiles at 300K. (b) Heating profiles of IONPs, MIONPs and hMIONPs samples. (c) 
Normalized IONPs, MIONPs and hMIONPs hysteresis loop profiles (against the 
actual Fe3O4 weight percentage). (d) Summary table of the original MS values, Fe3O4 
weight fraction and the normalized MS values of IONPs, MIONPs and hMIONPs. 
3.3.6 In-vitro Cytotoxicity Assay of hMIONPs on NIH/3T3 Cells 
For hMIONPs to be useful for various biomedical application, e.g. magnetic 
hyperthermia agents or MR contrast agent, aqueous solubility is not the sole 
determining factor. The cytotoxicity of the nanocrystals and their constituents, e.g. 
surface coating/capping agents were also critical. To assess the potential cytotoxicity 
of the hydrophilic functional ligands, in-vitro cell viability tests on NIH/3T3 
fibroblast cells was performed. NIH/3T3 cells were incubated with hMIONPs samples 
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at various iron concentrations for 24 hours, The number of viable cells were then 
analyzed by using CCK-8 assay (based on the dehydrogenases of living cells activity), 
From Figure 3-15, the cell viability results indicted that hMIONPs did not induce any 
significant cytotoxicity effects up in nanocrystals’ concentration range of 6.37 µg.mL-
1
 (0.08 mM Fe) to 1.22 µg.mL
-1
 (15.86 mM Fe). The observations under microscope 
showed that even at high iron concentration, the NIH/3T3 cell growth was not 
interrupted. Overall, the good colloidal stability and low cytotoxicity of hMIONPs 
renders the obtained nanocrystals to be very promising for biomedical applications. 
Furthermore, the hydrolysis of MOA ligands into hMOA would inherently yield 
unbound carboxylic acid functional groups which were suitable as a good anchor for 
further bio-functionalization. 
 
Figure 3 - 15: In-vitro cell viability assay of NIH/3T3 fibroblast cells incubated with 
various iron concentrations of hMIONPs for 24 hours prior to the measurement. The 
NIH/3T3 cells counting were done through CCK-8 assay. 
3.3.7 MR Relaxivity of hMIONPs 
 Due to the presence of superparamagnetic core IONPs, hMIONPs were 
potentially useful as MR contrast agents. To assess this, the MR relaxivity of 
hMIONPs sample with different iron concentrations was measured at room 
temperature. Figure 3-16a showed the concentration dependent 1/T1 and 1/T2 plots of 
hMIONPs. From the plot, the calculated r2 and r1 values of hMIONPs sample were 










 respectively. The r2 value of hMIONPs 
was much higher than any commercial and clinically approved T2 MR imaging 












) [42] The 
overall relaxivity r2/r1 ratio of hMIONPs sample was 1814.9 (with r2/r1 >> 10), 
making it a suitable T2 MR imaging contrast agent. With merely 0.115 mM iron 
concentration hMIONPs samples, high relaxivity value of 62.82 s
-1
 can be achieved. 
The MR T2-weighted phantom images were given in Figure 3-16b. However, the 
concentration-dependent T2 darkening effect was not clearly observed since at very 
low 0.115 mM the darkening effect was very prominent as compared to the control 
sample (water). As mentioned earlier, it is possible for dimerization or trimerization to 
occur during the MIONPs synthesis process. The unintended mild aggregation 
between hMIONPs enhanced the localized perturbation by the magnetic field which 
caused faster relaxivity, hence higher r2 value. 
 
Figure 3 - 16: (a) Plot of T1 and T2 relaxation rate (1/T1 and 1/T2) against the iron 
concentrations of hMIONPs sample in water. (b) T2-weighted MR images of 
hMIONPs sample in water and its relaxation rate at various iron concentrations. 
3.3.8 Other Nanocrystals System 
The strategy for synthesizing water dispersible nanocrystals was potentially 
applicable and extendable to other functional nanocrystals system whereby 
unsaturated fatty acids are generally required during synthesis process. These 
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nanocrystals system includes (i) various metal ferrites (MFe2O4 where M = Fe, Co, 
Ni, Mn and etc), (ii) zinc oxide (ZnO), (iii) manganese oxide (MnO and Mn2O3), (iv) 
semiconductor quantum dots (e.g. CuInS2, CdSe, CdTe) as well as (v) upconversion 
nanocrystals (e.g. NaYF4:Yb, Er). [9-19, 43-46]  
3.4 Summary 
In summary, an efficient and simple strategy to synthesize water dispersible 
nanocrystals was demonstrated. Fe3O4 system was chosen to study and establish the 
combination between in-situ oleic acid maleinization reaction with high temperature 
thermolysis synthesis in non-polar solvent. Through this process, well-defined 
nanocrystals capped with MOA ligands were obtained. A simple hydrolysis process 
would allow the conversion of hydrophobic MOA ligands conversion onto its 
hydrophilic analogue hMOA which would stabilize the nanocrystals system in 
aqueous phase. hMOA-stabilized Fe3O4 nanocrystals were found to exhibit high 
colloidal stability in both water and PBS 1x solution. In addition, the cell viability test 
with NIH/3T3 fibroblast cells highlighted that hMOA-capped Fe3O4 nanocrystals 
exhibited suitable biocompatibility up to 15.86 mM iron concentration. In a simple 
MR relaxivity test, hMOA-stabilized Fe3O4 nanocrystals with its high colloidal 







making it suitable as MR T2 contrast agent. Lastly, the overall strategy to synthesize 
water-dispersible nanocrytals was extendable to other functional nanocrystals system 
where unsaturated fatty acids were employed as surface capping agent. 
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Chapter 4. Synthesis of Hydrophilic and Monodisperse 
Superparamagnetic Nanoparticles Capped with Amphiphilic 
Brush Copolymers  
 
4.1 Introduction 
 As highlighted in Chapter 1, section 1.5, it has been well recognized that the 
single encapsulation of hydrophobic nanoparticles with amphiphilic polymers is the 
most reliable pathway to achieve water soluble nanoparticles with good colloidal 
stability and suitable biocompatibility. [1-2] For example, Parak et al. employed 
amphiphilic poly (isobutylene-alt-maleic anhydride) grafted with dodecyl (C12) brush 
copolymers to encapsulate various hydrophobic nanoparticles systems. [3] Moreover, 
similar amphiphilic brush copolymers such as poly (maleic anhydride-alt-1-
tetradecene) and poly (maleic anhydride-alt-1-octadecene) were also demonstrated to 
have such similar capabilities. [4-6] With such amphiphilic brush copolymers, 
increments of 75% to 250% in hydrodynamic size were reported previously. Apart 
from the brush copolymers, amphiphilic block copolymers such as pluronic F127 
(PEO-PPO-PEO) were also proposed to encapsulate and water solubilize hydrophobic 
nanoparticles. A significant hydrodynamic size increment over 200% was reported 
when F127 was used as the surface coating. [7] These different types of amphiphilic 
polymers succeeded in phase-transferring hydrophobic nanoparticles on aqueous 
solvent. Some of these results were tabulated in Table 4-1. The hydrophobic–
hydrophobic interaction between the hydrophobic segments of the polymer coating 
and the nanoparticles surfactant caused intercalation which retained the hydrophobic 
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nanoparticles inside the polymeric coating. Meanwhile, the hydrophilic segment of 
the polymer backbone helped to stabilize the overall nanocomposite system.  
Table 4 - 1: Summary of the previously reported phase transfer protocols using 
amphiphilic polymers and its reported hydrodynamic size. 
System Coatings
a






Oleic Acid CHCl3 7.6 ± 1.8 -  
PMAT (C14) Borate Buffer 13.6 ± 1.6 78.95% [6] 
PMAO (C18) Borate Buffer 15.8 ± 2.2 107.89% 
 
ϒ-Fe2O3 
Oleic Acid CHCl3 9.2 ± 0.6 - 
 
PMAT (C14) Borate Buffer 17.9 ± 0.3 94.57% [6] 
PMAO (C18) Borate Buffer 19.7 ± 0.3 114.13% 
 
ϒ-Fe2O3 
Oleic Acid CHCl3 12.9 ± 0.8 - 
 
PMAT (C14) Borate Buffer 22.5 ± 0.1 74.42% [6] 








PBS 1x 13.4 ± 3.4 ~82.67% [8] 
PSMA/Polyetheramine 
M-1000 
PBS 1x 17.8 ± 4.3 ~137.33%  
PMAO/Ethanolamine PBS 1x 24.5 ± 8.2 ~250.00%  
Green 
CdSe/ZnS 
TOPO CHCl3 5.7 ± 0.5 - 
 
PMAT (C14) Water 19.2 ± 2.0 236.84% [5] 
Red 
CdSe/ZnS 
TOPO CHCl3 11.6 ± 2.8 -  
PMAT (C14) Water 23.6± 2.0 103.45%  
Fe3O4 
Oleic Acid CHCl3 ~8nm (TEM) - 
 
PMAO (C18) Water 43.7 446.25% [9] 







TOPO CHCl3 5.8 to 8.4 - 
 
PMAO-g-PEG 
(PEG mw 700) 
Water 24.0 185.71% 
 
PMAO-g-PEG 
(PEG mw 2000) 
Water 28.5 239.29% [10] 
PMAO-g-PEG 
(PEG mw 6000) 
Water 38.7 360.71%  
PMAO-g-PEG 
(PEG mw 9900) 
Water 42.1 401.19%  
PMAO-g-PEG 
(PEG mw 19300) 
Water 45.9 446.43%  
Fe3O4 
Oleic Acid CHCl3 ~21.6 (TEM) - 
 
PMAO (C18) Water 34.0 57.41% [11] 
PMAO-g-PEG Water 39.8 – 69.3 84.26 - 220.83% 
 
Fe3O4 
Oleic Acid - ~10 (TEM) -  
Oleic Acid - ~13 (DLS) - [7] 
F127 Water ~36 (DLS) ~276.92%  
a 
TOPO: trioctylphosphine oxide; PMAT: poly (maleic anhydride-alt-1-tetradecene); PSMA: poly (styrene-co-maleic anhydride) 
or poly (styrene-alt-maleic anhydride); PMAO: poly (maleic anhydride-alt-1-octadecene); PEG: polyethylene glycol.  
b
 As reported by DLS for water soluble nanocrystals or as reported by TEM for hydrophobic nanocrystals. 
c
 Calculated against the hydrophobic nanocrystals average size obtained from TEM or DLS experiment. 
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In general, the abrupt increase in the average nanocrystals hydrodynamic size 
after polymer encapsulation (as compared to their original hydrophobic counterparts 
in non-polar solvent) was a common problem in obtaining the water soluble 
nanoparticles using amphiphilic polymeric coating. There were many others reported 
phase transfer of hydrophobic nanoparticles using amphiphilic polymers into aqueous 
phase which did not disclose the hydrodynamic diameter size of the resultant water-
dispersible nanocrystals. [12-18] Therefore such results were not included in Table 4-
1. Ideally, water-dispersible polymer coated nanoparticles should have core/shell 
structure morphology. The significant increases in the hydrodynamic size indicated 
multiple nanoparticles encapsulation. Such collective coatings without proper control 
are deemed to be undesirable in biomedical applications, especially in nanomedicine 
as it disrupts the benefit of nanostructured nanocrystals. [19] In order to achieve 
successful biomedical applications, the overall hydrodynamic size of the magnetic 
nanocrystals must be minimized, especially during water solubilization process.  
In this chapter, SPM such as magnetite and manganese-doped ferrite 
nanocrystals, were synthesized via a thermal decomposition method in non-polar 
solvent (e.g. benzyl ether and 1-octadecene) in the presence of oleic acid as surface 
capping agent. The water solubilization of such hydrophobic nanocrystals was carried 
out by employing amphiphilic brush copolymers, dodecyl grafted poly (isobutylene-
alt-maleic anhydride) or PIMA-g-C12. The focus of this chapter is to optimize the 
processing parameters that lead to the monodiperse phase transfer of hydrophobic 
nanocrystals with PIMA-g-C12, in order to minimize the size increase after water 
solubilization. PIMA-g-C12 coated magnetic nanocrystals were also reported with 
good colloidal stability in various conditions and exhibited excellent in-vitro 
biocompatibility with both NIH/3T3 fibroblast and MCF-7 breast cancer cells.  In 
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addition, PIMA-g-C12 can be tagged with fluorescence dye such as fluoresceinamine 
during the polymer synthesis process. The fluoresceinamine-tagged PIMA-g-C12 
coated WIONPs and WMFNPs will be investigated for its cellular uptake and imaging 
demonstration. Lastly, these nanoparticles will also be analyzed for its MR T2 
relaxivity. 
4.2  Experimental Procedures 
4.2.1 Materials 
Poly (isobutylene-alt-maleic anhydride) (PIMA; MW 6000; 85%), 1-
dodecylamine (C12; 98%), manganese (II) acetylacetonate (Mn(acac)2), iron (III) 
oxide (FeOOH, 30-50 mesh), benzyl ether (99%), tetrahydrofuran (THF; 99.9%), 1-
octadecene (90%), 1,10-phenanthroline (≥99.0%) and hydroxylamine hydrochloride 
(99.0%) were purchased from Sigma Aldrich. Iron (III) acetylacetonate (Fe(acac)3; 
97%), oleic acid (≥99%) and ammonium iron (II) sulphate hexahydrate (Mohr’s Salt; 
≥99%) were purchased from Fluka. Chloroform (CHCl3; 99.99%), hexane (99.9%), 
sodium hydroxide pellets (97.0%) and 0.22µm syringe filter (Minisart
®
) were used as 
received. Millipore
®
 water used for dialysis as well as nanoparticles dispersion was 
filtered using the 0.22µm syringe filter prior to the experiment. Standard RC dialysis 
tubing Spectra/Por2 (MWCO: 12-14 kDa) was purchased from SpectrumLabs and 
stored at 4
o
C. Iron (III) oxide was ground (ball-milled) into fine powder as the 
precursor for the nanocrystals synthesis. For cell experiment, Cell Counting Kit-8 
(CCK-8; Dojindo) was obtained from Dojindo Molecular Technologies, Inc. 
4.2.2 Synthesis of Magnetite Fe3O4 Nanoparticles (IONPs) 
Spherical and monodisperse magnetite nanoparticles (Fe3O4; ~10nm; IONPs) 
were synthesized following the protocols reported by Colvin et al. [20] Typically, 
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FeOOH (8 mmol, 0.7108 g), oleic acid (32 mmol, 9.038 g) and 1-octadecene (20g) 
were charged into a three-neck round bottom flask equipped with a condenser. Prior 
to the reaction, the system was purged with N2 gas for 30 minutes. The temperature of 
the reaction mixture was then increased to 180
o
C and held for 1 hour isothermally. 
Subsequently, the reaction mixture was simply refluxed at 320
o
C for 30 minutes 
before the black mixture was allowed to cool down slowly to room temperature. The 
resultant nanoparticles were washed by repeated dispersion and precipitation using 
hexane and isopropanol mixture. The final IONPs product was dispersed in CHCl3 
(~50mg.mL
-1
) and the resultant black ferrofluid was stored at 4
o
C. 
4.2.3 Synthesis of Manganese Ferrite MnFe2O4 Nanoparticles (MFNPs) 
Monodisperse octahedral-shaped manganese ferrite nanoparticles (MnFe2O4; 
~18nm; MFNPs) were synthesized following the protocols reported by our group with 
slight modification. [21] Typically, Fe(acac)3 (8 mmol, 2.825 g), Mn(acac)2 (4 mmol, 
1.1026 g), oleic acid (28 mmol, 7.908 g) and benzyl ether (35 mL) were charged into 
a three-neck round bottom flask equipped with a condenser. Prior to the reaction, the 
system was purged with N2 gas for 30 minutes. The temperature was then increased to 
165
o
C and held for 30 hour isothermally. Subsequently, the reaction mixture was 
simply refluxed at 280
o
C for 30 minutes before the black mixture was allowed to cool 
down slowly to room temperature. The resultant nanoparticles were washed by 
repeated dispersion/precipitation using hexane/isopropanol mixture. Magnetic 
separation (ferrofluid incubation with strong rare-earth magnet) was performed to 
remove large ferromagnetic nanoparticles aggregates. The final MFNPs product was 
dispersed in CHCl3 (~50mg.mL
-1
) and the resultant black ferrofluid was stored at 4
o
C. 
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4.2.4 Synthesis of Amphiphilic Brush Copolymer PIMA-g-C12 
Amphiphilic brush copolymers were obtained by grafting PIMA with 
alkylamine, following the previously published protocols. [3] A simple alkylamine, 1-
dodecylamine (C12) was used. Typically, PIMA (1 mmol, 1.5g; 9.75 mmol 
anhydrides) was charged with 1-dodecylamine (30 mmol, 1.34g; equivalent to 75% of 
anhydrides amount) into a 50 mL conical flask. Subsequently, tetrahydrofuran (15 
mL) was added, the flask was sealed and bath-sonicated for 10 minutes in order to 
obtain a uniform mixture. The reaction mixture was heated up to 60-70
o
C using hot-
plate equipped with magnetic stirring for 24 hours. Within few minutes of heating, 
PIMA dissolution in THF leaded to the formation of transparent solution. As shown in 
Figure 4-1, there is no by-product expected from the reaction and the resulting 
PIMA-g-C12 can be simply obtained by a complete solvent evaporation (drying) of 
THF at 60-70
o
C for few hours. The white solid powder of PIMA-g-C12 was obtained 
when the samples was vacuum-dried at room temperature over a week. The molecular 
weight of PIMA-g-C12 was approximately ~11400g/mol. 
 
Figure 4 - 1: Reaction scheme for grafting PIMA (n = 39) with dodecylamine (C12). 
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4.2.5 Water Solubilization of Single Hydrophobic Nanoparticles 
Hydrophobic (oleic-acid coated MNPs), both IONPs and MFNPs, were water 
solubilized into aqueous phase by using as-synthesized PIMA-g-C12 as surface 
coating following previously published protocols with slight modification and 
simplification. [3] Sodium hydroxide was simply employed as hydrolyzing agent. [9] 
Typically, 5–50 mg of MNPs dispersed in CHCl3 (at certain concentration, e.g. 
~50mg.mL
-1
) was mixed with PIMA-g-C12 solution dispersed in CHCl3 at certain 
PIMA-g-C12/MNPs mass ratio (NPratio). As shown in Figure 4-2, the PIMA-g-
C12/MNPs mixture was bath-sonificated for at least 10 minutes in an ultrasonic bath in 
order to ensure a uniformly mixed PIMA-g-C12 and MNPs dispersion. Afterwhich, 
CHCl3 was evaporated simply by blowing nitrogen gas for 30 minutes to 1 hour. The 
thin layer of PIMA-g-C12/MNPs composite film was obtained when the film was 
further vacuum-dried for 1 day. The resultant thin layer of film was then re-dissolved 
into aqueous solution of sodium hydroxide (at various concentrations). The amount of 
sodium hydroxide needed was calculated as the followings (the calculation serves as a 
guidelines to determine the total amount of hydrolyzing agent needed): 
- 1 mmol of PIMA = 39 mmol equivalent of maleic anhydride (n = 39). 
- 1 mmol of maleic anhydride = 2 mmol equivalent carboxylic acid (after hydrolysis). 
- 1 mmol maleic anhydride reaction with DDA would result in 1 mmol carboxylic acid. 
- 75% DDA (C12) grafting would leave 25% of the remaining maleic anhydride unreacted. 
- Total amount of carboxylic acid in PIMA-g-C12 (75%) after hydrolysis is equal to carboxylic acid 










 = 48.75 mmol. 
- Minimum amount of sodium hydroxide needed is approximately equal to the total amount of 
carboxylic acid in PIMA-g-C12 after hydrolysis = 48.75 mmol. 
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The mixture was then bath-sonificated for 90 minutes whereby the amphiphilic brush 
copolymers PIMA-g-C12 would encapsulate and stabilize MNPs in aqueous phase, 
resulting in a complete dispersion of MNPs in aqueous solution. The dispersion of 
MNPs in aqueous solution was purified through (i) simple filtration using 0.22µm 
syringe filter followed by (ii) dialysis against Millipore
®
 water or PBS 1x solution. 
The final product was a clear dark brown solution of MNPs in aqueous phase. 
 
Figure 4 - 2: (a) Illustration of hydrophobic magnetic nanocrystals encapsulation with 
PIMA-g-C12. (b) Illustration of MNPs water solubilization process with PIMA-g-C12. 
Thin intermediate composite film layer of PIMA-g-C12/MNPs was formed, followed 
by the subsequent re-dispersion into aqueous phase through sodium hydroxide 
(hydrolyzing agent) catalyzed maleic anhydride ring opening 
4.2.6 pH and colloidal Stability Tests 
The colloidal stability of MNPs encapsulated with PIMA-g-C12 was assessed 
simply incubating (dispersing) PIMA-g-C12 encapsulated MFNPs (WMFNPs) into 
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hydrochloric acid solution (pH 4.0–6.0), sodium hydroxide solution (pH 8.0–13.0) 
and Millipore
®
 Water (pH 7.0) and lastly PBS 1x solution (pH ~7.4). The 
hydrodynamic size of MNPs in various aqueous solvents was measured by dynamic 
light scattering (DLS) experiment. 
4.2.7 Water Solubilization using Poly (Maleic Anhydride-alt-1-Octadecene) 
Poly (maleic anhydride-alt-1-octadecene) or PMAO (MW 30000–50000) was 
obtained from Sigma-Aldrich. Briefly 1 mL of MFNPs (in CHCl3; 50 mg.mL
-1
) was 
mixed with 10 mL of PMAO (in CHCl3; 100 mg.mL
-1
). The NPratio was maintained at 
10. The mixture of MFNPs/PMAO was then sonificated for 10-20 minutes in an 
ultrasonic bath. Subsequently, the solvent (CHCl3) was then evaporated by nitrogen 
gas blowing for 1 hour. The thin layer of composite film was then further vacuum-
dried for 1 day. The resulting dried film was then re-dissolved into 11.25 mL of 1.0 M 
sodium hydroxide with the aid of ultrasonic bath for 60 minutes at 60
o
C. Sodium 
hydroxide was removed through dialysis against Millipore
®
 water (dialysis MWCO: 
12-14 kDa) and excess polymers were removed through centrifugation. 
4.2.8 Materials Preparation for Characterization 
For VSM experiment, hydrophobic magnetic nanoparticles were washed a few 
times using a mixture of hexane and acetone before drying. Meanwhile for 
hydrophilic magnetic nanoparticles coated with PIMA-g-C12, the samples were freeze 
dried for 4–5 days. For DLS measurement, the samples were directly measured from 
the nanoparticles solution in sodium hydroxide without neutralization. For samples 
tested at 37
o
C, the samples were equilibrated at 37
o
C for 1 minute prior to the 
measurement. For each sample, 5 sets of measurements were taken and the average 
was computed.  
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4.3  Results and Discussions 
4.3.1 Synthesis and Characterization of IONPs 
 
Figure 4 - 3: (a) TEM images and (b) high resolution TEM image of spherical and 
monodisperse IONPs in CHCl3 (inset: SAED pattern). (c) TEM size distribution of 
hydrophobic IONPs in CHCl3. (d) Hydrodynamic diameter size distribution of IONPs 
in CHCl3. (e) XRD pattern of IONPs. (f) Hysteresis loop profile of IONPs at 300K. 
Typical superparamagnetic Fe3O4 nanoparticles (IONPs) were synthesized 
through the thermal decomposition of iron carboxylate salts precursors in the presence 
of hydrophilic surfactant, oleic acid as capping agents. High boiling point non-polar 
solvent, 1-octadecene (b.p.320
o
C) was used.  The hydrophobic capping agent 
rendered the IONPs to be insoluble in aqueous solvent, but such nanoparticles were 
readily dispersed in various non-polar organic solvents such as hexane, toluene and 
CHCl3. The TEM image of the as-synthesized IONPs in Figure 4-3 revealed 
monodisperse and spherical nanoparticles. The HRTEM image showed a crystalline 
lattice arrangement with 2.99Ǻ lattice separation that corresponded to magnetite (220) 
lattice plane d-spacing. From the TEM size distribution in Figure 4-3c, the average 
IONPs size was calculated to be 10.2 ± 0.8 nm. The corresponding size distribution 
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from DLS experiment (Figure 4-3d) revealed that IONPs average hydrodynamic size 
was 15.6 ± 0.1 nm when dispersed in CHCl3. Since there was no secondary peak, both 
TEM and DLS indicated that there was no significant nanoparticles aggregation. The 
XRD pattern of IONPs (Figure 4-3e) was indexed against the magnetite characteristic 
peaks (JCPDS #65-3107), confirming the formation of cubic inverse spinel magnetite 
structure. The characteristic peaks at 2θ at 30.1o, 35.4o, 42.0o, 57.0o and 62.5o 
indicated the presence of (220), (311), (400), (511) and (440) planes. The SAED 
pattern (inset of Figure 4-3b) revealed diffraction rings of (220), (311), (400), (511) 
and (440) indices of magnetite crystal structure. The magnetic properties of IONPs 
were probed by VSM experiment. At room temperature, the measured hysteresis loop 
showed negligible magnetic remanence (MR) and negligible coercivity (HC) which 
indicated the superparamagnetic behavior of IONPs. The saturated magnetization 
(MS) of IONPs was found to be 42.15 emu.g
-1
. 
4.3.1 Synthesis and Characterization of PIMA-g-C12 
To prepare the surface coating agent, amphiphilic brush-like copolymers 
structure was prepared, simply by grafting poly (isobutylene-alt-maleic anhydride) 
(PIMA) backbone with alkylamine. Various alkylamine, such as octylamine (C8), 
dodecylamine (DDA, C12) and oleylamine (C18) can be used as the side-chain. [3] The 
reaction proceeded through a simple maleic anhydride ring opening with amine 
functional groups from alkylamine to form (i) amide linkage (–CONH–) which 
connects the backbone with the alkylamine and (ii) free carboxylic acid functional 
group. Such reaction occurred instantaneously at slightly elevated temperature (60–
70
o
C) in anhydrous solvent such as tetrahydrofuran (THF). The grafting process of 
alkylamine to PIMA backbone would result in many hydrophobic side chains like a 
brush structure. The free carboxylic acid functional group from anhydride ring-
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opening reaction would render PIMA backbone hydrophilic. Because of this, PIMA-
g-C12 copolymers were considered amphiphilic. The amount of DDA used was 
calculated so that approximately 75% of maleic anhydride rings were reacted. The 
remaining maleic anhydride rings would remain intact until it undergoes hydrolysis 
during water solubilization process. 
 
Figure 4 - 4: (a) FT-IR spectra of 1-dodecylamine (C12), poly (isobutylene-alt-maleic 
anhydride) (PIMA) and poly (isobutylene-alt-maleic anhydride) grafted with dodecyl 
(PIMA-g-C12, 75% C12 grafted). 
The chemical structure of amphiphilic brush copolymers PIMA-g-C12 after 
grafting was verified by FT-IR spectroscopy and
 1
H-NMR. The FT-IR spectra of 
PIMA-g-C12 together with its reactants were given in Figure 4-4. The main 
characteristic peaks of PIMA at 1770 cm
-1
 and 1840 cm
-1
 were ascribed to the 





 were contributed by the stretching of C–O of the anhydride. Overall, the 
grafting of DDA onto PIMA backbone would reduce these characteristic peaks 
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significantly, indicating that maleic anhydride rings had reacted. The presence of O–H 
stretching resonance from the carboxylic acids (formed after the anhydride opening) 
was confirmed by the broad adsorption peak from 3000–3600 cm-1. The rings opening 





 which  indicated the C=O stretching bond of carboxylic acid and 
amides, respectively. The grating process of the amine to carboxylic acid to form 
amide bonds was verified by the presence of the absorption peak at 1566 cm
-1
 that 
corresponded to the N–H bending of amides. All other absorption peaks, such as C–H 
bonds (due to the alkyl chain of C12), at 2855 cm
-1
 and 2930 cm
-1
 remains unchanged. 
 
Figure 4 - 5: 
1
H-NMR spectra of PIMA-g-C12 (solvent: chloroform-d, 300MHz). 
The 
1
H-NMR spectra of PIMA-g-C12 (given in Figure 4-5) was used to further 
analyze the chemical structure of PIMA-g-C12. The chemical shift was analyzed by 
referencing to solvent peak (δ = 7.24 ppm for chloroform-d). The spectra indicated 
few main characteristic peaks due to resonance of alkyl chain (C12) of the 
hydrophobic section of PIMA-g-C12 at around 0.84 – 1.64 ppm. Moreover, the 
characteristic peaks of PIMA were successfully identified as follow: 0.84 ppm (– 
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(CH)11–CH3 ), 0.9 – 1.1ppm (–CH2–C(CH3)2), 1.22 ppm (–CH2–CH2–), 1.41– 1.64 
ppm (–CH2–C(CH3)2, –HN–CH2–CH2–CH2–), 2.55 – 2.74 ppm (HOOC–CH–CH–), 
2.97 – 3.17 ppm (–CH–CH–CH3, –HN–CH2–CH2–CH2–). The peak of amide bond 
functional group that resulted from the anhydride ring-opening reaction with 
alkylamine was not observed. This was due to the lack of amide bond abundance as 
compared to other hydrogen proton of alkyl chain C12 and PIMA backbone. 
4.3.3 Optimization of Monodisperse Phase Transfer of Hydrophobic IONPs  
 
Figure 4 - 6: (a) Average hydrodynamic size of PIMA-g-C12 coated WIONPs as a 
function of the NaOH/carboxyl molar ratio. (b) Average hydrodynamic size of PIMA-
g-C12 coated WIONPs as a function of the PIMA-g-C12/MNPs mass-ratio (NPratio); 
inset: TEM image of WIONPs at different NPratio. 
The as-synthesized amphiphilic brush copolymers PIMA-g-C12 was used to 
encapsulate the oleic acid capped IONPs. The presence of unbound carboxylic acid 
functional groups on PIMA-g-C12 backbone would render IONPs soluble in aqueous 
medium (water soluble IONPs coated with PIMA-g-C12 are denoted as WIONPs). 
Such nanocrystals encapsulation involved high degree of hydrophobic – hydrophobic 
interaction between the hydrophobic brush segments of PIMA-g-C12 with the alkyl 
chain capping agent of the IONPs (C18). As depicted the schematic diagram Figure 4-
2, the encapsulation process involves an intermediate process in which dried film of 
PIMA-g-C12/IONPs was obtained and subsequently re-dispersed into aqueous phase 
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containing hydrolyzing agent. Inexpensive sodium hydroxide (NaOH) was used as an 
effective hydrolyzing agent [9] in order to accelerate PIMA-g-C12 remaining maleic 
anhydride rings opening process. After the complete hydrolysis of the remaining 
anhydride rings, the presence of unbound carboxylic acid functional groups would 
stabilize the IONPs in aqueous phase while maintaining the hydrophobic–
hydrophobic interaction between C12 and C18 chain. The overall water solubilization 
process can be optimized through the hydrodynamic size minimization by fine-tuning 
several determining parameters of the process. Basically, there are three important 
parameters to be fine-tuned during the water solubilization process: (i) amount of 
hydrolyzing agent (NaOH) used during the dissolution of PIMA-g-C12/IONPs film, 
(ii) amount of PIMA-g-C12 with respect to IONPs (mass ratio) and lastly (iii) the 
initial IONPs concentration used for water solubilization process. 
 
Figure 4 - 7: (a) Size distribution of WIONPs at different NaOH/carboxyl molar ratio. 
(b) Summary of the WIONPs hydrodynamic size against NaOH/carboxyl molar ratio. 
In general, the amount of NaOH hydrolyzing agent used to disperse the 
intermediate PIMA-g-C12/IONPs film had the most significant influence on the 
overall encapsulation process. Figure 4-6a summarized the hydrodynamic size of 
WIONPs against the NaOH/carboxyl molar ratio used during the water solubilization 
process. When the amount of NaOH was less than twice of the total carboxylic acids 
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amount (inclusive of the originally un-hydrolyzed anhydride groups), partial 
dispersion and solubilization of IONPs into aqueous phase were observed. On the 
other hand, when the amount of NaOH exceeded twice of the total carboxylic acids 
amount, WIONPs hydrodynamic size had increased significantly with the amount of 
NaOH. When the amount of NaOH increased, the remaining anhydride groups of 
PIMA-g-C12 were quickly hydrolyzed before allowing the ample time for stabilization 
and encapsulation of IONPs in water. This resulted in more collective encapsulation. 
Moreover, the tendency of PIMA-g-C12 to exist in a partial un-coiled state (extended 
chain) increased as the amount of NaOH increased. [22-24] Because of such chain 
conformation, multiple IONPs were possibly encapsulated together by PIMA-g-C12. 
 
Figure 4 - 8: (a) Average WIONPs hydrodynamic size at different NaOH 
concentration. (b) Summary of WIONPs hydrodynamic size against NaOH 
concentration. 
Briefly, it was when the amount of NaOH hydrolyzing agent was about twice 
of the total amount of carboxylic acid required, an optimum hydrodynamic size and 
minimization of inter-particle aggregation can be achieved. The variation of WIONPs 
size distributions against the amount of NaOH used was given in Figure 4-7. A 
further investigation also revealed that the hydrolyzing agent concentration used 
(while maintaining the total amount of NaOH used at 0.2 mmol) have insignificant 
effect on the overall hydrodynamic size (see Figure 4-8). 
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In addition to the NaOH/carboxylic acid ratio, the overall PIMA-g-C12/IONPs 
mass ratio (NPratio) was investigated to assess the encapsulation efficiency. By 
maintaining the NaOH/carboxylic acid ratio at 2, it was observed from Figure 4-6b 
that WIONPs hydrodynamic size constantly decreased when NPratio was increased 
from 2 to 15. This indicated that the encapsulation efficiency improved and the 
hydrodynamic size was suppressed when more PIMA-g-C12 amount was used. A 
further experiment revealed that the initial concentration of IONPs has significant 
effect on the overall resultant WIONPs hydrodynamic size. For instance, when IONPs 




, the average hydrodynamic 
size decreased. Overall, these two results highlighted that the amphiphilic brush 
copolymers encapsulation method was indeed suitable to water solubilize high 
concentrations (large amount) of hydrophobic nanocrystals simultaneously while 
maintaining the optimal hydrodynamic size. 
 
Figure 4 - 9: (a) Size distribution of WIONPs and (b) summary of the WIONPs 
hydrodynamic size against different PIMA-g-C12/MNPs mass ratio. 
The effect of initial IONPs concentration and PIMA-g-C12 amount on the 
average WIONPs hydrodynamic size can be best illustrated by schematic diagram 
shown in Figure 4-11. As the initial IONPs concentration and PIMA-g-C12 amount 
increased, the inter-distance between IONPs and polymers narrowed, thus resulting in 
an increase in probability of IONPs being singly encapsulated by amphiphilic brush 
copolymers PIMA-g-C12.  
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Figure 4 - 10: (a) Size distribution of WIONPs against PIMA-g-C12/MNPs mass ratio 
at different initial MNPs concentration (i.e. 10, 20 and 50 mg.mL
-1
). (b) Summary of 
the WIONPs hydrodynamic size against PIMA-g-C12/MNPs mass ratio an initial 
MNPs concentration. 
Based on the optimization results, the optimum conditions to achieve 
minimized hydrodynamic size were: (i) NaOH/carboxylic acid molar ratio of 
approximately ~2, (ii) NPratio of approximately ~10 and (iii) 50 mg.mL
-1
 (or even 
much higher) nanoparticles initial concentration. By employing these parameters, 
IONPS were successfully transferred from CHCl3 to aqueous phase while maintaining 
its hydrodynamic size. The WIONPs hydrodynamic size optimization occurred when 
each individual IONP nanoparticle was encapsulated separately by PIMA-g-C12 and 
no collective encapsulation of IONPs occurred.  
 
Figure 4 - 11: Schematic diagram depicting the effect of increasing MNPs 
concentration as well as increasing PIMA-g-C12 amount during MNPs encapsulation. 
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The size and morphology of WIONPs were probed by TEM. The TEM images 
of WIONPs in both water and PBS 1x (Figure 4-12a,b) showed minimal inter-
particle aggregation. A thin layer of organic coating that corresponded to PIMA-g-
C12 was observed under the microscope. This confirmed the success of single and 
monodisperse encapsulation process. The average hydrodynamic size of IONPs 
increased from 15.6 ± 0.1 nm in CHCl3, to 18.5 ± 0.1 nm in NaOH and lastly 19.6 ± 
0.3 nm in PBS 1x after hydrolysis. The increase in the IONPs hydrodynamic size 
from CHCl3 to NaOH and PBS1x were calculated to be 17.97% and 25.06% 
respectively. In PBS 1x, the hydrodynamic size slightly increased due to the presence 
of various metal-ions which interact closely with the carboxylic acid functional group 
from PIMA-g-C12 thin layer coating. 
 
Figure 4 - 12: TEM images of PIMA-g-C12 coated WIONPs (a) in NaOH (un-
dialyzed) and (b) in PBS 1x, after dialysis against PBS 1x (insets are the respective 
HRTEM of WIONPs in their solvent). (c) Hydrodynamic size evolution of IONPs 
during water solubilization process, from CHCl3, NaOH to PBS 1x. 
The successful coating of IONPs by PIMA-g-C12 to form WIONPs was 
studied by using FT-IR spectroscopy. The comparison of the FT-IR spectra of IONPs, 
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PIMA-g-C12 and WIONPs were given in Figure 4-13. From the IONPs spectra, the 
presence of Fe–O stretching at around 570-590 cm-1 indicated the bonding between 
oleic acid capping agent to IONPs. Such bonding existed through the formation of –
COO
–
 functional group as indicated from the asymmetric and symmetric stretching 
vibrations of –COO– within 1530-1580 cm-1 range. The presence of oleic acid was 





 as well as the –CH3 bending vibration at 1404 cm
-1
. After 
the formation of PIMA-g-C12 encapsulated IONPs, few characteristic peaks of both 
IONPs and PIMA-g-C12 were observed simultaneously with no additional new peaks. 
This indicated no significant chemical interaction between amphiphilic brush 
copolymers and IONPs.  
 
Figure 4 - 13: FT-IR spectra of (a) IONPs, (b) PIMA-g-C12 and (c) WIONPs. 
Based on the FT-IR spectra, the coating of PIMA-g-C12 amphiphilic brush 
copolymer onto IONPs can only proceed through the hydrophobic–hydrophobic 
interaction between the alkyl chain (oleic acid, C18) from IONPs and dodecylamine 
(C12) from PIMA-g-C12. 
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4.3.4 Synthesis and Phase Transfer of MFNPs 
 
Figure 4 - 14: (a) TEM images of octahedral-shaped and monodisperse MFNPs in 
CHCl3. (b) HRTEM image of MFNPs in CHCl3 (inset: SAED pattern of respective 
MFNPs samples). (c) TEM size distribution of hydrophobic MFNPs in CHCl3. (d) 
XRD pattern of crystalline MFNPs. (e) Hysteresis loop profile of MFNPs at 300K. 
Using the optimum conditions to achieve minimum hydrodynamic size, the 
water solubilization was extended to other types of hydrophobic oleic-acid capped 
nanocrystals. Superparamagnetic MnFe2O4 nanocrystals with unique octahedral shape 
(denoted as MFNPs) were successfully synthesized. [21] The TEM and HRTEM of 
the as-synthesized MFNPs dispersed in CHCl3 were shown in Figure  4-14a,b. Based 
on the TEM size distribution, MFNPs with an average size of 18.9 ± 2.4 nm was 
obtained (longest tip to tip distance). MFNPs were well-dispersed and no aggregation 
was observed. The inset in Figure 4-14b showed a lattice separation of 4.825Ǻ which 
corresponded closely to the manganese ferrite (111) plane d-spacing. The SAED 
pattern was indexed against the characteristic lattice planes of MnFe2O4. The XRD 
pattern further confirmed the crystal structure of MFNPs as all MFNPs peaks were 
indexed against jacobsite (MnFe2O4) phase reference data (JCPDS #74-2403). From 
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the VSM result at ~300K, MFNPs exhibited superparamagnetic behavior despite its 
high MS value (97.06 emu.g
-1
) that was almost twice of the IONPs MS value. 
 
Figure 4 - 15: TEM images of PIMA-g-C12 coated WMFNPs (a) in NaOH (un-
dialyzed) and (b) in PBS 1x, after dialysis against PBS 1x (insets are the respective 
HRTEM of WMFNPs in their solvent). (c) Hydrodynamic size evolution of MFNPs 
during water solubilization process, from CHCl3, NaOH to PBS 1x. 
By retaining similar water solubilization parameters as of WIONPs (from 
previous section), oleic acid- capped MFNPs have been successfully phase-transferred 
into aqueous phase (PIMA-g-C12 coated MFNPs was denoted WMFNPs) without 
having any aggregation and colloidal instability problems. The TEM analysis (in 
Figure 4-15a,b) of WMFNPs indicated no morphological or size changes as well as 
no inter-particle aggregation after water solubilization (dispersion in NaOH) or after 
purification through dialysis (dispersion in PBS 1x). Similar to WIONPs, a thin 
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amphiphilic brush copolymers coating layer was observed around WMFNPs (inset of 
Figure 4-15a). The hydrodynamic size distribution of MFNPs in CHCl3, NaOH and 
PBS 1x confirmed the TEM observation on the MFNPs monodispersity. The average 
hydrodynamic size of MFNPs in CHCl3, NaOH and PBS 1x were 22.7 ± 0.1 nm, 26.3 
± 0.1 nm and 30.1 ± 0.1 nm respectively. Overall, the increases of MFNPs 
hydrodynamic size from CHCl3 to NaOH and PBS 1x solution were 15.88% and 
32.56% respectively. Such increase suggested that octahedral-shaped MFNPs were 
singly coated by PIMA-g-C12 despite the non-spherical nanocrystals shape. 
 
Figure 4 - 16: (a) Hysteresis loop of MFNPs (solid line) and WMFNPs (dotted line). 
(b) TGA heating profile of WMFNPs under N2 atmosphere protection. (c) Magnified 
hysteresis loops of MFNPs (solid line) and WMFNPs (dotted line). 
To investigate the effect of polymer coating on the magnetic properties of 
PIMA-g-C12 coated nanocrystals, WMFNPs hysteresis loop was recorded by VSM at 
~300K as shown in Figure4-16a. From the loop, WMFNPs still behave 
superparamagnetically after PIMA-g-C12 coating. A significant decrease in the mass 
saturation magnetization value of 84.77% (from 97.06 to 14.78 emu.g
-1
) was observed 
can be ascribed to the presence of PIMA-g-C12. This was later further confirmed by 
TGA experiment (Figure 4-16b) of WMFNPs which highlighted the presence of 
organic components, approximately 83.92% of the WMFNPs total weight (inclusive 
of PIMA-g-C12). This accounted for the overall decrease in MFNPs MS value. The 






 was due 
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to the presence of inorganic components (MFNPs). From the magnified hysteresis 
loop of MFNPs and WMFNPs in Figure 4-16c, WMFNPs has zero remanent 
magnetization and zero coercivity as opposed to the MFNPs which still possessed 
slight remanent magnetization. Such result significantly indicated that the presence of 
PIMA-g-C12 was able to give rise to steric hindrance between amphiphilic brush 
copolymers coating. Therefore the MFNPs was distanced against each other and the 
dipole–dipole interaction (or magnetic coupling) between MFNPs can be minimized.  
A further investigation revealed that the optimized water solubilization 
parameters demonstrated previously to obtain WIONPs and WMFNPs can be readily 
extended to other amphiphilic brush copolymer systems, such as poly (maleic 
anhydride-alt-1-octadecene) or PMAO. [6] From the TEM image given in Figure 4-
17a, MFNPs was successfully water solubilized using PMAO. No aggregation was 
observed on the PMAO coated MFNPs. The HRTEM image indicated the presence of 
0.297 lattice spacing which corresponded to manganese ferrite (220) plane d-spacing. 
From the DLS experiment, the hydrodynamic size of PMAO coated MFNPs in NaOH 
and PBS 1x were recorded to be 30.8 ± 0.2 nm and 32.5 ± 0.2 nm. 
 
Figure 4 - 17: (a) TEM images of poly (maleic anhydride-alt-1-octadecene) or 
PMAO coated WMFNPs (inset: HRTEM image of WMFNPs with (220) plane d-
spacing of 0.297 nm). (b) Hydrodynamic size evolution of PMAO coated MFNPs 
during water solubilization process, from CHCl3, NaOH to PBS 1x. 
  - 110 - 
 
4.3.5 Colloidal Stability of PIMA-g-C12 stabilized MFNPs 
 
Figure 4 - 18: Time-dependent hydrodynamic size of WMFNPs at room temperature 
(25
o
C): (a) in Millipore
®
 water and (b) in PBS 1x. Time-dependent hydrodynamic 
size of WMFNPs at 37
o
C: (c) in Millipore
®
 water and (d) in PBS 1x.  Average 
hydrodynamic size summary of MFNPs: (e) in Millipore® water and (f) in PBS 1x. 
In various biomedical applications, high colloidal stability in aqueous 
solutions under various conditions such as buffer solution, pH and temperature were 
essentially compulsory for various types of biomedical applications. From the DLS 
experiment, WIONPs and WMFNPs were very stable in NaOH (<0.1M) solution, 
Millipore
®
 water as well as PBS 1x solution. On top of this, WIONPs and WMFNPs 
were found to be very stable at room temperature and at elevated temperature (37
o
C) 
for more than 10 days. The time-dependent average sizes plot of both samples given 
in Figure 4-18a-d demonstrated that WIONPs and WMFNPs were both very stable 
despite no cross-linker being used. [3-5] When stored in NaOH solution (<0.01M) 
solution, both samples were stable for more than two years without any significant 
precipitation or morphology change. In this section, MFNPs were chosen as the 
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representative model to investigate the stability due to its distinctive shape that might 
give rise to more complications to encapsulation stability. 





C were 30.4 ± 0.6 nm and 31.2 ± 0.5 nm (over approximately 12 days) in water 
and 28.9 ± 3.2 nm and 30.3 ± 3.7 nm (over approximately 5 days) in PBS 1x solution. 
Based on these results, there was no observable size variation over a period of few 
days which demonstrated that low molecular weight amphiphilic brush copolymers 
PIMA-g-C12 could efficiently encapsulate and stabilize MFNPs in aqueous phase. The 
overall stability were contributed by (i) steric hindrance in between the amphiphilic 
brush copolymers coating as well as (ii) the hydrophobic – hydrophobic interaction 
between C12 and oleic acid (C18) which kept MFNPs intact inside the polymeric 
coating. With both synergistic effects, PIMA-g-C12 was expected to individually 
isolate MFNPs, preventing the interaction with the surrounding adjacent MFNPs. 
 
Figure 4 - 19: Incubation of WMFNPs in water at various pH conditions. 





C with various pH conditions (pH 4.0–13.0). 
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On top of the time-dependent stability, WMFNPs were also stable at various 
pH conditions (pH: 4.0 – 13.0), at either 25oC or 37oC (Figure 4-19). As the pH was 
varied from 4.0 to 13.0, the recorded hydrodynamic sizes were found not to exceed 
the aforementioned original WMFNPs average sizes. The changes in WMF Ps ζ-
potentials at various pH conditions were also recorded at both temperatures. The pH-
dependent ζ-potentials generally increased as the pH decreased. The results suggested 
that the isoelectric point of the PIMA-g-C12 coated nanocrystals was below pH 4.0. 
Below pH 4.0, WMFNPs precipitated due to the lack of electrostatic repulsion. In a 
simulated physiological environment such as PBS 1x (pH 7.4), the ζ-potentials 
(surface charge) of WMFNPs were –40.3 and –35.0 mV at 25oC and 37oC would 
provide electrostatic repulsion that stabilized the WMFNPs colloidal system. Overall, 
from the colloidal stability assessment, PIMA-g-C12 well stabilized and protect 
hydrophobic nanocrystals in various conditions. 
4.3.6 In-vitro Cytotoxicity Assay of PIMA-g-C12 stabilized IONPs and MFNPs 
 
Figure 4 - 20: Concentration-dependent cell cytotoxicity evaluation of NIH/3T3 
mouse fibroblast cells (a,b) and MCF-7 human breast cancer cells (c,d) after 24 hours 
of incubation with PIMA-g-C12 coated WIONPs and WMFNPs in PBS 1x. 
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The in-vitro cell cytotoxicity assays of WIONPs and WMFNPs nanocrystals 
were assessed simply by incubating both samples (at various iron concentrations) 
together with NIH/3T3 fibroblast cells and MCF-7 human breast cancer cells at 37
o
C 
for 24 hours. The iron content determination was carried out by using colorimetric 
assay. [25] The cell viability was determined from the CCK-8 assay (Dojindo) by 
quantifying the dehydrogenase enzyme activity in live cells.  
As presented in Figure 4-20a,b, the cytotoxicity results suggested that 
NIH/3T3 cell viability would decrease when WIONPs and WMFNPs exceeded 3.9 
mM and 1.9 mM iron concentrations respectively. For NIH/3T3 cell viability, it was 
observed that WMFNPs induced more toxicity as compared to WIONPs. One possible 
mechanism was that the optimized hydrodynamic size induce more cellular uptake in 
NIH/3T3 cells. After internalization, disintegration may occur and WMFNPs induced 
more toxicity towards NIH/3T3 cells than WIONPs because of the release of 
manganese ions. With MCF-7, the cell viability was higher as compared to NIH/3T3 
especially at high iron concentration. As shown in Figure 4-20c,d, MCF-7 cell 
viability would decrease drastically when WIONPs and WMFNPs exceeded 6.4 mM 
and 7.7 mM iron concentrations respectively. Below these aforementioned 
concentrations, WIONPs and WMFNPs exhibited mild toxicities towards both types 
of cells with more than 65% of cells remained viable after 24 hours incubation. At 
concentration of <2 mM Fe, both WIONPs and WMFNPs samples were highly 
biocompatible either with NIH/3T3 or MCF-7 samples. Together with its superb 
colloidal stability results, the in-vitro cytoxicity study showed that water dispersible 
PIMA-g-C12 coated nanocrystals were very promising for biomedical applications, 
especially in nano bio-medicine. 
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4.3.7 In-vitro Cellular Imaging Demonstration and Cell-uptake Study using 
Fluoresceinamine-tagged PIMA-g-C12 stabilized MFNPs 
 
Figure 4 - 21: TEM images of fluoresceinamine-modified PIMA-g-C12 coated (a) 
WIONPs and (b) WMFNPs. (c). Digital photograph of fluoresceinamine-modified 
PIMA-g-C12 coated WMFNPs under UV 365nm excitation. (d) Hydrodynamic size 
distribution of fluoresceinamine-modified PIMA-g-C12 coated WMFNPs in PBS 1x. 
Confocal image of NIH/3T3 cells incubated with (e) WMFNPs (negative) and (f) 
Fluoresceinamine-modified PIMA-g-C12 coated WMFNPs (positive). 
Due to its excellent biocompatibility, WIONPs and WMFNPs were potentially 
useful as multi-modality imaging agent. The superparamagnetic core IONPs and 
MFNPs enabled WIONPs and WMFNPs samples to be potentially used as MR 
contrast agent. To allow additional modality, in a simple experiment, PIMA-g-C12 can 
be pre-tagged with fluoresceinamine dye (< 5% of total maleic anhydride). [26] Due 
to lack of fluoresceinamine abundance in fluoresceinamine-tagged PIMA-g-C12, the 
chemical structure was unable to be properly characterized and therefore not included 
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in this section. The TEM analysis in Figure 4-21a,b showed the fluoresceinamine-
tagged PIMA-g-C12 coated WIONPs and WMFNPs respectively, dispersed in water. 
Despite the lack of characterization result to demonstrate the successful grafting of 
fluoresceinamine, fluoresceinamine-tagged PIMA-g-C12 coated WMFNPs exhibited 
yellow fluorescence under UV lamp illumination. The overall hydrodynamic size of 
fluoresceinamine-tagged PIMA-g-C12 coated WMFNPs in water (26.7 ± 0.2 nm) was 
quite close to the original hydrodynamic size of WMFNPs. Such presence of 
fluoresceinamine functional group enables the nanocomposites to be used as labeling 
agents in cellular imaging.  
 
Figure 4 - 22: CLSM images of NIH/3T3 cells (at different z-depth) that were used to 
re-construct 3D stacking images of NIH/3T3 cells: (a) bright field, (b) fluorescence 
and (c) combined images. 
The in-vitro cellular imaging using fluoresceinamine-tagged PIMA-g-C12 
coated WMFNPs was demonstrated on NIH/3T3 fibroblast cells. PIMA-g-C12 coated 
WMFNPs sample was used as negative control. WMFNPs sample was assessed 
instead of WIONPs due to its potential to induce cell cytotoxicity from the manganese 
content. The staining of NIH/3T3 cells was probed by using confocal laser scanning 
microscope (CLSM, fluorescence imaging mode). Figure 4-21e,f showed the CLSM 
images of NIH/3T3 cells after 24 hours incubation with PIMA-g-C12 coated 
WMFNPs (negative staining) and fluoresceinamine-tagged PIMA-g-C12 coated 
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WMFNPs (positive staining). Both fluoresceinamine-tagged PIMA-g-C12 coated 
WMFNPs and PIMA-g-C12 coated WMFNPs did not induce any substantial 
cytotoxicity effect on NIH/3T3 cells after the internalization (cellular uptake). 
The high resolution CLSM images of single NIH/3T3 cells at various depths 
were given in Figure 4-22. From such individual CLSM z-stack images, a three 
dimensional view of the cells and fluoresceinamine-tagged PIMA-g-C12 coated 
WMFNPs were then re-constructred (Figure 4-23). From both images, 
fluoresceinamine-tagged PIMA-g-C12 coated WMFNPs were not adhered into cell 
surface. Instead, internalization occurred and majority of the nanoparticles were 
accumulated inside the cell cytoplasm. From the various depths analysis, there was no 
staining observed inside cell nuclei, suggesting that fluoresceinamine-tagged PIMA-
g-C12 coated WMFNPs were not sufficient enough to pass the nucleus barrier. [27] 
 
Figure 4 - 23: Reconstructed 3D NIH/3T3 cell model from the CLSM (a) bright field, 
(b) fluorescence and (c) combined bright field and fluorescence z-stack images. 
To further investigate on the internalization mechanism of fluoresceinamine-
tagged PIMA-g-C12 coated WMFNPs into cell cytoplasm, simple time-dependent 
study was performed to observe the cell behavior and endocytosis process during the 
incubation period. Figure 4-24 summarized the sequence of single NIH/3T3 cell 
interaction with fluoresceinamine-tagged PIMA-g-C12 coated WMFNPs at different 
time window (image taken every hour). Initially, 20 µL of fluoresceinamine-tagged 
PIMA-g-C12 coated WMFNPs was immersed onto the growth medium containing 
seeded NIH/3T3 to allow natural uptake processes. The solution required 
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approximately 1 hour to reach the cells that were seeded on the bottom of the plate. 
Between 2–4 hours after incubation period, the fluoresceinamine-tagged PIMA-g-C12 
coated WMFNPs were seen to undergo endocytosis, whereby the starting pathway 
were the extended cell surface protrusion or pseudopodium (indicated by the white 
arrows). [28] Beyond 5 hours incubation, after washing off the excess surrounding 
nanoparticles, NIH/3T3 cells with internalized fluoresceinamine-tagged PIMA-g-C12 
coated WMFNPs similar to Figure 4-34 would be obtained. Longer incubation time 
typically was preferred as it could enhance the non-specific cellular uptake process. 
[29] The incubation study also highlighted the behavioral interaction between the 
fluoresceinamine-tagged PIMA-g-C12 coated WMFNPs and the NIH/3T3 whereby 
during the process, no apoptosis were observed due to its low cytotoxicity effect. 
 
Figure 4 - 24: CLSM images of NIH/3T3 cells incubated for over 5 hours period with 
fluoresceinamine-modified PIMA-g-C12 coated WMFNPs (20 µL injection). 
Due to the presence of negatively charged cellular membrane surface, neutral 
and negatively charged nanoparticles uptakes are slower than positively charged 
nanoparticles. [30-31] From Figure 4-19, the zeta-potential measurement indicated 
that typically PIMA-g-C12 coated nanoparticles was negatively charged (anionic 
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coating) due to the presence of carboxylic acid functional groups on its surface. 
Despite the unfavorable interaction, the fluoresceinamine-tagged PIMA-g-C12 coated 
nanoparticles cellular uptake was still observed. As many have reported previously, 
such internalization was believed to take place through non-specific binding and 
aggregation of the anionic particles on the positively charged segment on the surface 
membrane, leading to endocytosis. [32] 
4.3.8 MR Relaxivity of PIMA-g-C12 stabilized IONPs and MFNPs 
 
Figure 4 - 25: Plot of (a) T2 relaxation rate (1/T2) and (a) T1 relaxation rate (1/T1) 
against the iron concentration for both fluoresceinamine-tagged PIMA-g-C12 coated 
WIONPs and WMFNPs samples.  
To be potentially used for the dual-modality imaging application, both 
fluoresceinamine-tagged PIMA-g-C12 coated magnetic nanoparticles, WIONPs and 
WMFNPs were also investigated for T2 MR imaging contrast agent. Figure 4-25a,b 
showed the concentration-dependent 1/T2 and 1/T1 relaxation rate plot against the iron 
concentration for both samples. The enhanced T2 relaxation for both samples was 
observed. From the linear fitting of the relaxation rate at various iron concentrations, 









WIONPs and WMFNPs samples respectively. Meanwhile, the r1 values were 








 for WIONPs and WMFNPs 
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samples respectively. Since the r2/r1 ratio of WIONPs (r2/r1 = 89.8) and WMFNPs 
(r2/r1 = 118.1) were greater than 10, both samples were suitable as T2 contrast agent. 
4.4  Summary 
In summary, hydrophobic magnetic nanoparticles (two systems: ~10nm 
IONPs and ~18nm MFNPs) synthesized from the high temperature thermolysis 
synthetic route were successfully water solubilized into aqueous phase, simply by 
using amphiphilic brush copolymer PIMA-g-C12. The parameters that leaded to the 
optimized water soluble nanocrystals hydrodynamic size were investigated to obtain 
water solubilization process. Such parameters were inclusive of (i) the amount of 
hydrolyzing agent (NaOH) used and its concentration, (ii) the amphiphilic brush co-
polymer to magnetic nanoparticle ratio as well as (iii) the initial magnetic 
nanoparticles concentration used. Using the optimized parameters, the inter-particle 
aggregation that normally would lead to aggregation problems can be evaded and the 
overall water soluble WIONPs and WMFNPs hydrodynamic sizes can be controlled 
to have the increment of no more than approximately 33% as compared to the original 
IONPs and MFNPs hydrodynamic size in oil-phase (see Table 4-2 for the 
hydrodynamic size summary and its increment). Such increments in the 
hydrodynamic size indicated higher probability that IONPs and MFNPs were indeed 
single encapsulated during the process.  
Both water soluble WIONPs and WMFNPs possessed excellent colloidal 
stabilities in both water and PBS 1x medium as well as at various pH conditions (pH 
4.0 – 13.0; both at room temperature and at 37oC). Both samples also demonstrated 
good biocompatibility (up to total iron concentrations of 5 mM) when incubated with 
two different types of cells: NIH/3T3 fibroblast cells and MCF-7 breast cancer cells. 
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For dual imaging, fluoresceinamine dye was conjugated to PIMA-g-C12. The 
fluoresceinamine-tagged PIMA-g-C12 coated WIONPs and WMFNPs have been 
investigated for imaging demonstration and cellular uptake through live-monitoring. 
Lastly, these nanoparticles were also analyzed for its MR relaxivity. The r2 value for 




, more than three times of WIONPs sample r2 value 





Table 4 - 2: Summary of IONPs and MFNPs hydrodynamic sizes. 
Nanocrystals Coatings Solvent Average dhyd (nm) 




Oleic Acid CHCl3 15.6 ± 0.1 - 
PIMA-g-C12 NaOH 18.5 ± 0.1 17.97% 
PIMA-g-C12 PBS 1x 19.6 ± 0.3 25.06% 
MFNPs 
(MnFe2O4) 
Oleic Acid CHCl3 22.7 ± 0.1 - 
PIMA-g-C12 NaOH 26.3 ± 0.1 15.88% 
PIMA-g-C12 PBS 1x 30.1 ± 0.1 32.56% 
MFNPs 
(MnFe2O4) 
PMAO (C18) NaOH 30.8 ± 0.2 35.50% 
PMAO (C18) PBS 1x 32.5 ± 0.2 42.98% 
Note: (a) Initial MNPs concentration = 50 mg.mL
-1
, (b) NaOH/Carboxyl molar ratio = 2:1 and (c) 
PIMA-g-C12/MNPs mass ratio = 10:1. 
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Chapter 5. Synthesis of Hydrophilic PEGylated 
Multifunctional Magnetic Nanoclusters 
 
5.1 Introduction 
As described in Chapter 1, often in biomedical field, particularly for cancer 
treatment, nanostructured materials that possess theranostic (therapeutics and 
diagnostic) as well as multimodality imaging abilities are highly desirable. [1-6] 
Various colloidal functional inorganic nanoparticles, exhibiting unique size-dependent 
physical properties, such as fluorescence properties (e.g. semiconductor quantum dots 
or QDs, up-/down-conversion nanoparticles) [7-8], magnetic properties (e.g. metal 
oxide nanoparticles) [1] and plasmonic properties (e.g. noble metallic nanoparticles) 
[9-10] have been widely explored for such theranostic purposes. Magnetic 
nanoparticles have a widespread range of applications in bio-imaging (MRI), pay-load 
delivery (drug or gene), biosensors and magnetic hyperthermia. [11-15] Up-/down- 
conversion and QDs nanoparticles find their niche in bio-imaging while noble 
metallic nanoparticles can be used for photothermal therapy and bio-sensing. [16-17] 
It is of great interest if such independent functional properties can be combined into a 
single and multifunctional platform to synergistically harness its potential.  
In the past few years, there have been remarkable and extensive research 
efforts in developing hybrid fluorescent-magnetic nanostructured platform. [18-31] 
For instance, the magnetic element allowed the nanoparticles to respond to the applied 
external magnetic field, to dissipate heat when exposed to an alternating external 
magnetic field, as well as to provide an enhanced MRI contrast for bio-imaging. 
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Meanwhile, the fluorescence element allowed the nanoparticles to be used for 
fluorescent imaging, especially for cell labelling and cell sorting. The fluorescence 
element for such hybrid nanostructures range from the use of fluorescence dye (or 
polymers) to the inorganic semiconductor QDs. As compared to the various 
conventional fluorescent dyes that undergo photo-bleaching, compromising their 
stability, colloidal QDs are particularly of interest due to their photostability. [32] 
To date, there have been several ways developed to fabricate multifunctional 
nanostructures consisting of two or more types of functional nanoparticles, ranging 
from (i) the direct formation of heterostructures between various functional inorganic 
nanoparticles (through seed-mediated and epitaxial growth), (ii) the formation of 
covalent bonding between various functional inorganic nanoparticles to (iii) the 
collective encapsulation of different types of functional inorganic nanoparticles within 
host matrices. The direct formation of the inorganic heterostructures involved the 
direct growth of secondary nanoparticles on the seed nanoparticles (some examples 
include: FePt–CdS, Fe2O3–/Fe3O4–CdSe and etc). [33-35] Such seed-mediated growth 
was a surface sensitive technique which is highly specific to certain nanocrystal 
system only. On the other hand, the covalent conjugation between two different 
nanoparticles moieties can also be used to cross-link two or more different functional 
nanoparticles. [26,36] The conjugation however, depends heavily on the availability 
of the functional groups on the nanoparticle surface. Last but not least, the collective 
encapsulation of two or more different types of functional inorganic nanoparticles has 
been the most attractive and promising method to form such multifunctional 
nanostructures. Such encapsulation can be accomplished through various hosts, such 
as inorganic silica host [37] as well as various types of polymeric hosts including 
dendrimers, liposomes and amphiphilic copolymers. [21,38-39] Among different 
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types of polymeric matrices host, amphiphilic copolymers are of interest, particular 
amphiphilic block copolymers such as pluronic F127 (PEO-PPO-PEO) and 
amphiphilic brush copolymers such as poly (maleic anhydride-alt-1-octadecene) are 
preferred due to their abundant commercial availability as well as its inexpensive cost. 
[38-45] These various amphiphilic copolymers have been widely utilized to form 
water-dispersible nanoparticles with excellent colloidal stability and can be easily 
functionalized with other targeting moieties. 
 
Figure 5 - 1: Schematic diagram illustrating the formation of nanoclusters. The 
nanoclusters was formed from hydrophobic nanoparticles (magnetic, semiconductor, 
metallic and etc) using amphiphilic brush co-polymers. 
In this chapter, the formation of functional and multifunctional nanoclusters 
using poly (maleic anhydride-alt-1-octadecene) or PMAO amphiphilic brush 
copolymers was proposed. Such polymeric structure not only served as a host, but 
also can be pre-modified (before water solubilization process) to carry some 
functional groups such as polyethylene glycol (PEG). Commercially available PMAO 
was chosen due to its versatility of surface functionalization with other functional 
molecules as well as its reactive succinic anhydride rings. PEG was grafted onto 
PMAO through a simple acid-catalyzed esterification reaction between the hydroxyl 
group of mPEG-OH and the succinic anhydride ring of PMAO to yield PEGylated 
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PMAO (denoted as PMAO-g-PEG). [46-47] Using PMAO-g-PEG (as illustrated in 
Figure 5-1), nanoclusters were formed through oil-in-water miniemulsion and solvent 
evaporation process. [45] In the first part of this chapter, nanoclusters were formed 
with only manganese-doped ferrite magnetic nanoparticles (MFNPs). The versatility 
of tuning the core nanoparticles as well as the loading amount of the MFNPs onto 
nanoclusters was demonstrated. By exposing such single-functional nanoclusters to 
the alternating external magnetic field, the magnetic hyperthermic response was 
assessed. 
In the latter part of this chapter, AgInS2-ZnS quantum dots (AIZS QDs) were 
synthesized and incorporated together with MFNPs into PMAO-g-PEG polymeric 
hosts to form multifunctional nanoclusters, A-MFNCs. Using these QDs-loaded 
nanoclusters, cellular imaging was conducted on NIH/3T3 cells. Furthermore, the MR 
relaxivity values of the MFNPs containing nanoclusters were assessed. Lastly, cellular 
cytotoxicity tests with NIH/3T3 cells and various colloidal stability tests inclusive of 
pH- and temperature-dependent assessment demonstrated the biocompatibility and 
colloidal stability of the as-formed nanoclusters. The results presented suggested that 
the presence of PEG in the nanoclusters formed by PMAO-g-PEG prevented protein 
adsorption better than the nanoclusters formed only by PMAO. Overall, due to the 
robustness of tuning the nanolusters as well as the excellent biocompatibility and 
colloidal stability of the resultant nanoclusters, the formation of multifunctional 
nanoclusters using PMAO-g-PEG is promising for various biomedical applications. 
  - 127 - 
 
5.2 Experimental Procedures 
5.2.1 Materials 
Iron (III) acetylacetonate (Fe(acac)3; 97%), oleylamine (OAM; 70%), oleic 
acid (OA; ≥99%), manganese (II) acetylacetonate (Mn(acac)2), poly (maleic 
anhydride-alt-1-octadecene) (PMAO; MW 30000–50000), poly (ethylene glycol) 
methyl ether (mPEG–OH; MW 2000), polyvinyl alcohol (87.0%), silver nitrate 
(AgNO3; ≥99.0%), indium (III) acetate (In(Ac)3; 99.99%), zinc stearate (Zn(St)2), 
benzyl ether (99%), tetrahydrofuran (THF; 99.9%), 1-octadecene (ODE; 90.0%), 1-
dodecanethiol (DDT; 98.0%) and trioctylphosphine (TOP; 90%) were purchased from 
Sigma Aldrich. Chloroform (CHCl3; 99.99%) and hexane (99.99%) were obtained 
from Fisher Scientific. Cell counting kit-8 was purchased from Dojindo Molecular 
Technologies. Syringe filtered Millipore
®
 water was used in all experiments. 
5.2.2 PEGylation of Poly (Maleic Anhydride-alt-1-Octadecene) 
PEG was grafted onto brush copolymer PMAO through esterification reaction, 
involving maleic anhydride ring opening process in the presence of hydroxyls from 
mPEG–OH and acidic condition. [46-47] The schematic diagram of esterification 
reaction was given in Figure 5-2. Briefly, PMAO (3 grams) was mixed with mPEG–
OH (2.25 grams) and THF (20 mL) in a conical flask with an attached condenser. 
During the course of the reaction, fuming hydrochloric acid (37wt% HCl; 3-6 mL) 
was added to catalyse the esterification reaction. The mixture was refluxed at 80
o
C for 
24 hours and subsequently cooled down to room temperature. The resulting polymer 
was then precipitated with acetonitrile and separated using centrifugation (10000rpm, 
10 mins). This process was repeated 3 times and the purified PEG grafted PMAO 
(PMAO-g-PEG) was dried in-vacuo for 7 days. 
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Figure 5 - 2: Reaction scheme for grafting hydrophilic functional group of 
polyethylene glycol (PEG) onto the backbone of the hydrophobic poly (maleic 
anhydride-alt-1-octadecene) (or PMAO). The reaction proceeds through a simple 
acid-catalyzed esterification reaction of PMAO with mPEG-OH. 
5.2.3 Preparation of Manganese Ferrite Nanoparticles (MFNPs) 
Manganese ferrite (MnFe2O4) nanoparticles (denoted as MFNPs) were 
synthesized through thermal decomposition of metal-acetylacetonate precursors 
following the method published previously. [48-49] Typically for ~11nm sized 
MFNPs, Fe(acac)3 (8 mmol), Mn(acac)2 (4 mmol), OA (28 mmol) and benzyl ether 
(35 mL) were charged into a three-neck round bottom flask with an attached 
condenser. The reaction chamber was purged with nitrogen gas for 30 minutes prior to 
the synthesis process. The solution mixture was then heated slowly to 165
o
C and held 
isothermally for 30 minutes. Subsequently, the mixture temperature was increased to 
~280
o
C to reflux. The mixture was allowed to reflux for another 30 minutes before 
the black colour solution was cooled down naturally to room temperature. The as-
synthesized MFNPs were precipitated by ethanol and isolated by centrifugation and 
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re-dispersed into CHCl3. The final product was completely dispersed in CHCl3 at 50 
mg.mL
-1
. The black ferro-fluid was then stored in a sealed glass vials at 4
o
C. 
5.2.4 Preparation of Zn-doped AgInS2 Quantum Dots (AIZS) 
Zn-doped ternary chalcopyrite type (I-III-VI2) semiconductor nanoparticles 
AgInS2 (AIZS) were synthesized following the method previously. [50] Typically for 
orange color emission AIZS, In(Ac)3 (29.2 mg), AgNO3 (16.8 mg), OA (45 µL), TOP 
(46 µL), DDT (1.2 mL) and ODE (4 mL) were charged into a 50 mL three neck round 
bottom flask. The mixture was heated up to 160
o
C and hold for a few minutes. 
Simultaneously, sulphur (S, 19.2 mg) dissolved in ODE (200 µL)/OAM (400 µL) and 
Zn(St)2 (379 mg) dissolved in ODE (400 µL)/OAM (400 µL) were pre-heated to 
120
o
C. When the temperature in the round bottom flask reached 160
o
C, 5 drops of 
sulphur in ODE/OAM solution were injected to the round bottom flask. The solution 
was then incubated for 10 minutes before 10 drops of Zn(St)2 in ODE/OAM solution 
was injected. The solution mixture was then heated-up quickly to 210
o
C and another 
10 drops of Zn(St)2 in ODE/OAM solution was added. Subsequently, the mixture was 
held isothermally for 1 hour before cooling down. The solution mixture was 
precipitated and dispersed using a mixture of ethanol/hexane repeatedly. Finally, 
AIZS nanoparticles were re-dispersed into CHCl3 and stored at room temperature.  
5.2.4 Preparation of MFNPs-containing Nanoclusters (MFNCs) 
In order to water solubilize the hydrophobic nanoparticles into aqueous phase, 
nanoclusters consisting of hydrophobic nanoparticles (e.g. MFNPs or AIZS) 
encapsulated by amphiphilic PMAO-g-PEG was synthesized. The nanoclusters were 
formed by mini-emulsion/solvent evaporation technique as illustrated in Figure 5-1. 
[45] Briefly, MFNPs in CHCl3 (0.2 mL; 50mg.mL
-1
) was mixed with PMAO-g-PEG 
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(in 1 mL CHCl3; 20mg.mL
-1
). The mixture was emulsified with PVA (1wt%; 12 mL) 
in water using ultrasonic homogenizer for 12 minutes. The resulting oil-in-water 
emulsion was transferred to a pre-heated beaker (70
o
C) and the non-polar solvent 
(CHCl3) was then evaporated away for 30 minutes. The resulting water soluble 
MFNCs were precipitated by using methanol, isolated by using centrifugation 
(10000rpm, 10 minutes) and re-dispersed into Millipore
®
 water. The precipitation and 
re-dispersion of MFNCs were carried out three times and finally the MFNCs in 
Millipore
®
 water were stored at room temperature at concentration of 5mg.mL
-1
 
MFNPs. By using the same procedures, MFNPs and AIZS (in CHCl3) can be 
encapsulated simultaneously, forming multifunctional nanoclusters (A-MFNCs). 
5.2.5 Temperature-, pH- and time-dependent Stability Test 
Time-dependent colloidal stability was carried out by incubating MFNCs 
samples with 10% BCS over a period of 2 days at room temperature followed by 37
o
C 
for another 2 days. Temperature-dependent colloidal stability was carried out by 





colloidal stability was studied by incubating A-MFNCs into hydrochloric acid 
solution (pH 1.0-6.0), sodium hydroxide solution (pH 8.0-14.0) and lastly Millipore
®
 
water (pH 7.0). In all stability tests, the hydrodynamic size (as well as zeta-potential 
value) of the nanoclusters samples in various aqueous solvent was recorded by 
dynamic light scattering (DLS) measurement. 
5.2.6 Materials Preparation for Characterization 
All the dried samples for FTIR, TGA and VSM characterization were prepared 
through the vacuum drying for 3-7 days. For the DLS measurement, prior to the 
measurement at 37
o
C, the sample was equilibrated for 10 minutes. 
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5.3 Results and Discussion 
5.3.1 Synthesis and Characterization of MFNPs 
 
Figure 5 - 3: TEM images of the as-synthesized various sizes of hydrophobic MFNPs 
dispersed in CHCl3.(a) 6 nm (MFNPs-A), (b) 11 nm (MFNPs-B), (c) 14 nm (MFNPs-
C) and (d) 18 nm (MFNPs-D). Insets: SAED patterns and the high resolution TEM 
images of the respective MFNPs samples. 
Superparamagnetic manganese-doped ferrite (MnFe2O4) nanoparticles 
(denoted as MFNPs) were synthesized through the high temperature decomposition 
process of mixed metal-acetylacetonates (iron and manganese) precursors in the 
presence of non-polar oleic acid surfactant. From Figure 5-3, various sizes of MFNPs 
were successfully synthesized, simply by tuning the total amount of acetylacetonate 
precursors. Four different sizes of MFNPs were obtained, 6 nm (MFNPs-A), 11 nm 
(MFNPs-B), 14 nm (MFNPs-C) and 18 nm (MFNPs-D). The size distribution 
histogram of MFNPs A-D given in Figure 5-4 highlighted 5.7 ± 0.4 nm, 10.6 ± 1.0 
nm, 13.5 ± 1.0 nm and 18.2 ± 1.6 nm for MFNPs-A, MFNPs-B, MFNPs-C and 
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MFNPs-D respectively. The resultant oleic-acid capped MFNPs formed perfect 
ferrofluids when dispersed in non-polar organic solvent (hexane, toluene or CHCl3).  
 
Figure 5 - 4: TEM size distributions of: (a) MFNPs-A (6 nm), (b) MFNPs-B (11 nm), 
(c) MFNPs-C (14 nm) and (d) MFNPs-D (18 nm). 
The crystal structures of MFNPs A-D were further verified by the XRD 
patterns (Figure 5-5a) and the SAED patterns (insets of Figure 5-3). The XRD 
patterns were indexed against the characteristic diffraction peaks of cubic spinel 
ferrite structure of Jacobsite (MnFe2O4; JCPDS #74-2403). The characteristic peaks at 
2θ of 30.2o, 35.6o, 43.2o, 53.0o, 62.8o corresponded to (220), (331) (400) (422), (333) 
and (440) diffraction planes respectively. From the XRD patterns comparison, the 
peak broadening from MFNPs-D to MFNPs-A was ascribed to the nano-crystallite 
size effect. The XRD patterns indicated that MFNPs A-D exhibited high degree of 
crystallinity. The highly crystalline structure was also observed from the well-defined 
lattice fringes from the HRTEM images (inset of Figure 5-3). The interplanar 
distances of approximately ~0.29 nm and ~0.49 nm were associated with the (220) 
and (111) lattice plane d-spacings of manganese ferrite structure. 
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Figure 5 - 5: (a) XRD patterns of various MFNPs recorded at 300K. (b) Hysteresis 
loop profiles of various MFNPs samples measured by VSM experiment at 300K. 
The magnetic properties of MFNPs probed by VSM experiment indicated that 
MFNPs behaved superparamagnetically with the absence of the magnetic hysteresis 
loop. The field-dependent magnetization curve in Figure 5-5b showed negligible 
remanent magnetization (MR) and coercivity (HC). The saturation magnetization (MS) 







 and 83.4 emu.g
-1
 respectively. Because of the presence of the oleic acid 
capping agent as well as the surface defects, these MS values were far below the 
theoretical value of bulk MnFe2O4, i.e. 120.8 emu.g
-1
. Afterall, smaller MFNPs size 
has more surfaces over volume ratio which inherently associated with the increase of 
its surface defects. [51] Due to the nano-size effect, therefore, the overall magnetic 
properties of MFNPs A-D samples generally increased as the average size increased. 
5.3.2 Synthesis and Characterization of PMAO-g-PEG 
The obtained hydrophobic MFNPs nanoparticles were subjected to water 
solubilization process to convert it to hydrophilic samples. Typically, various 
amphiphilic brush copolymers which contain both hydrophobic and hydrophilic 
segments have been well studied in the literature, e.g. polystyrene/polyacrylic acid 
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block copolymers (PS-b-PAA), polyacrylic acid/P123 block copolymers (PAA-b-
P123), poly (isobutylene-alt-maleic anhydride) grafted with dodeceylamine (PIMA-g-
C12), poly (maleic anhydride-alt-1-octadecene) (PMAO), carboxylated pluronic 
(F127-COOH) and so on. [39, 40, 45] In the earlier attempt to synthesize water 
soluble magnetic nanoclusters, PMAO was used due to its low-cost and commercial 
availability. Besides, PMAO was previously reported to individually encapsulate 
hydrophobic nanocrystals. [46-47] 
 
Figure 5 - 6: TEM images of magnetic nanoclusters formed by PMAO with different 
MFNPs-B loading: (a) 2.5:1 MFNPs/PMAO ratio (MFNCs-P2) and (b) 1.25:1 
MFNPs/PMAO ratio (MFNCs-P1). (c) Hysteresis loop of MFNCs-P1 and MFNCs-P2 
samples recorded at 300K. (d) Hydrodynamic size distribution of MFNCs-P1 and 
MFNCs-P2 samples measured by DLS experiment in water solvent. 
From TEM images in Figure 5-6a,b, PMAO was able to collectively 
encapsulate MFNPs (core: MFNPs-B) to form magnetic nanoclusters with different 
core loading. By using different initial MNFPs concentration, 25 mg.mL
-1
 and 50 
mg.mL
-1
, spherical shape MFNCs-P1 (low loading) and MFNCs-P2 (high loading) 
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nanoclusters were successfully fabricated. The VSM results in Figure 5-6c showed 
that both MFNCs-P1 and MFNCs-P2 samples still behave superparamagnetically with 




 respectively. The DLS average 
hydrodynamic size of 180.2 ± 4.2 nm and 163.7 ± 3.5 nm were obtained for MFNCs-
P1 and MFNCs-P2 samples. The nanoclusters size formed by pure PMAO polymers 
was rather large, conveniently because of the presence of hydrophobic segments of 
PMAO polymers. The high hydrophobicity of PMAO, characterized by its 
hydrophilic-lipophilic balance (HLB) value, prevents the emulsion sonification to 
break up the oil phase and therefore resulting in a very large cluster sizes. Such large 
hydrodynamic size (> 150 nm) was unsuitable for biomedical applications due to its 
potential colloidal instability that will increase its toxicity. 
 
Figure 5 - 7: (a) Cell cytotoxicity of PMAO-coated MFNCs-P2 (magnetic core: 
MFNCs-B), incubated with NIH/3T3 for 24 hours. (b) Hydrodynamic size of MFNCs 
formed by PMAO at different incubation time at room temperature. 
When incubated with NIH/3T3 cells for 24 hours, MFNCs-P2 showed mild 
sign of toxicity. The cell viability shown in Figure 5-7a was reduced to 60-80% of 
initial cell population with 0.5 and 2.0 mM iron concentration of MFNCs-P2 sample. 
Moreover, the MFNCs-P1 or MFNCs-P2 formed under 12 minutes sonication was 
relatively large and was reduced simply by extending the sonication time during the 
mini-emulsion/solvent evaporation process. As a results, as indicated in Figure 5-7b, 
relatively smaller nanoclusters (128.54 ± 1.2 nm) was obtained. From the time-
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dependent stability test, after 6 days and 12 days incubation, the average 
hydrodynamic size of these nanoclusters has increased by ~27% and ~40% from its 
original hydrodynamic size.  
 
Figure 5 - 8: FT-IR spectra of (a) mPEG-OH, (b) pure PMAO and (c) PMAO-g-PEG. 
Overall, large and aggregation-prone nanoclusters with mild toxicity were 
obtained when PMAO polymers was used. This prompted the need for further 
modification to the amphiphilic copolymer PMAO. Conveniently, the presence of 
versatile succinic anhydride functional groups on the PMAO backbone allowed its 
ydrophilicity to be easily tuned or modified with other water soluble functional 
moieties (and also more hydrophilic), such as fluorescence dye or polyethylene glycol 
(PEG). Such modification could proceed through the chemical functionalization of 
succinic anhydride with (i) amine functional groups (to form amide linkage) and (ii) 
hydroxyl functional groups (esterification reaction to form ester linkage). [44-47] 
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From Figure 5-2, mPEG-OH was employed to functionalize PMAO simply because: 
(1) mPEG-OH was cheap and commercially available and (2) the grafting proceed 
through a simple acid-catalyzed esterification reaction, (3) the grafting would 
eliminate the need for post-PEGylation process to improve its biocompatibility after 
nanocluster formation, (4) it directly tuned the hydrophilicity of PMAO which 
eventually predicted to increase the HLB value of the polymer that would reduce the 
overall oil-in-water droplet size during emulsion and lastly (5) it improved the 
colloidal stability of the synthesized nanoclusters (as given in the latter section). 
The acid-catalyzed esterification reaction that conjugated PEG functional 
group to the PMAO backbone was verified by FT-IR spectroscopy. The FTIR 
spectrum of the building blocks PMAO and mPEG-OH, as well as the resultant 
PMAO-g-PEG were presented in Figure 5-8. After the PEGylation, it was observed 
that most of the maleic anhydride rings were either reacted during the esterification or 
partially hydrolyzed which would result in the diminishing succinic anhydride C=O 
symmetric and asymmetric stretching at 1776 cm
-1
 and 1811 cm
-1
, as well as the 
diminishing succinic anhydride C–O stretching vibration at around 1200 cm-1. During 
such processes, more unbound carboxylic acids were also formed as reflected from 
the carboxylic acid C=O stretching at 1717 cm
-1
 as well as the hydroxyl –OH  
stretching at 3400 – 3700 cm-1. The esterification reaction between the carboxylic 
acid (from PMAO anhydride rings) and the hydroxyls group (from mPEG-OH) was 
confirmed from the ester linkage formation. This was indicated by the enhancement 
of the stretching vibration at around 1700 – 1730 cm-1 due to ester C=O which 
partially overlapped with the carboxylic acid C=O stretching vibrations.  
To further confirm the presence of PEG after PEGylation, 1H-NMR 
spectroscopy was performed on PMAO-g-PEG sample using CDCl3. From the NMR 
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spectrum, the characteristic peaks due to the resonance of –CH3 and –CH2– of C18 
alkyl chain (from octadecene) of the PMAO hydrophobic segments were observed 
around 0.9 ppm and 1.2 – 1.3 ppm respectively. The acid catalyzed esterification 
reaction would open the succinic anhydride ring, leaving one carboxylic acid and one 
ester bond between PMAO and mPEG-OH. The presence of PEG was confirmed by 
characteristic chemical shift of PEG chain at 3.6 – 3.7 ppm and 4.0 – 4.25 ppm. The 
ester linkage was not clearly observed due to the lack of abundance of the bond as 
compared to other linkages. The amount of PEG grafted onto PMAO was also 
estimated from the NMR spectrum. By using the integrated intensity of the relevant 
protons contribution from PEG as well as from PMAO, approximately 0.8–2.7% of 
PMAO has been grafted with PEG. 
 
Figure 5 - 9: 
1
H-NMR spectra of PMAO-g-PEG (solvent: chloroform-d, 300 MHz). 
The chemical shifts for PMAO-g-PEG. 
1
H-NMR (Bruker DPX300, 300MHz, CDCl3), δ = 0.9 ppm (f; –
CH2–CH2–CH3 ), 1.2 – 1.3ppm (d,e; –CH2–CH2–), 2.6 – 3.2 ppm (c; C–O–C–CH–CH–C–), 3.6 – 3.7 
ppm (b; O–CH2–CH2–O–CH3), 4.0 – 4.25 ppm (a; O–CH2–CH2–O–CH3). 
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5.3.3 Formation of Water Soluble MFNCs: Tuning the MFNPs Core 
 
Figure 5 - 10: SEM images of magnetic nanoclusters formed using PMAO-g-PEG at 




 and (c) 
50mg.mL
-1
 (insets: TEM images of the respective samples). (d) Hydrodynamic size 
distributions of the magnetic nanoclusters in water, prepared using different PMAO-
g-PEG concentrations. 
To find the optimum condition and the nanoclusters formability when using 
PMAO-g-PEG, various PMAO-g-PEG amounts (concentration) were used to form 







). As shown Figure 5-10, the TEM analysis of the nanoclusters 
highlighted the optimum amount of PMAO-g-PEG at 20 mg.mL
-1
 in order to form 
perfect spherical nanoclusters. As compared to MFNCs formed by PMAO 
(hydrodynamic size around 160–180 nm), the overall hydrodynamic size of MFNCs 
formed using PMAO-g-PEG was reduced significantly, to approximately ~100nm. 
Such decrease in size occurred due to the PEGylation effect which increased the HLB 
value of PMAO, causing the reducing in the oil-in-water droplet during mini-
emulsion/solvent evaporation process. [52-53] As PMAO-g-PEG still possessed the 
hydrophobic C18 backbone arranged in brush-like form, such structure acted as a good 
  - 140 - 
 
binder to host the hydrophobic nanocrystals despite the presence of hydrophilic PEG 
functional group.  
 
Figure 5 - 11: TEM images of water soluble MFNCs with various MFNPs magnetic 
core sizes encapsulated with PMAO-g-PEG, (MFNPs/PMAO-g-PEG ratio = 2.5:1): 
(a,e) 6 nm (MFNCs-A), (b,f) 11 nm (MFNCs-B), (c,g) 14 nm (MFNCs-C) and (d,h) 
18 nm (MFNCs-D). (i) Plot of MFNCs A-D MS values against the MFNPs core 
diameter sizes. (j) Hydrodynamic size distributions of MFNCs A-D samples in water 
recorded at 300K. 
Using the optimum PMAO-g-PEG amount, four different samples, namely 
MFNCs-A, MFNCs-B, MFNCs-C and MFNCs-D were prepared. Each of this 
samples consisted of different MFNPs (different core sizes), MFNCs-A with MFNPs-
A (~6nm), MFNCs-B with MFNPs-B (~11nm), MFNCs-C with MFNPs-C (~14nm) 
and lastly MFNCs-D with MFNPs-D (~18nm). Figure 5-11 depicted the TEM images 
of MFNCs A-D with increasing core sizes, showing individually separated 
nanoclusters without any significant aggregation. The SAED analysis of MFNCs A-D 
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(inset of Figure 5-11a-d) confirmed the presence of MFNPs inside MFNCs. No 
significant deterioration of crystallinity was observed in the SAED patterns of 
MFNCs as compared to MFNPs, indicating that the oil-in-water mini-
emulsion/solvent evaporation fabrication process did not affect the structural integrity 
of the core nanoparticles. 
 
Figure 5 - 12: (a) Hysteresis loop profiles of MFNCs A-D measured by VSM 
experiment at 300K. (b) TGA results of MFNCs A-D samples. 
The magnetic properties of MFNCs A-D were analyzed by VSM and 
summarized in Figure 5-11i and Figure 5-12a. The hysteresis loop of MFNCs A-D 
indicated that the as-synthesized nanoclusters were still superparamagnetic with no 
remnant magnetization. The MS value of MFNCs-A, MFNCs-B, MFNCs-C and 






 and 26.75 
emu.g
-1
 respectively. Figure 5-11i summarized the relationship between the MFNP 
core sizes with the resulting MFNCs overall effective MS values. The increase in MS 
values of MFNCs can be ascribed to the original core loaded onto MFNCs. The TGA 
results (in Figure 5-12b) indicated that the major weight loss was approximately 70-
80% for MFNCs A-D samples, contributed by the organic molecules. The loading 
percentages and their physical properties of MFNCs A-D were summarized in Table 
5-1. As plotted in Figure 5-11j, the DLS measurement of MFNCs A-D showed no 
secondary peaks which typically associated with significant inter-particle aggregation. 
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The average hydrodynamic size of MFNC-A, MFNCs-B, MFNCs-C and MFNCs-D 
measured from DLS experiment were 104.7 ± 1.5 nm, 106.2 ± 1.1 nm, 79.2 ± 1.0 nm 
and 82.5 ± 0.9 nm respectively. 
Table 5 - 1: Summary of various MFNCs A-D samples with different loading 
Sample MFNPs Core dhyd (nm) MS (emu.g
-1
) MFNPs Weight Fraction (%) 
MFNCs-A ~6nm/MFNCs-A 104.7 ± 1.5 11.93 19.69% 
MFNCs-B ~11nm/MFNCs-B 106.2 ± 1.1 16.83 19.59% 
MFNCs-C ~14nm/MFNCs-C 79.2 ± 1.0 19.46 26.54% 
MFNCs-D ~18nm/MFNCs-D 82.5 ± 0.9 26.75 24.97% 
The successfully formation of MFNCs using PMAO-g-PEG was verified by 
using FT-IR spectroscopy analysis. The main characteristic of hydrophobic MFNPs 
peaks were observed from the presence of oleic acid surfactant adsorption peaks. 
From Figure 5-13, Fe–O stretching at around 567 cm-1 indicated the bonding between 
the Fe (from MFNPs) and the oxygen containing functional group (from oleic acid). 
This bonding would involve the formation of –COO– group that interacts with the Fe 
atom. The characteristic peaks of –COO– group asymmetric and symmetric stretching 
vibrations were observed at 1527 cm
-1
 and 1571 cm
-1
 respectively. The presence of 
oleic acid alkyl chain was verified through the existence of asymmetric and 
symmetric –CH2 stretching vibrations at 2845 cm
-1
 and 2914 cm
-1
 as well as the 
existence of the asymmetric and symmetric –CH3 bending vibrations at 1399 cm
-1
.  
After the formation of MFNCs, it can be observed that the carboxylic acid 
adsorption peaks from PMAO-g-PEG, mainly C–O and C=O stretching vibrations at 
1168 cm
-1
 and 1697 cm
-1
 were presence on top of –COO– group from oleic acid/Fe 
atom interactions. The characteristic Fe–O stretching vibrations at 567 cm-1 remained 
unchanged indicating the presence of MFNPs. Overall, the FT-IR results suggested 
the simultaneous presence of MFNCs and PMAO-g-PEG mixture. 
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Figure 5 - 13: FT-IR spectra of (a) PMAO-g-PEG, (b) MFNPs and (c) MFNCs. 
5.3.4 Formation of Water Soluble MFNCs: Tuning the MFNPs Loading 
 
Figure 5 - 14: TEM images of water soluble MFNCs with various MFNPs-B 
magnetic core loadings with MFNPs/PMAO-g-PEG mass ratio of: (a) 0.3125 : 1 
(MFNCs-B1), (b) 0.625 : 1 (MFNCs-B2), (c) 1.25 : 1 (MFNCs-B3), (d) 2.5 : 1 
(MFNCs-B4) and (e) 5 : 1 (MFNCs-B5). (f) Plot of MFNCs B1–B5 MS values against 
the MFNPs/PMAO-g-PEG initial mass ratio. (g) Hydrodynamic size distributions of 
MFNCs B1–B5 samples in water recorded at 300K. 
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Besides the core size tuning, the loading of MFNCs can be simply adjusted by 
varying the initial MFNPs concentration used in the oil-in-water mini-
emulsion/solvent evaporation process. To demonstrate this, five samples, namely 
MFNCs-B1, MFNCs-B2, MFNCs-B3, MFNCs-B4 and MFNCs-B5 were fabricated 









 and 100 mg.mL
-1
 respectively. The TEM analysis in Figure5-14a-e 
showed the increase in the MFNPs loading as the initial MFNPs concentration was 
increased. The magnetic properties of MFNCs B1-5 were analyzed by VSM and 
summarized in Figure 5-14f and Figure 5-15a. The hysteresis loop of MFNCs A-D 
indicated that the as-synthesized nanoclusters were still superparamagnetic with no 
remnant magnetization. The MS value of MFNCs-B1, MFNCs-B2, MFNCs-B3, 









 and 19.47 emu.g
-1
 respectively.  
 
Figure 5 - 15: Hysteresis loop profiles of various MFNCs samples with different 
magnetic core loading measured by VSM experiment at 300K. (b) TGA results of 
various MFNCs samples with different magnetic core loadings in nitrogen gas 
atmosphere. 
Figure 5-14f summarized the relationship between the MFNPs/PMAO-g-PEG 
mass ratio and the resulting MFNCs overall effective MS values. The increase in MS 
values of MFNCs can be ascribed to the changes in the effective MFNPs weight 
percentage in the system. The TGA results (in Figure 5-15b) showed that the MFNPs 
weight fraction in the MFNCs samples increased with the increase of MFNPs-B 
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loading. The TGA results and the magnetization plot against the loading amount 
agreed well with the observed particle density of MFNPs given in Figure 5-16. The 
loading percentages and their physical properties of MFNCs B1-5 were summarized 
in Table 5-2. 
 
Figure 5 - 16: Plot of particle density against initial MFNPs loading amount. 
As plotted in Figure 5-14g, the hydrodynamic sizes measured from the DLS 
experiment were 120.2 ± 0.6 nm, 93.1 ± 0.4 nm, 86.7 ± 0.7 nm, 81.1 ± 1.2 nm and 
75.9 ± 0.4 nm for MFNCs-B1 MFNCs-B2, MFNCs-B3, MFNCs-B4 and MFNCs-B5.  
















MFNCs-B5 20 mg 1.0 25.1 x 10
-5
 82.08 19.47 
MFNCs-B4 10 mg 0.5 12.4 x 10
-5
 86.39 9.35 
MFNCs-B3 5 mg 0.25 9.18 x 10
-5
 90.64 6.04 
MFNCs-B2 2.5 mg 0.125 11.3 x 10
-5
 94.92 1.78 
MFNCs-B1 1.25 mg 0.0625 5.3 x 10
-5
 96.20 1.62 
On top of the hydrodynamic size, the TEM average sizes of MFNCs A-D and 
MFNCs B1-5 were counted manually and summarized in Table 5-3. The number of 
nanoparticles per nanoclusters was also estimated. The sampling size for the 
measurement was at least 60 nanoclusters. From the size distribution histograms in 
Figure 5-17, the TEM average size for MFNCs-A, MFNCs-B, MFNCs-C and 
MFNCs-D were 91.1 ± 12.1 nm, 96.0 ± 16.9 nm, 52.6 ± 6.1 nm and 64.3 ± 11.0 nm. 
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Meanwhile, from the size distribution histograms in Figure 5-18, the TEM average 
size for MFNCs-B1, MFNCs-B2, MFNCs-B3, MFNCs-B4 and MFNCs-B5 were 71.4 
± 5.0 nm, 69.0 ± 7.33 nm, 76.1 ± 7.2 nm, 67.0 ± 11.0 nm and 66.5 ± 7.5 nm. In 
general, as the nanoparticles core size increases or the loading amount decreased, the 
number of magnetic nanoparticle per nanoclusters decreased. 
Table 5 - 3: Summary of MFNCs TEM average sizes, DLS hydrodynamic sizes and 
the number of particles per nanoclusters for different MFNCs formulation. 
 
 
Figure 5 - 17: Magnetic nanoclusters TEM average sizes of: (a) MFNCs-A, (b) 
MFNCs-B, (c) MFNCs-C and (d) MFNCs-D. 




Figure 5 - 18: Magnetic nanoclusters TEM average sizes of: (a) MFNCs-B1, (b) 
MFNCs-B2, (c) MFNCs-B3, (d) MFNCs-B4 and (e) MFNCs-B5. 
Figure 5-20 compared both TEM and DLS average size of the nanoclusters 
with different core-size and loading amount. The hydrodynamic sizes, for both cases, 
were always larger than the TEM average size. The discrepancies between the TEM 
and the DLS average size can be explain from the measurement conditions. During 
DLS measurement, the hydrodynamic sizes of MFNCs were measured as the samples 
were dispersed in aqueous solvent (i.e. water). In this condition, the MFNCs would 
swell during measurement, especially with the presence of the hydrophilic PEG 
functional group in the PMAO-g-PEG. Thus the hydrodynamic size of the 
nanoclusters always included this swelling effect and size expansion due to water 
penetration into the nanoclusters. On the other hand, when MFNCs were observed 
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under electron microscope, the nanoclusters were in its dried-state. Hence, the 
MFNCs would appear much smaller as the structure collapsed. 
 
Figure 5 - 19: TEM and DLS average size of magnetic nanoclusters with different 
formulations: (a) core-size and (b) loading amount. Plot of the number of 
nanoparticles per nanoclusters against (a) MFNPs core sizes and (b) MFNPs/PMAO-
g-PEG mass ratio. 
In its dried state, the TEM average sizes of MFNCs-B1 to MFNCs-B5 were 
relatively the same (Figure 5-19b). The tuning of the nanoclusters loading amount 
would barely affect the TEM average size of the nanoclusters. This highlighted the 
fact that as long as the core size nanoparticles were relatively similar in size, the 
nanoclusters with similar size can be obtained despite the loading amount. The 
hydrodynamic size of the nanoclusters increased as the MFNPs/PMAO-g-PEG mass 
ratio was decreased. The decrease in MFNCs loading was equivalent with the 
presence of more PMAO-g-PEG. As it contained more PMAO-g-PEG, the overall 
hydrodynamic size increased due to more swelling in aqueous conditions. 
When the core nanoparticles size decreased, the resultant nanocluster sizes 
increased as the system required to overcome larger energy barrier to break-down the 
oil-in-water droplet. As illustrated in Figure 5-20, smaller MFNPs core possessed 
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higher surface energy due to nano-size effect whereby the surface-to-volume ratio 
increased. Such core tends to form small aggregates in order to minimize the total 
system energy. Thus it is easier for the sonication process during mini-
emulsion/solvent evaporation process to break-down the oil-in-water droplet to 
smaller droplet size if the core nanoparticles did not aggregate together. As a results 
of this, the number of nanoparticles recorded per nanoclusters also decrease as the 
MFNPs core size increased. 
 
Figure 5 - 20: Schematic diagram illustrating the nanoclusters formation with 
different MFNCs magnetic core sizes. 
5.3.5 Magnetic Hyperthermia Study of MFNCs 
By exposing MFNCs to alternating magnetic field (AMF), heat dissipation due 
to the synergistic effect from Brownian and Neel relaxation losses was studied. The 
heat dissipation can be recorded in the form of AMF exposure time-dependent 
temperature increment curve. In this study, two samples heavily loaded with MFNPs-
2 core were selected, namely MFNCs-B4 (low loading) and MFNCs-B5 (high 





 were presented in Figure 5-21. The time taken for the MFNCs-B4 and 
MFNCs-B5 samples to reach 42
o
C from room temperature were 627 seconds and 557 
seconds. At low field (Figure 5-21b), such as 48.11 kA.m
-1
, the heating profiles of 
both samples were approximately similar.  
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Figure 5 - 21: Time dependent temperature curve of 1 mL of 0.3mg.mL
-1
 MFNCs-B4 
and MFNCs-B5 samples at different AMF exposure: (a) 59.99 kA.m
-1
 and (b) 48.11 
kA.m
-1
 AC field at 240 kHz frequency. (c) Summary of SAR values of MFNPs-B4 




SAR values were recorded as 295.3 W.g
-1
 and 307.91 W.g
-1
 for low field 
(48.11 kA.m
-1
) for MFNCs-B4 and MFNCs-B5 respectively. Meanwhile, at high field 
(59.99 kA.m
-1




 were recorded for 
MFNPs-B4 and MFNPs-B5 respectively. Although MFNCs-B4 and MFNCs-B5 
showed comparable SAR values at low field, the SAR values of MFNCs-B4 and 
MFNCs-B5 differ quite significantly at high field. This can be attributed to the 
presence of long chain PEG which hindered the overall nanoclusters rotation at high 
field; therefore slowing down the relaxation process and its heat dissipation. [54] 
During magnetic hyperthermia measurement (or photothermal therapy if 
metallic nanoparticles core was used instead), it was critical for the MFNCs samples 
to withstand temperature shock. In Figure 5-21d, the temperature-dependent stability 
demonstrated that multifunctional nanoclusters hydrodynamic sizes were quite 
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constant, even after being heated for around 20
o




5.3.6 Formation of AIZS-loaded MFNCs (A-MFNCs) 
 
Figure 5 - 22: (a) TEM image of orange color AIZS dispersed in CHCl3 (inset: 
HRTEM image of the AIZS sample). (b) XRD pattern of the orange color AIZS. 
Besides loading the MFNCs with superparamagnetic MFNPs, the nanoclusters 
could also be formed with other functional nanocrystals such as inorganics QDs, 
metallic nanoparticles as well as up-/down-conversion nanoparticles. In this section, a 
simultaneous loading of AgInS2–ZnS (AIZS) QDs and superparamagnetic MFNPs-B 
was presented to demonstrate the formability of multifunctional nanocomposites. 
Based on the aforementioned TEM average size analysis, MFNPs-B core was selected 
due to its comparable core size with typical AIZS QDs. Orange color AIZS QDs were 
synthesized through a one-pot high temperature thermal decoposition method in 
which Zn diffused into AgInS2 nanoparticles, forming a heterodimer structure. [50] 
The TEM images of the as-synthesized hydrophobic AIZS QDs in Figure 5-23a 
revealed an average nanoparticle size of 5.7 ± 1.1 nm. The HRTEM image of the 
AIZS QDs showed lattice fringe d-spacing of approximately 0.14 nm; which 
corresponded to (112) plane of the orthorhombic AgInS2 structure. The crystalline 
structure of AIZS QDs was confirmed from its XRD pattern (Figure 5-23b). Three 
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major characteristic peaks were observed at 2θ around 27o, 46o and 54o. The obtained 
AIZS peaks lied in between the characteristic peaks of bulk ZnS (JCPDS #65-0309) 
and bulk AgInS2 (JCPDS #25-1328) which confirmed the formation of both AgInS2 
and ZnS heterodimers. The standard XRD patterns of ZnS and AgInS2 were included. 
 
Figure 5 - 23: TEM images of AIZS-loaded MFNCs (A-MFNCs) dispersed in water. 
(a) Low magnification TEM image of A-MFNCs. (b) TEM image of single A-
MFNCs. (c) High resolution TEM image of A-MFNCs showing the presence of both 
MFNPs-B and AIZS cores inside the A-MFNCs clusters. TEM EDX elemental 
mapping of A-MFNCs, 6 elements were mapped, mainly: (d) Iron (Fe), (e) 
Manganese (Mn), (f) Silver (Ag), (g) Indium (In), (h) Zinc (Zn) and (i) Sulfur (S). (j) 
EDX spectrum of A-MFNCs and its elemental analysis. 
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Similar to the MFNCs formation, multifunctional nanoclusters A-MFNCs 
were formed by simply replacing the MFNPs solution (in CHCl3) with a mixture of 
MFNPs/AIZS solution (in CHCl3). Figure 5-23a-c showed the TEM and HRTEM 
images of A-MFNCs in water. Both MFNPs-B and AIZS were successfully 
encapsulated inside PMAO-g-PEG polymer matrix. Figure 5-23a indicated that each 
A-MFNC was isolated from each other and no significant aggregation was observed. 
Moreover, no MFNPs or AIZS QDs were encapsulated individually. The presence of 
MFNPs and AIZS QDs could be clearly observed from the HRTEM image of A-
MFNCs in Figure 5-23c. The formation of such heterostructures had no effect on the 
individual building block crystallinity. For example, the HRTEM showed the well-
defined lattice fringes of MFNPs with interplanar distances of approximately ~0.29 
nm that corresponded directly to (220) lattice plane d-spacing. The inset in Figure 5-
23a highlighted the A-MFNCs samples in water with orange fluorescence under 
normal lighting conditions (left) and under UV illumination (right, λmax = 365 nm). 
In order to verify that both MFNPs and AIZS QDs have been successfully 
encapsulated together, A-MFNCs samples were subjected to EDX mapping analysis 
during the TEM measurement. As shown in Figure 5-23d-i, the elemental EDX 
mapping verified the presence of all the 6 main elements in A-MFNCs, mainly Fe, 
Mn, Ag, In, Zn and lastly S, as well as their spatial distributions in the polymer 
matrix. The presence of FNPs was confirmed with the presence of metal Fe and Mn 
elements. Meanwhile, the presence of AIZS QDs was confirmed with the presence of 
Ag, In, Zn and S elements. The EDX spectrum of A-MFNCs and their elemental 
quantification analysis (Figure 5-23j) revealed a breakdown of 6.68 at% Fe, 0.97 at% 
Mn, 8.33 at% Ag, 4.05 at% n, 3.88 at% Zn and 16.04 at% S. The remaining 60.05 at% 
was attributed to the presence of oxygen (O).  
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Table 5 - 4: Quantum yields summary 
Samples Solvent Emission (nm) QYs 
AIZS QDs Hexane 634 35.00% 
A-MFNCs Water 610 13.73% 
A further characterization of AIZS fluorescence properties indicated a 
significant drop in the quantum yield (QY) from 35% of hydrophobic AIZS in hexane 
to 13.7% after the formation of A-MFNCs with MFNPs-B. The quenching of the 
























QYQY    …(7) 
where F is the spectrally integrated photon flux measured (area under the emission 
spectrum which has been corrected for blank emission), f is the absorption factor and 
n is the refractive index. In the measurement, rhodamine 101 dye in ethanol (literature 
QYst = 100%) with emission range of 600-650 nm that was close to the orange AIZS 
emission was used as standard materials. [56] Such decrease can be ascribed to the 
increase in the AIZS surface defect induced by sonication during the formation 
process, as well as the absorption of visible wavelength due to the combinatorial 
presence of PMAO-g-PEG polymers and MFNPs-B in A-MFNCs sample. Similar 
reduction in QY (more than 40%) due to sonication effect has been reported 
previously when orange AIZS were combined with graphene oxide materials. [57] 
 
Figure 5 - 24: TEM EDX elemental mapping of MFNCs-B2: (a) original high 
magnification TEM image of MFNCs-B2 to be mapped. (b) Actual position of 
MFNCs-B2 during mapping process. 2 elements were mapped for MFNCs-B2, 
mainly (c) Iron (Fe) and (d) Manganese (Mn). 
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As a comparison, a simple TEM EDX elemental mapping analysis (Figure 5-
24) of MFNPs-B2 samples was given. The presence of MFNPs was similarly 
confirmed with the presence of spatially distributed Mn and Fe elements over the 
polymer matrix. A breakdown of 75.25 at% Fe and 4.77 at% Mn were obtained from 
the EDX elemental quantification analysis. From both EDX analysis of MFNCs-B2 
and A-MFNCs, it was apparent that the atomic ratio between Mn and Fe indicated 
that Mn was actually doped onto Fe3O4 structures. 
 
Figure 5 - 25: (a) Hysteresis loop of A-MFNCs and MFNCs-B4 measured by VSM 
experiment at 300K. (b) Hydrodynamic size distribution of A-MFNCs sample 
dispersed in water measured at 300K. 
The magnetic properties of A-MFNCs were expected to be comparable to 
those of MFNCs with a similar total amount of nanoparticle loadings (MFNCs-B4). 
This was clearly indicated from the A-MFNCs hysteresis loop given in Figure 5-25a 
which was close to those of MFNCs-B4. The MS value of A-MFNCs was about 8.76 
emu.g
-1
, slightly lower than that of MFNCs-B4 of 9.35 emu.g
-1
.  A-MFNCs samples 
still behaved superparamagnetically despite the presence of AIZS quantum dots. 
Moreover, the hydrodynamic size of A-MFNCs was found to be 119.8 ± 1.0 nm with 
no secondary aggregation peaks (Figure 5-25b). With the excess of fluorescence 
AIZS in the multifunctional nanoclusters, the contribution from the magnetic 
nanoparticles core would diminish. As such, the MR relaxivity performance as MRI 
T2 contrast agent would be deteriorated. On the other hand, when the amount of 
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fluorescence AIZS was reduced, the fluorescence signals from the nanoclusters would 
diminish and the QY would be negligible. Hence, during the multifunctional 
nanoclusters formation, the balance between the inorganic cores must be maintained. 
5.3.7 In-vitro Cellular Imaging Demonstration 
 
Figure 5 - 26: Confocal image of NIH/3T3 cells incubated with MFNCs-B4 (negative 
staining): (a) bright field and (b) CLSM images. Confocal image of NIH/3T3 cells 
incubated with A-MFNCs (positive staining): (c) bright field and (d) CLSM images. 
Reconstructed three-dimensional model of NIH/3T3 cells from (e) bright field z-stack 
images and (f) CLSM z-stack images. 
The presence of AIZS QDs loading inside A-MFNCs enabled the 
nanocomposites to be used as labeling agents in cellular imaging demonstration. The 
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in-vitro cellular imaging using A-MFNCs was demonstrated on NIH/3T3 fibroblast 
cells. The staining of NIH/3T3 cells using A-MFNCs nanocomposites was probed by 
confocal laser scanning microscope (CLSM; 405 nm laser source). Figure 5-26 
demonstrated the CLSM images of NIH/3T3 cells after 24 hours incubation with 
MFNCs-B4 (negative staining) and A-MFNCs (positive staining). The high resolution 
image (Figure 5-27) verified that majority of A-MFNCs were located inside the cell 
cytoplasm, suggesting that A-MFNCs internalization/cellular uptake have taken place. 
This was consistent with literatures in which the internalization and the saturation of 
the nanoparticles could be achievable within few hours of incubation. [58-59]  
 
Figure 5 - 27: High magnification CLSM image of NIH/3T3 cells incubated with A-
MFNCs: (a) microscope image, (b) fluorescence image and (c) combined image.  
From the 24 hours incubation with NIH/3T3 cells, A-MFNCs that contained 
AIZS (Cd and Pd free semiconductor quantum dots), it was assured that A-MFNCs 
could not induce severe toxicity effect on NIH/3T3 cells even after cellular uptake 
and prolonged incubation time. To further verify the exact position of A-MFNCs after 
the intracellular uptake process, the image of planes at various depths (z-direction) of 
NIH/3T3 cells were obtained (after 24 hours incubation with A-MFNCs). The z-stack 
images were then reconstructed into three-dimensional image as shown in the CLSM 
image of Figure 5-26e,f. It was clearly indicated that the internalization of A-MFNCs 
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has occurred and A-MFNCs were located and accumulated in the cell cytoplasm. 
Despite the cellular uptake, A-MFNCs were unable to penetrate the cell nucleus. [60] 
5.3.8 Protein Adsorption, Colloidal Stability and In-vitro Cellular Cytotoxicity  
 
Figure 5 - 28: (a) Comparison of the time-dependent colloidal stability of 
nanoclusters formed with PMAO and PMAO-g-PEG incubated with 10% BCS (in 
PBS 1x). (b) Cell viability of NIH/3T3 cells incubated with MFNCs-D for 24 hours. 
Plots of colloidal stability testing of A-MFNCs: the average hydrodynamic size and 
zeta potentials against pH (1.0–14.0) at different temperatures (c) 25oC and (d) 37oC.  
For designing any nanocomposites structure for biomedical applications, their 
colloidal stability and biocompatibility must be taken into consideration. When 
administered to human body, various plasma proteins would interact and adhere to 
nanomaterials that could lead to serious foreign body response (FBR). In order to 
assess the effect of having the PEG functional group onto the protein adsorption, 
MFNCs samples synthesized with PMAO and PMAO-g-PEG were incubated 
individually with 10% bovine calf serum (BCS) solution. As shown in the time-
dependent colloidal stability test in Figure 5-28a, without the presence of PEG 
functional group, the hydrodynamic size increased around 8–17% immediately after 
the addition of the BCS at room temperature and further increased by another 5% 
  - 159 - 
 
after the temperature was increased and equilibrated to 37
o
C. Such size increment was 
caused by the non-specific adsorption of various proteins onto MFNCs surface which 
were not favorable in biomedical applications.  
In contrast to this, with the presence of PEG functional group, the 
hydrodynamic size increased only around 1–5% after BCS addition at room 
temperature and at 37
o
C. The average hydrodynamic size of MFNCs synthesized with 
PMAO-g-PEG was rather constant throughout the time-dependent stability test and no 
significant interparticle aggregation was observed. These time-dependent colloidal 
studies of MFNCs formed with PMAO and PMAO-g-PEG results demonstrated that 
PEGylation would indeed help to minimize the potential for non-specific protein 
adsorption onto nanoclusters surface. The biocompatibility of the as-synthesized 
MFNCs was assessed by incubating NIH/3T3 mouse fibroblast cells with MFNCS-D 
samples at various iron concentrations. MFNCs-D loaded with the largest MFNPs 
core (high manganese content among the other MFNPs core) was selected as a role 
model to study the cytotoxicity effect due to its excellent magnetic properties which 
associated with high aggregation-risk. From the in-vitro cytotoxicity given in Figure 
5-28b, MFNCs-D sample was found to exhibit excellent biocompatibility with 
NIH/3T3 cells up to 1.75 mM iron concentration with cell viability of more than 
96.8%. No significant cell death or proliferation was observed with NIH/3T3 cells 
incubated with MFNCs-D under optical microscope observation. In comparison with 
the earlier results of PMAO-coated nanoclusters (Figure 5-7) whereby over 20% of 
NIH/3T3 cell death was resulted, the presence of PEG on the MFNCs corona helped 
to improve the overall biocompatibility. 
As pH various at different location in human body, the multifunctional 
nanoclusters sould also have high tolerance towards pH changes in order to be 
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functional and colloidally stable inside human body. To assess such pH stability, A-
MFNCs sample was simply incubated under various pH conditions and their 
hydrodynamic sizes (together with its zeta potentials ζ) were monitored. In Figure 5-
28c,d, after incubation at various pH conditions, the isoelectric point (pI) of the 
nanoclusters formed with PMAO-g-PEG was determined to be around ~2.0 to 3.0. 
Under physiological condition (pH 7.4, 37
o
C), the surface charge of A-MFNCs was 
approximately –23.1 mV. Under such conditions, the negative surface charge due to 
the presence of carboxylic acid could provide electrostatic repulsion to stabilize the 
A-MFNCs in aqueous phase. In addition, the presence of hydrophilic PEG chain also 
provided steric hindrance to prevent possible interparticle aggregation. 
Overall, the hydrodynamic sizes of A-MFNCs were quite stable across pH 4.0 
to pH 13.0. Below pH 4.0 and above pH 13.0, the hydrodynamic sizes increased 
significantly. Below pH 4.0, the zeta potential of A-MFNCs became positive 
indicating the protonation of the carboxylic acid functional group from PMAO-g-
PEG. At this pH range, due to its harsh condition, the core nanoparticles could 
dissolve as well. [49] On the other hand, above pH 13.0, no protonation of carboxylic 
acid was observed, indicated by the negative charged surface of A-MFNCs. The 
abrupt size increase indicated that the PMAO-g-PEG matrix could have swelled and 
dis-integrated; leading to severe MFNPs core nanoparticle aggregation. 
5.3.9 MR Relaxivity Testing 
The presence of superparamagnetic MFNPs loading allowed the MFNCs 
samples (e.g. MFNCs-B4 and A-MFNCs) to be potentially useful as T2 MR imaging 
contrast agent. Both MFNCs-B4 (106.2 ± 1.1 nm) and A-MFNCs (119.8 ± 1.0 nm) 
were loaded with same MFNPs core size (~11 nm MFNPs-B) and comparable loading 
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amount. Plot of T1 and T2 relaxation rate of MFNCs-B4 and A-MFNCs together with 
MFNCs-A (104.7 ± 1.5 nm) and MFNCs-D (82.5 ± 0.9 nm) were given in Figure 5-
29. From the T2-weighted images, the concentration-dependent T2 darkening effects 
were observed for all 4 samples with the greatest enhancement recorded for MFNCS-
B4. The r2 relaxivity values of the four samples, calculated from the relaxation rate 
plot against the iron concentration, indicated that MFNCs-B4 exhibited the highest r2 




. At similar iron concentration, the r2 relaxivity value of 




 was quite close to that of MFNCs-B4. This 
indicated the coupling of MFNPs with other nanoparticles system such as AIZS QDs 
had a negligible effect on the contrast enhancement of the T2 effect. 
Meanwhile, based on the core size consideration, MFNCs-D with ~18 nm 
MFNPs core  was expected to have higher r2 value as compared to MFNCs-A (~6 nm 
MFNPs) and MFNCs-B4. However, from Figure 5-29a,c, the r2 relaxivity value was  









. Such discrepancies can be explained if the data presented in 
Figure 5-19c was considered. MFNCs-D, being nanoclusters with the smallest 
average hydrodynamic size of 82.5 ± 0.9 nm which contained the largest ~18 nm 
MFNPs core size, definitively has lowest packing density (number of nanoparticles 
per nanocluster). When compared with MFNCs-A and MFNCs-B4, the nanoparticles 
clustering effect was less prominent in MFNCs-D. By considering a simplistic model 
of large magnetized spheres [45], MFNCs-D caused less local magnetic perturbations 
to the surrounding water protons as compared to MFNCs-A and MFNCs-B4. 
Therefore, MFNCs-A and MFNCs-B4 produced higher T2 relaxivity improvement. 
The r1 relaxivity values presented in Figure 5-29 appeared to be much lower as 
compared to the conventionally used Ferucarbotran and Resovist. [61] While 
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enhancing T2-effect, the overall nanoclusters formation suppressed the T1-effect 
significantly. This was consistent with the agglomeration results reported previously 
in the literature. [61-64] 
 
Figure 5 - 29: Plot of the T1 and T2 relaxation rate (1/T1 and 1/T2) against various iron 
concentrations of (a) MFNCs-A, (b) MFNCs-B4, (c) MFNCs-D and (d) A-MFNCs 
(insets: the relaxivity values r1 and r2 for respective MFNCs samples). T2-weighted 
images of respective MFNCs samples were given below the plot.  
5.4 Summary 
In summary, a simple and versatile method to form multifunctional 
nanoclusters using PEG functionalized amphiphilic brush copolymers PMAO was 
demonstrated. Simply by tuning the core sizes and the initial nanocrystals amount 
(nanocrystals to polymer mass ratio), MFNPs were used to demonstrate the versatility 
of tuning the loading of the nanoclusters. The resultant nanoclusters were found to 
have a well-controlled spherical shape. Moreover, the types of nanoparticles loaded to 
the nanoclusters can be changed simply by changing the core hydrophobic 
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nanocrystal. In order to demonstrate the formability of multifunctional nanoclusters 
with different types of inorganic nanocrystals, Zn-doped AgInS2 QDs was loaded 
together with MFNPs nanocrystals during the nanoclusters formation to obtain bi-
functional nanoclusters with fluorescent and magnetic behaviors. The MR relaxivity 
test confirmed that the loading of different types of nanocrystals together with MFNPs 
has negligible effect on the overall properties of the nanoclusters. T2 relaxivity value 








 could be achieved with 
MFNCs loaded with 11 nm MFNPs and MFNCs loaded with 11 nm MFNPs together 
with AIZS QDs respectively. Additionally, such bifunctional nanoclusters were also 
successfully demonstrated for in-vitro cellular bio-imaging using NIH/3T3 cells. The 
in-vitro incubation of the bifunctional nanoclusters with NIH/3T3 cells for 24 hours 
also showed no sign of toxicity. Besides, MFNCs were also potentially used as 
magnetic hyperthermia agents. The heating through AMF exposure indicated that 
MFNCs, loaded with 11 nm MFNPs, could deliver SAR value up to 540.5 W.g
-1
 with 
concentration as low as 0.3 mg Fe.mL
-1
 (under 59.99 kA.m
-1
 field). 
From the time-dependent colloidal stability test, the presence of PEG chain 
grafted onto PMAO was able to reduce protein adsorption onto the nanocluster 
surface. The pH-dependent stability test was performed to investigate on the 
isoelectric point of the MFNCs as well as to further assess the coating protection by 
PMAO-g-PEG amphiphilic brush copolymers. Lastly, the in-vitro test was also 
carried out to demonstrate the biocompatibility of PMAO-g-PEG and MFNCs with 
NIH/3T3 mouse fibroblast cells. As suggested from our results, such biocompatibile 
and colloidally stable nanoclusters (with an approximate size of 80 – 120 nm) formed 
using amphiphilic brush copolymers PMAO-g-PEG have high potential for various 
biomedical applications. 
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Chapter 6. Synthesis of Hydrophilic Superparamagnetic 
Nanocrystals/Graphene Oxide Nanocomposites 
 
6.1 Introduction 
Recently, the incorporation of superparamagnetic nanoparticles (SPM) with 
graphene oxide (GO) to form magnetic nanocomposites has attracted a wide research 
interest. Such nanocomposites are highly favored in biomedical applications due to 
their good colloidal stability in water and biocompatibility with biological moieties. 
[1-5] Currently, there were several methods that have been reported to synthesize GO-
based magnetic nanocomposites, including: (1) direct precipitation of magnetic 
nanoparticles on GO sheets dispersed in water; (2) solvothermal/thermolysis synthesis 
of magnetic nanoparticles in polar solvent with the presence of GO sheets; (3) 
covalent integration of magnetic nanoparticles with GO. [6-18]  
Despite the efforts made to make various GO-based magnetic nanocomposites, 
there were several challenges associated with the current approaches. For instance, the 
synthetic protocols for SPM such as co-precipitation, solvothermal and thermolysis in 
polyol solvents would lead to low-quality and poly-disperse magnetic nanoparticles. 
Meanwhile, the covalent integration of magnetic nanoparticles onto GO requires a 
well-established surface functionalization of nanoparticles, which is highly sensitive 
to the nanoparticles type and surface functional groups availability. Besides, so far 
there has been no good control over the composites in terms of size, size distribution 
and the loading amount of the magnetic nanoparticles. All these challenges have to be 
overcome in order to enable the composites to be useful in biomedical applications. 
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For the magnetic nanoparticle synthesis route, as discussed in Chapter 1, 
section 1.4.2, high temperature thermal decomposition in non-polar solvent was 
typically preferred over the remaining synthetic routes because of the excellent 
nanoparticle size and morphology control. [19-26] Inspired by the need to water 
solubilize such hydrophobic nanocrystals using amphiphilic polymers and the recent 
studies on the amphiphilicity of GO sheets, a brand new concept of using GO sheets 
to host the hydrophobic nanoparticles. [27-29] Such approach would allow GO to 
replace the current need of polymer nanocarriers as well as taking the advantages of 
GO in biomedical applications mentioned earlier. 
 
Figure 6 - 1: Schematic diagram illustrating: (a) formation of oleylamine modified 
nano-size graphene oxide sheets (GO-g-OAM), followed by (b) synthesis of water-
soluble MFNPs/GO nanocomposites (MGONCs) and (c) PEGylation of MGONCs 
using carbodiimide chemistry to improve the colloidal stability. 
Based on the proposed concept, a simple, versatile and straight-forward route 
to anchor hydrophobic superparamagnetic manganese-doped ferrite nanocrystals onto 
nano-size GO sheets was realized. The schematic diagram presented in Figure 6-1 
illustrated the strategy to form water soluble and biocompatible magnetic 
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nanoparticles/GO composites for biomedical applications. Basically, high quality 
manganese-doped ferrite MnFe2O4 SPM (MFNPs) was prepared separately through 
the thermal decomposition of metal acetylacetonate precursors in the presence of non-
polar organic solvent. Manganese-doped ferrite was chosen due to its excellent 
magnetic properties for various theranostic applications such as magnetic 
hyperthermia agents and MRI T2 contrast agent, as mentioned previously in Chapter 
1. [30] Subsequently, nano-size GO sheets were modified with oleylamine to render 
the GO sheets to be processable in non-polar solvents (Figure 6-1a). The non-
covalent attachment of the hydrophobic MFNPs onto the modified GO sheets to yield 
MFNPs/GO nanocomposites (denoted as MGONCs) was proceeded by simple mini-
emulsion method without any emulsion stabilizer, followed by subsequent solvent 
evaporation process (Figure 6-1b). 
By using the above mentioned approach, the tuning of MFNPs loading amount 
could be realized by varying the mass ratio of MFNPs to GO. Meanwhile, the overall 
hydrodynamic size range of MGONCs could be controlled by simply adjusting the 
sonication time during the emulsion process. Moreover, due to the need to enhance 
the colloidal stability as well as to improve the biocompatibility of the 
nanocomposites, polyethylene glycol (PEG) functional groups were then grafted on 
MGONCs through the well-established carbodiimide chemistry (Figure 6-1c) to yield 
MGONCs-PEG. [2,4] Both prolonged sonication process to form MGONCs 
nanocomposites and its subsequent PEGylation were found to have insignificant 
effect towards the crystallinity of the original MFNPs core. Lastly, MGONCs and 
MGONCs-PEG samples were investigated for its potential in MFH and MRI 
applications. By simply tuning the hydrodynamic size of the MGONCs 
nanocomposites and the core MFNPs loading, the SAR values and the T2 relaxivity 
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can be altered. A simple in-vitro demonstration will also be conducted to determine 
the efficacy of using MGONCs as MFH agent. 
Because the conceptualized approach did not require any prior surface 
modification of the nanocrystals, it provided an adaptable, robust and versatile 
opportunity to form water-dispersible nanocomposites; not only with hydrophobic 
magnetic nanoparticles but it will serve as a universal platform for any other 
hydrophobic nanoparticle systems. To verify the idea, other nanoparticle system such 
as Fe3O4 iron oxide nanocubes will also be demonstrated to be decorated on GO layer. 
6.2 Experimental Procedures 
6.2.1 Materials 
Graphite flakes (2-15µm) were obtained from Alfa-Aesar. Sodium nitrate 
(NaNO3), concentrated sulphuric acid (H2SO4, 98%), potassium permanganate 
(KMnO4) and hydrogen peroxide (H2O2) were used as received. Manganese (II) 
acetylacetonate (Mn(acac)2), benzyl ether (99%), oleylamine (70%), N-
Hydroxysuccinimide (NHS; 98%), iron (III) acetylacetonate (Fe(acac)3; 97%), N-(3-
Dimethylaminopropyl)- ′-ethylcarbodiimide hydrochloride (EDC; ≥99.0%) and oleic 
acid (≥99%) were purchased from Sigma Aldrich. Amine functionalized polyethylene 
glycol (mPEG-NH2; Mw 5000) was purchased from Nanocs. Chloroform (CHCl3; 
99.99%) and hexane (99.9%) and 0.2 µm syringe filter Minisart
®
 from Sartorius 
Stedim Biotech were used as received. Standard RC dialysis tubing Spectra/Por2 
(MWCO: 12-14 kDa) was purchased from SpectrumLabs. Cell Counting Kit-8 (CCK-
8) was purchased from Dojindo Molecular Technologies, Inc and stored at -20
o
C).  
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6.2.2 Preparation of Graphene Oxide (GO) 
Graphene oxide was prepared through modified Hummer’s method. [31] 
Typically graphite flakes (2-15µm; 1 g) were mixed with NaNO3 (1 g) in a one neck 
round bottom flask in ice-bath (0
o
C). Concentrated H2SO4 (~98%; 46 mL) was added 
to this solid mixture and the black colour solution was stirred for 1 hour at 0
o
C. 
Subsequently KMnO4 (6 g) was added slowly to the 0
o
C solution mixture under 
magnetic stirring condition. After all the KMnO4 was added, the solution mixture was 
incubated for 1 hour at 0
o
C under vigorous stirring condition. Next, the solution 
temperature was increased to 35
o
C and kept for 72 hours. After the incubation, water 
(40 mL) was added and the temperature was further increased to 90
o
C. The entire 
solution mixture was further diluted by adding additional water (200 mL) and 
incubated for another 72 hours before the addition of H2O2 (6 mL). The graphene 
oxide solution was washed several times with 4% HCl and water (each for 5-6 times) 
with the aid of centrifugation (10000rpm for 10 minutes). The washed GO solution 
was then sonicated by bench-top ultrasonic homogenizer for 4 hours and oven-dried. 
6.2.3 Preparation of MnFe2O4 Nanoparticles (MFNPs) 
MFNPs were synthesized through the thermolysis of metal-acetylacetonate 
precursors following the protocols published with a slight modification. [32] 
Typically for an approximately ~11 nm size octahedral MFNPs, Fe(acac)3 (2.825 g; 8 
mmol), Mn(acac)2 (1.0126 g; 4 mmol), oleic acid (7.908 g; 28 mmol) and benzyl ether 
(35 mL) were charged into a three-neck round bottom flask with an attached 
condenser. The flask was purged with nitrogen gas for 15-30 minutes prior to the 
synthesis process. The solution temperature was initially increased to 165
o
C and held 
isothermally for 30 minutes. Subsequently, the temperature was further increased to 
reflux (~280
o
C) and held isothermally for 30 minutes. The black colour solution was 
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cooled down naturally to room temperature and washed by a repeated dispersion and 
precipitation by using hexane/isopropanol mixture. The isolation of the particles was 
done through centrifugation. The final product was completely dispersed in CHCl3 at 
50 mg.mL
-1
 concentration and the black ferro-fluid was stored at 4
o
C. 
6.2.4 Preparation of GO Grafted with Oleylamine (GO-g-OAM) 
To prepare GO grafted with oleylamine, dried GO flakes (20 mg) were mixed 
with oleylamine (5 mL) and CHCl3 (7 mL). The solution mixture was then sonicated 
by ultrasonic homogenizer for 30 minutes. GO oxide was initially insoluble in the 
mixture of oleylamine/hexane. After few minutes of sonication, the overall solution 
would turn into dark brown color, indicating that GO has been successfully 
transferred to non-polar organic solvent (this is applicable not only to CHCl3, but also 
for toluene and hexane). To simply purify GO-g-OAM, ethanol was added to 
precipitate GO-g-OAM. The solution was centrifuged at 10000 rpm for 10 minutes to 
isolate GO-g-OAM. Subsequently CHCl3 was added to the dark brown color 
precipitate to make total concentration of GO-g-OAM in CHCl3 become 4.12 mg.mL
-
1
 and 7.2 mg.mL
-1
. The resulting solution was sonicated in an ultrasonic bath for 20 
minutes and kept in a sealed glass vial at room temperature without washing. 
6.2.5 Preparation of Water Soluble MFNPs/GO-g-OAM Nanocomposites  
Water soluble MFNPs/GO-g-OAM composites (MGONCs) were prepared 
through the typical mini-emulsion process coupled with solvent evaporation. 
Typically GO-g-OAM (in CHCl3; 4.12 or 7.2 mg.mL
-1
; 1 mL) was mixed with 
magnetic nanoparticles (MFNPs in CHCl3; 50 mg.mL
-1
; 0.2 mL) and sonicated for 5 
minutes in an ultrasonic bath to obtain a uniform mixture. To this mixture, 12 mL 
water (CHCl3 to water ratio = 1:10) was added and the resulting mixture was 
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emulsified with water for 5 minutes (or longer) with bench-top ultrasonic 
homogenizer. Subsequently, the light brown emulsion was transferred onto a pre-
heated beaker at 60-70
o
C equipped with magnetic stirring function. The CHCl3 was 
allowed to evaporate at the aforementioned temperature for 30 minutes under rigorous 
magnetic stirring. The dark brown transparent aqueous solution containing MGONCs 
was centrifuged (10000rpm, 10 minutes) to remove large contaminant. No further 
washing step was needed and the sample can be stored for extended period of time. 
6.2.6 PEGylation of MGONCs 
Polyethylene glycol (PEG) was conjugated to improve the colloidal stability of 
MGONCs in saline solution such as phosphate buffer solution or PBS 1x (pH ~7.4). 
Typically, MGONCs-4 (0.3 mg.mL
-1
 of GO; 9 mL) was mixed with mPEG-NH2 (40 
mg.mL
-1
; 5 mL) and sonicated for 30 minutes in an ultrasonic bath. To this solution, 
EDC (10 mg.mL
-1
; 3 mL) and NHS (8 mg.mL
-1
; 3 mL) were added. Subsequently the 
solution mixture was stirred at 1000rpm for 24 hours. PEGylated MGONCs sample 
was then purified by dialyzing against Millipore
®
 water for 5 days in a dialysis 
membrane (MWCO: 12-14 kDa). Millipore® water was exchanged thrice a day. The 
dialyzed MGONCs-PEG was then syringe filtered. GO-g-PEG was also synthesized 
by PEGylating the GO sheets through the similar procedures mentioned above. 
6.2.7 Materials Preparation for Characterization 
For DLS measurement, the samples were measured in either Millipore
®
 water 
or PBS 1x. For sample measured at 37
o
C, the samples were equilibrated at 37
o
C for 
10 minutes prior to the measurement. For in-vitro cell viability test, magnetic 
hyperthermia study, and MRI characterization, iron and manganese concentrations of 
MGONCs and PEGylated MGONCs samples were determined by ICP-OES.  
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6.3 Results and Discussion 
6.3.1 Synthesis and Characterization of MFNPs 
 
Figure 6 - 2: TEM images of the MFNCs nanocrystals of various sizes: (a) 6 nm 
(MFNPs-1), (b) 11nm (MFNPs-2) and (c) 14nm (MFNPs-3). (d) XRD patterns of the 
respective MFNPs samples. 
Similar to MFNPs results presented in Chapter 5, by varying the amount of 
mixed metal-acetylacetonate precursors, three different hydrophobic MFNPs sizes 
were obtained. These nanocrystals were denoted as MFNPs-1, MFNPs-2 and MFNPs-
3 respectively and summarized in Figure 6-2. As shown from the TEM images 
MFNPs-1 were spherical while MFNPs-2 and MFNPs-3 exhibited octahedral 
morphology. Similar to any other types of magnetic ferrofluid, the obtained MFNPs 
1-3 samples were extremely stable when dispersed in CHCl3 for more than a year 
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without precipitation, even at high concentration of 50 mg.mL
-1
. The size distribution 
of MFNPs 1-3, measured by analyzing 200–300 nanocrystals per MFNPs sample,  
(given in Figure 6-3a-c) indicated average size of 5.8 ± 1.0 nm, 10.9 ± 2.0 nm and 
13.9 ± 2.1 nm respectively for MFNPs-1, MFNPs-2 and MFNPs-3. The average size 
of MFNPs samples indicated that three different MFNPs mainly ~6 nm, ~11 nm and 
~14 nm were successfully fabricated from the thermolysis process. No significant 
large aggregates were observed from the low magnification TEM images of all three 
MFNPs samples. 
 
Figure 6 - 3: TEM size distribution of: (a) MFNPs-1 (5.78 ± 1.04 nm), (b) MFNPS-2: 
(10.94 ± 1.97 nm) and (c) MFNPs-3 (13.93 ± 2.08 nm). The data was obtained by 
analyzing 200-300 nanocrystals per sample from low magnification TEM images. (d) 
Magnetic hysteresis loops of MFNPs 1-3 samples. (e) Magnified hysteresis loops of 
MFNPs 1-3 samples. The measurement was done by VSM experiment at 300K. 
The crystalline phases of MFNPs were analyzed from the XRD patterns. From 
Figure 6-2d, all the present peaks were indexed against cubic spinel ferrite structure 
of MnFe2O4 (Jacobsite; JCPDS #74-2403). The EDX analysis of MFNPs verified the 
presence of the manganese contents (see Table 6-1). The EDX analysis however 
showed that stoichiometric ratio between manganese (Mn) and iron (Fe) was not 
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maintained for MFNPs 1-3, suggesting that doping of manganese into iron oxide 
structure was one possibility. [33] The crystalline phases of MFNPs were also 
reflected clearly from the SAED patterns in the insets of Figure 6-2a-c. Meanwhile, 
the HRTEM images showed the well-resolved lattice fringes which further 
demonstrated the high crystallinity of MFNPs. The lattice spacing between two 
adjacent planes was measured to be approximately ~0.49 nm and ~0.29 nm which 
corresponded to the (111) and (220) lattice planes d-spacing respectively. 









MFNPs-1 5.8  1.0 62.65 5.02 32.34 49.93 
MFNPs-2 10.9  2.0 47.68 7.60 44.73 66.27 
MFNPs-3 13.9  2.1 74.28 2.41 23.32 74.53 
The magnetic properties of MFNPs 1-3 were characterized by VSM 
experiment at room temperature. The hystresis loop profiles and the magnified 
hysteresis loop profiles given in Figure 6-3d,e showed that all MFNPs exhibited 
superparamagnetic behavior without significant coercivity field (HC) and remnant 





 and 74.53 emu.g
-1
 for MFNPs-1, MFNPs-2 and MFNPs-
3 respectively.  
6.3.2 Preparation of Nano-size Graphene Oxide 
In this section GO that was obtained from modified Hummer’s method was 
characterized to determine its size and size distribution. [31] From the high 
magnification AFM image of GO sheets and its cross section analysis in Figure 6-
4a,b, the height of GO sheets was about 0.939 nm which was considered within a 
single-layer GO sheet range (6-12Ǻ). [34] The XRD patterns of the GO sheets (inset 
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of Figure 6-4a) showed a distinct peak at 2θ = 10.6o which corresponded to the 
interlayer distance spacing (approximately 0.84 nm) of the GO sheets. [15] A further 
analysis from the low magnification AFM tapping mode image of GO (Figure 6-4c), 
a wide range of size distribution in which majority of GO lateral dimensions were 
within 50-150 nm range. The quantification of the oxygen-containing functional 
groups was revealed through the XPS analysis. The C 1s XPS spectrum of GO sheets 
was fitted and assigned into three corresponding carbon atoms components at 
different positions mainly: C–C (at 284.6 eV), C–O (286.7 eV) and C=O (288.3 eV). 
Due to the presence of these oxygen-containing functional groups, the obtained GO 
sheets were found to be highly stable in aqueous solution for more than 6 months 
without precipitation (after exfoliation). 
 
Figure 6 - 4: Nano-size graphene oxide (GO). (a) Tapping mode AFM images (insets: 
XRD pattern of GO). (b) Cross section profiles of GO sheets (taken along the black 
line, marked with the red and green arrow markers). (c) Low magnification tapping 
mode AFM image of GO sheet. (d) XPS C 1s spectrum of GO sheets. 
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6.3.3 Preparation of Amphiphilic Graphene Oxide (GO-g-OAM) 
 
Figure 6 - 5: (a) TEM image of oleylamine modified GO (GO-g-OAM) (inset: digital 
photograph showing the dispersion of GO and GO-g-OAM in CHCl3). (b) FT-IR 
spectra of GO and GO-g-OAM dried powder. 
As illustrated in the schematic diagram in Figure 6-1, the obtained GO sheets 
were then modified with oleylamine to obtain GO-g-OAM composites that was 
dispersible in CHCl3. Figure 6-5a showed the typical TEM image of the as-prepared 
GO-g-OAM dispersed in CHCl3. Overall, the lateral size of GO-g-OAM was in 100–
400 nm range which has increased significantly as compared to the lateral size of the 
original GO sheets mentioned previously. As illustrated in Figure 6-6, one possible 
reason was the non-covalent hydrophobic – hydrophobic interaction between the GO-
g-OAM that would lead to slight aggregation. Moreover, the TEM analysis also 
indicated that GO-g-OAM has tendency to exist in folded or scrolled state. This could 
be attributed to the need to stabilize the amphiphiles thermodynamically as reported 
previously. [35] The colloidal solution of GO-g-OAM was found to be very stable in 
organic non-polar phase such as hexane or CHCl3 for a few months. In order to 
measure the overall hydrodynamic size of GO-g-OAM, GO-g-OAM was simply 
transferred onto the aqueous phase with the assistance of the mini-emulsion (30 min 
sonication) and solvent evaporation process (70
o
C for 30 minutes). Because of the 
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sample preparation process, the overall hydrodynamic size of GO-g-OAM in water 
from DLS experiment was significantly reduced to 68.2 ± 2.3 nm from the 
aforementioned 100–400 nm TEM size (inset of Figure 6-5a). 
 
Figure 6 - 6: Illustrations of the dispersion of (a) GO in water and (b) GO-g-OAM in 
non-polar organic solvent (hexane or CHCl3). 
The formation of stable solution of GO-g-OAM in non-polar solvent can be 
ascribed to three possible synergistic interactions between oleylamine and GO sheets: 
(1) amine (–NH2) functional group from oleylamine that was reacted with epoxy 
group and carboxyl group (–COOH) in GO to form amide bonding during extended 
sonication process. (2) oleylamine could attach onto GO through the chemisorption in 





 ionic bonding and (3) alkenyl functional group (–CH2=CH2–) of 
oleylamine would interact with the aromatic and C=C double bond of GO non-
covalently through the electron π–π stacking interaction. [7-8,15,35-39] As a 
comparison, 1-dodecylamine and oleic acid were also used to solubilize GO sheets in 
non-polar phase. The attempts to disperse GO into hexane by using 1-dodecylamine 
(containing only an amine –NH2 functional group) and oleic acid (containing only an 
alkenyl functional group (–CH2=CH2–) group were unsuccessful, suggesting that the 
presence of both functional groups were needed to synergistically stabilizing GO in 
the non-polar solvent. 
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GO-g-OAM was further examined by FT-IR spectrum, to confirm the 
presence of the oleylamine functional group. As shown in Figure 6-5b, the reaction 
between amine-reactive epoxy group and amine functional group from oleylamine 
was demonstrated by the diminishing of the epoxide stretching vibrations at 1120-
1250 cm
-1
 of GO-g-OAM. As a result, the amide covalent bonding was formed, 
indicated by the subsequent appearance of the –C–N– stretching vibrations of amides 
at 1456.3 cm
-1
, together with overlapping C=O stretching vibrations and amide –N–H 
bending vibrations at 1610.5 cm
-1
. The non-covalent bonding attachment of 
oleylamine to GO through –COO–NH3
+
 ionic bonding was verified by the 
disappearance of the –C=O (from –COOH) stretching vibration at 1705.0 cm-1 and the 
appearance of two new peaks at 1610.5 cm
-1
 and 1456.3 cm
-1
 associated with the 
asymmetric and symmetric stretching vibrations of –COO–. Lastly, the presence of 
oleylamine characteristic peaks such as (1) –CH2 symmetric and asymmetric 
stretching vibrations at 2910.6 cm
-1
 and 2850.8 cm
-1
, (2) 937.2 cm
-1
 of =CH2 bending 
vibrations and (3) –CH2 bending vibrations at 709.8 cm
-1
, on top of the GO 
characteristic peaks indicated the presence of oleylamine on GO through either 
covalent or non-covalent bonding. [35] 
6.3.4 Formation of water soluble MFNPs/GO Nanocomposites (MGONCs) 
The obtained MFNPs were functionalized and combined with the GO-g-OAM 
in order to prepare the water soluble MFNPs/GO-g-OAM nanocomposites (denoted as 
MGONCs). In the early attempts, MFNPs-3 with ~14 nm particle size was used to 
form MGONCs. Three different MGONCs sample, namely MGONCs-1, MGONCs-2 
and MGONCs-3, prepared using GO/MFNPs mass ratio of 1:1.39, 1:2.42 and 1:2.78 
were synthesized. The sonication time for preparing MGONCs 1-3 samples was fixed 
at 5 minutes. The TEM images of the obtained MGONCs 1-3 were shown in Figure 
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6-7. The inset figures showed the high magnification TEM images, indicated that 
MFNPs were well attached on the GO nanosheets. The oleylamine acted as a binder 
to bridge the MFNPs and the GO nanosheets. Further characterization by DLS 
experiment demonstrated that the variation of the MFNPs loading amount had no 
significant effect towards the hydrodynamic size. The hydrodynamic size distributions 
of MGONCs 1-3 were given in Figure 6-7d. The hydrodynamic size of MGONCs-1 
(101.5 ± 1.3 nm), MGONCs-2 (90.2 ± 0.4 nm) and MGONCs-3 (105.8 ± 1.5 nm) 
were found to be in similar magnitude and within the size range of 90–100nm. The 
SAED patterns verified that there was no damage to the MFNPs crystal structure, 
especially after the formation of MGONCs that involved the probe-sonication. 
 
Figure 6 - 7: Formation and morphology tuning of MGONCs (magnetic core: 
MFNPs-3). TEM images of MGONCs samples synthesized using GO/MFNPs ratio 
of: (a) 1 : 1.39 (MGONCs-1), (b) 1 : 2.42 (MGONCs-2) and (c) 1 : 2.78 (MGONCs-3) 
(insets: high magnification TEM images and SAED patterns of the respective 
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Figure 6 - 8: High magnification SEM image of MGONCs-2 showing the dispersion 
of MFNPs on GO sheets.  
From the TEM analysis, the number of MFNPs nanocrystals on GO sheets 
increased with the increasing of loading amount of MFNPs (higher MFNPs/GO mass 
ratio). Moreover, it was also observed that MFNPs preferentially distributed on the 
basal regions and there were less MFNPs-3 on the edges of the GO nanosheets. This 
preferential attachment could be simply explained by considering the 
hydrophobicity/hydrophilicity of different region of the GO nanosheets. At the edges 
of the GO nanosheets, it was reported that more oxygen containing functional group 
such as carboxylic acids and hydroxyls dominated this region which was more 
hydrophilic than the functional group presence on the basal plane of GO, such as 
aromatic carbon and epoxide functional groups. [34] In this case, since GO-g-OAM 
was used to form MGONCs, the adsorbed oleylamine to the aromatic carbon ring via 
the π–π stacking would further increase the hydrophobicity of the basal plane. 
Because of the difference in the hydrophilicity of the GO region, MFNPs were 
believed to preferentialy reside on the more hydrophobic region due to the need to 
maximize the hydrophobic – hydrophobic interactions, as well as exposing more of 
the hydrophilic region onto the water/aqueous phase. This phenomenon was found to 
support the finding results by Zhang et al. [14] whereby the covalent attachment of 
the hydrophilic dimercapto-succinic acid (DMSA) capped magnetite nanocrystals on 
  - 183 - 
 
the outer boundary of polyethyleneimine (PEI) modified graphene oxide sheets. This 
further confirmed the hydrophilic nature of the GO periphery and the hydrophobic 
nature of the GO basal planes. 
The SEM image of MGONCs-2 given in Figure 6-8 confirmed the 
morphology of the nanocomposites. The expected spherical encapsulation of MFNPs 
with GO sheets according to the typical emulsion processes (with amphiphilic 
polymer host), was not observed for this MFNPS/GO system. Instead, MFNPs were 
found to reside and decorated on top of the GO nanosheets, especially anchored on 
the basal plane (surface) of GO sheets.  
 
Figure 6 - 9: Tapping mode AFM images of MGONCs 1-3 (from left to right) in its 
dried state.  
The AFM tapping mode images in Figure 6-9 depicted the lateral view and 
the cross section analysis of MGONCs 1-3. The lateral dimensions of MGONCs 1-3 
sample (in its dried state) was around 100-200 nm. From the cross section analysis of 
MGONCs 1-3, the overall thickness (height of the nanocomposites) range of 
MGONCs-1, MGONCs-2 and MGONCs-3 samples in its dried state were found to be 
~10–15 nm, ~20–30 nm, ~35–45nm respectively. These heights were roughly the 
multiplication of the size of the parent MFNPs-3 (~14 nm). These height ranges 
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indicated that multi-layer or stacking of GO/MFNPs nanocomposites were formed 
with one, two and three layer(s) of stacking of MFNPs-3 for respective MGONCs 
samples. The nanocomposites dimension, whereby high aspect ratio between the 
lateral distances and the vertical height was observed, suggested that the sheet-like 
structure of GO was obtained with the MFNPs residue on either one or both surfaces 
of the GO nanosheets. 
The changes in the loading amount of MFNPs in MGONCs were further 
confirmed by its magnetic properties characterization. As shown in Figure 6-10a, the 
MS value of MGONCs-3 (30.52 emu.g
-1
) was almost 1.5 times of the MS value of 
MGONCs-1 (19.02 emu.g
-1
) which was close to the increment of MFNPs used. Such 
trend was also clearly indicated from the high magnification TEM images (in Figure 
6-7a-c) whereby as the GO/MFNPs ratio decreases, the MFNPs-3 nanocrystals 
loading in GO basal regions increased. The magnified hysteresis loop in Figure 6-10b 
highlighted that MGONCs-1 and MGONCs-3 had negligible coercivity and zero 
remnant magnetization which imply that the formation of the water-borne magnetic 
nanocomposites, MGONCs retained its superparamagnetic behavior. 
 
Figure 6 - 10: (a) Magnetic hysteresis loop profiles and (b) magnified hysteresis 
loops for MGONCS-1 and MGONCs-3 samples, measured by VSM experiment at 
300K.  
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Figure 6 - 11: Effect of sonication time on reducing MGONCs hydrodynamic size. 
TEM images of MGONCs synthesized using different MFNPs magnetic cores: (a) 
MFNPs-1 (MGONCs-4), (b) MFNPs-2 (MGONCs-5) and (c) MFNPs-3 (MGONCs-
6) with 12 minutes sonication time (insets: high magnification TEM images of 
respective MGONCs samples). (d) Hydrodynamic size distribution of MGONCs 4-5 
measured in water at 300K.  
By retaining the GO/MFNPs mass ratio at 1:2.42 another three MGONCs 
namely MGONCs-4, MGONCs-5 and MGONCs-6 were fabricated with different 
MFNPs nanocrystal core: MFNPs-1 (6nm), MFNPs-2 (11nm) and MFNPs-3 (14nm) 
respectively. The sonication time was then extended from 5 minutes to 12 minutes in 
an attempt to reduce the nanocomposite size. The TEM images of MGONCs 4-6 in 
Figure 6-11a-c suggested that the extension of sonication time led to the formation of 
more dispersed GO/MFNPs composites with smaller MFNPs clusters size. The DLS 
results (Figure 6-11d) revealed the average hydrodynamic size of MGONCs-4 (81.0 ± 
0.3 nm), MGONCs-5 (89.7 ± 0.4 nm) and MGONCs-6 (82.0 ± 0.5 nm) were within 
the size range of 80–90nm. The digital photographs of water-soluble MGONCs 4-6 
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samples showed very good dispersions in water phase with no residue to MFNPs 
remained in the hexane solvent. As expected, no aggregation or nanocomposites was 
observed in the boundary between the oil- and water-phase. 
 
Figure 6 - 12: Digital photographs showing the dispersion of (a) MFNPs in Hexane 
and (b) MGONCs samples in water after mini-emulsion/solvent evaporation process. 
The AFM tapping mode images in Figure 6-13 depicted the lateral view and 
the cross section analysis of MGONCs 4-6. The lateral dimensions of MGONCs 4-6 
samples (in its dried state) were reduced to approximately 70–80nm. This was a 
significant size reduction from the MGONCs 1-3. The cross section analysis of 
MGONCs 4-6 showed that the overall thickness of MGONCs 4-6 were between 10–
20nm range. These height ranges indicated that single layer of GO/MFNPs 
nanocomposites were most likely to be formed. Similar to MGONCs 1-3, the high 
aspect ratio between the lateral distances and the vertical height indicated the similar 
morphology as of MGONCs 1-3, sheet-like structure. 
 
Figure 6 - 13: Tapping mode AFM images of MGONCs 4-6 (from left to right). 
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The hysteresis loops presented in Figure 6-14a,b showed that MGONCs 4-6 
still retained the superparamagnetic properties. Negligible remnant magnetization and 
coercivity were observed for all samples. The measured MS values of MGONCs-4, 




 and 15.70 
emu.g
-1
 respectively. As the core MFNPs size increased, the hysteresis loops also 
indicated the increase in the magnetic susceptibility which suggested that the 
MGONCs sample would respond much quicker and strongly to the presence of 
external magnetic field.  
 
Figure 6 - 14: (a) Magnetic hysteresis loop profiles and (b) magnified hysteresis 
loops of MGONCS 4-6 at 300K. (c) TGA heating profiles of MGONCs-4 (solid line) 
and MGONCs-6 (dotted line). 
The significant reduction of the MGONCs 4-6 MS values as compared to the 
parent MFNPs could be explained from the TGA results (Figure 6-14c). The thermal 
behaviors of MGONCs-4 and MGONCs 6 showed approximately 72.9% and 75.5% 
weight loss after heating to 700
o
C. Such weight loss was contributed by the removal 
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of the oxygen-containing functional groups such as epoxide, hydroxyl, carbonyl and 
carboxyl (either from the GO or oleylamine), as well as the remaining and trapped 
water molecules. The remaining inorganic (MFNPs) components from MGONCs-4 
and MGONCs-6 were calculated to be 27.1% and 24.5% of the total weight of 
MGONCs. Because of the presence of more organic phase (GO and oleylamine) than 
the inorganic MFNPs mass ratio (1:3), the reduction of MGONCs 4-6 MS values by 
almost from 80% from its parent MFNPs cores. 
 
Figure 6 - 15: Further MGONCs hydrodynamic size reduction. TEM images of 
MGONCs synthesized using different MFNPs magnetic cores: (a) MFNPs-1 
(MGONCs-7), (b) MFNPs-2 (MGONCs-8) and (c) MFNPs-3 (MGONCs-9) with 60 
minutes sonication time. (d) Hydrodynamic size distribution of MGONCs 7-9 in 
water at 300K.  
The MGONCs size range could be further reduced to exteremely small size 
range, when the sonication time during the emulsification process was prolonged. 
Another three MGONCs samples, mainly MGONCs-7 (MFNPs-1 core), MGONCs-8 
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(MFNPs-2 core) and MGONCs-9 (MFNPs-3 core) were fabricated with 60 minutes 
sonication tie. As revealed from the TEM images and DLS results (Figure 6-15), the 
hydrodynamic sizes samples were 56.8 ± 1.1 nm 55.0 ± 0.6 nm and 56.2 ± 0.4 nm 
respectively for MGONCs-7, MGONCs-8 and MGONCs-9. Generally the size range 
of MGONCs samples decreased to 50–60 nm range from 80–90 nm by extending the 
sonication time from 12 to 60 minutes. In order to evaluate the sonication time effect, 
the hydrodynamic sizes of MGONCs formed with various sonication times were 
summarized in Figure 6-16. The overall hydrodynamic size of the nanocomposites 
reduction occurred when sonication time was extended. Prolonged sonication would 
result in a more stable and even emulsion, allowing the break-down of oil-in-water 
droplet to smaller droplet size. However, it was found out that sonication time beyond 
120 minutes was meaningless as the sonication energy was insufficient to further 
break-apart the oil-in-water emulsion droplet during the process. 
 
Figure 6 - 16: Sonication time effect towards the MGONCs hydrodynamic size. 
The TEM images obtained from MGONCs 7-9 samples presented in Figure 6-
15a-c were more or less similar with the TEM samples of WMFNPs obtained from 
water solubilization process involving amphiphilic brush copolymers, e.g. poly 
(isobutylene-alt-maleic anhydride) grafted with alkylamine or poly (maleic 
anhydride-alt-1-octadecene (as presented in Chapter 4). From the low magnification 
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TEM images, there was no clear distinction between the GO layer (or the MGONCs 
periphery), indicating ultra-small nanocomposites were successfully formed. 
 
Figure 6 - 17: SAED patterns of (a) MFNPs-3 and MGONCs samples prepared with 
various sonication time (magnetic core: MFNPs-3; GO/MFNP mass ratio 1:2.42): (b) 
MGONCs-2 (5 minutes), MGONCs-6 (12 minutes) and (d) MGONCs-9 (60 minutes).  
A further SAED patterns analysis of MGONCs 4-9 samples depicted in 
Figure 6-17 and Figure 6-18 verified that the core MFNPs crystal structure integrity 
was still maintained even after prolonged sonication time. The general diffraction 
rings for MFNPs, mainly the diffraction rings of (220), (311), (331), (422), (333) and 
(440) lattice planes of (indexed accordingly against Jacobsite structure) were intact 
and observable from the pattern. This demonstrated that prolonged sonication time 
has less adverse effect towards the crystallinity of the original MFNPs-3 core. It was 
observed that as the sonication time increased, GO-g-OAM broken down into much 
smaller pieces which resulted in clearer and brighter SAED ring pattern as there are 
less organic moieties, especially GO, covering the MFNPs. In addition to this, 
regardless of the MFNPs core size, the same trend was also observed for core 
MFNPs-1 and MFNPs-2. 
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Figure 6 - 18: SAED patterns of (a) MFNPs-1 and (d) MFNPs-2 in comparison with 
the respective MGONCs samples prepared with various sonication time: (b) 
MGONCs-4 and (e) MGONCs-5 (12 minutes); (c) MGONCs-7 and MGONCs-8 (60 
minutes).  
Further analysis by XRD experiments showed that MGONCs 4-6 samples 
exhibited similar XRD patterns (see Figure 6-19) as compared to its respective 
MFNPs core XRD patterns (from Figure 6-2d). The XRD patterns of MGONCs 4-6 
samples comprised of both characteristic peaks for MFNPs as well as for GO. This 
indicated that MGONCs were successfully synthesized  All characteristic peaks for 
manganese ferrite in the wide angle 2θ range of 20o–75o can be clearly observed and 
were indexed to (220), (311), (400), (333) and (440) lattice planes of cubic spinel 
ferrite structure of MnFe2O4. The observed peak broadening from MGONCs-6 to 
MGONCs-4 was due to the decreasing of the nanocrystals size (nanocrystallite size 
effect) indicating a significant change of core MFNPs from ~14nm to ~6nm was still 
observable, even after the nanocomposite formation.  
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Figure 6 - 19: XRD patterns of MGONCs 4-6. 
The additional peak between 2θ of 11.7o-11.9o was attributed to the presence 
of GO, was clearly observed. This peak was slightly broadened as compared to the 
original GO peak (at 2θ of 10.6o) described earlier. One of the possible reasons for the 
peak discrepancies was the disruption of GO structure and the increase in the 
attractive interaction between GO layer due to the presence of oleylamine and MFNPs 
core. When such interaction occurred, a shift of GO peak towards higher 2θ was 
recorded. Overall, the XRD pattern of MGONCs 4-6 confirmed that the manganese 
ferrite crystallinity was still maintained even after 12 minutes of sonication. 
6.3.5 PEGylation of MGONCs: Improving Colloidal Stability 
Although the MGONCs were found to be highly stable and dispersible in 
water, the attempt to disperse MGONCs samples into physiological solution such as 
phosphate buffer solution (PBS 1x) was a failure. Upon being immersed in PBS 1x, 
MGONCs would slowly aggregate, possible due to the interaction between the 
  - 193 - 
 
oxygen containing functional group as well as the oleylamine binder with the ions 
from PBS 1x. This similar phenomenon has been previously reported by various 
research groups. [39-41] The attempt to disperse pure GO into PBS 1x also resulted in 
disappointment as GO aggregated slowly and within 16 hours (see Figure 6-20), ost 
of GO has precipitated. One simple strategy to avoid such aggregation was illustrated 
in Figure 6-1, conjugation of additional non-ionic and biocompatible functional 
group such as PEG that would be able to shield MGONCs from the ionic charges. In 
the earlier attempt to functionalize pure GO, using conventional conjugation 
chemistry based on carbodiimide chemistry showed that PEGylated GO (or GO-g-
PEG) could resist or prevent such aggregation which successfully stabilized GO-g-
PEG into PBS 1x as shown in Figure 6-20. Such colloidal stability after PEGylation 
can be explained from the surface charge (zeta potentials) analysis later on. 
 
Figure 6 - 20: Digital photograph showing the colloidal stability of GO and 
PEGylated GO in water and PBS 1x. 
 To confirm the successful PEGylation using the carbodiimide chemistry, 
1
H-
NMR spectra of GO and GO-g-PEG in D2O solvent were obtained. From Figure 6-
21a, it was observed that there was no significant resonance peak from the spectrum 
of GO in the range of δ = 0–4.0 ppm, except for the presence of hydroxyl at δ = 1.2 
ppm. After PEGylation, the characteristic chemical shifts of PEG in the range of δ = 
3.0–4.0 ppm can be clearly observed from the NMR spectrum of GO-g-PEG (Figure 
6-21b) as labeled. Since GO-g-PEG sample has been purified repeatedly (through 
dialysis) from the excess reactant such as mPEG-NH2 and EDC/NHS, the presence of 
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such peaks verified the successful conjugation of PEG to GO. From the comparison of 
the integrated intensity of hydroxyl and PEG peaks in the NMR results given in 
Figure 6-21b, the hydroxyl:PEG ratio was estimated to be 1:1.01. 
 
Figure 6 - 21: 
1
H-NMR spectra of GO and GO-g-PEG using D2O as solvent. 
As a role model, MGONC-4 was PEGylated using mPEG-NH2 (MW 5000) 
through the similar carbodiimide chemistry (as illustrated in Figure 6-1). The TEM 
image of the MGONCs-4 sample after PEGylation in PBS 1x was shown in Figure 6-
22a. The high magnification TEM image confirmed the presence of the GO in 
MGONCs samples that was not observed in MGONCs-4 (Figure 6-11a). In 
MGONCs-4-PEG, the contrast enhancement of GO was due to the presence of grafted 
PEG functional groups (MW 5000). As shown in Figure 6-22b, the hydrodynamic 
size of MGONCs-4 after the PEGylation increased about ~43.1% from 81.0 ± 0.3 nm 
to 115.9 ± 0.8 nm. The increment of about ~35 nm in the hydrodynamic size could be 
attributed to the presence of grafted PEG chain onto MGONCs-4. Moreover, after the 
PEGylation, MGONCs-4-PEG could be dispersed in PBS 1x without notable 
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were 129.1 ± 1.1 nm and 138.3 ± 2.4 nm respectively, which further confirmed the 
size of MGONCs-4-PEG observed under TEM analysis. 
 
Figure 6 - 22: PEGylation of MGONCs-4 nanocomposites: (a) TEM image of 
PEGylated MGONCs-4 in PBS 1x (inset: high magnification TEM image of 
MGONCs-4-PEG showing the presence of GO sheet). (b) Hydrodynamic size 





Comparison of MFNPs-1, MGONCs-4 and MGONCs-4-PEG hysteresis loop profiles 
at ~300K. (d) TGA results of MGONCs-4 and MGONCs-4-PEG. (e) Tabulated 
physical value of VSM and TGA data for MGONCs-4 and MGONCs-4-PEG. 
The original as-synthesized MFNPs-1 exhibited 49.93 emu.g
-1
 saturation 
magnetization which reduced significantly to 9.09 emu.g
-1
 after the coupling with 
GO-g-OAM to form MGONCs-4.  After PEGylation, MGONCs-4-PEG was found to 
retain its superparamagnetism behavior with measured MS value of 1.01 emu.g
-1
. Such 
drastic decrease in the MS value was attributed to the presence of large amount of 
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organic moieties, especially PEG functional group. The overall drop in the MS value 
was highly expected due to the decrease in the fraction of the magnetic core MFNPs 
amount against the organic moieties amounts after the formation of the 
nanocomposites and PEGylation. By normalizing the MS values against the actual 
amount of inorganic nanoparticles, the normalized MS values for MGONCs-4 and 
MGONCs-4-PEG were found to be 33.54 emu.g
-1
 and 27.82 emu.g
-1
 respectively. The 
discrepancies in the normalized MS values of MGONCs-4 and MGONCs-4-PEG in 
comparison with the original MFNPs-1 samples could be ascribed to the remaining 
moisture in the nanocomposites samples. Also from the TGA result, the weight of 
MGONCs-4 increased significantly by 23.5% after PEGylation process. This 
indicated that there was approximately 0.047 mmol of PEG per gram of the 
nanocomposites. 
The successful conjugation of PEG to MGONCs-4 to form MGONCs-4-PEG 
was confirmed by FT-IR spectroscopy together with the MGONCs formation. The 
FT-IR spectrum in Figure 6-23 summarized the mPEG-NH2, GO-g-PEG, MFNPs, 
MGONCs and MGONCs-PEG spectrum. First of all, the chemical structure of the 
freshly purchased mPEG-NH2 was analyzed. The basic characteristic peaks of PEG 
such as stretching vibrations of –C–H alkanes, stretching vibrations of alcohols –C–O 
and ether C–O–C as well as scissoring and bending from the C–H alkanes from 
mPEG-NH2 were observed around 2850–2966 cm
-1
, around 1051–1237 cm-1, and 
1300–1450 cm-1 respectively. The presence of amine functional group was indicated 
by the presence of both –N–H stretching vibrations and the NH2 in-plane bending 
vibrations at both 3400–3500 cm-1 and 1514–1668 cm-1. These peak intensities were 
relatively weak as compared to the main PEG characteristic peaks due to the high 
PEG molecular weight (MW5000) which suppressed amine functional group signals. 
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Figure 6 - 23: FT-IR spectra of (a) mPEG-NH2, (b) MFNPs, (c) GO-g-PEG, (d) 
MGONCs-4 and (e) MGONCs-4-PEG. 
The main characteristic peaks of hydrophobic oleic acid capped MFNPs were 
observed from the FT-IR spectrum. The presence of Fe–O stretching at 570–589 cm-1 
indicated the presence of oleic acid surfactant bonding to the MFNPs nanocrystals. 
Such bonding proceeded through the formation of –COO– group of oleic acid and Fe 
atom was further verified by the existence of the asymmetric and symmetric 
stretching vibrations of –COO– group in the range of 1523–1558 cm-1. The main 
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characteristic of oleic acid that was due to the presence of the asymmetric and 
symmetric –CH2 stretching vibrations at 2916.4 cm
-1
 and 2845 cm
-1
 respectively. 
Meanwhile the resence of –CH3 bending vibrations was observed at 1396.5 cm
-1
. 
After PEGylation of GO in Figure 6-19, the main characteristic peak of PEG 
such as the stretching vibrations –C–H alkanes, stretching vibrations of alcohols –C–
O and ether C–O–C as well as the scissoring and bending from the –C–H alkanes 
were still observed around 2850–2966 cm-1, around 1051–1237 cm-1 and 1300–1450 
cm
-1
 respectively. The subsequent appearance of the –C–N– stretching vibrations of 
amides at 1442.8 cm
-1
 together with the overlapping C=O stretching vibrations of 
amide as well as amide –N–H bending vibrations at 1616.3 cm-1 indicated the 
formation of the amide covalent bonding. The amide linkage was the resultant of the 
reaction between carboxyl from GO sheet with amine from the mPEG-NH2 through 
the carbodiimide zero length crosslinker (EDC/NHS). 
  
Figure 6 - 24: SAED patterns of (a) MFNPs-1, (b) MGONCs-4 and (c) MGONCs-4-
PEG. 
The formation of MGONCs from MFNPs and GO-g-OAM however, was 
unable to be verified by FT-IR spectroscopy because of the non-covalent bonding 
between MFNPs and GO-g-OAM. There was no new bonding that was created. The 
spectra of MGONCs only showed the superimposed MFNPs characteristic peaks with 
GO-g-OAM characteristic peaks. Lastly, the successful grafting of PEG of MGONCs 
was indicated by the presence of both MGONCs characteristic peaks with PEG 
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characteristic peaks. Furthermore, the covalent bonding between PEG and MGONCs 
were confirmed with the presence of –C–N– stretching vibrations of amide at 1471.7 
cm
-1
 together with the enhance peaks at 1624.1 cm
-1
 due to overlapping C=O 
stretching vibrations and amide –N–H bending vibrations. 
The PEGylation of MGONCs-4 was investigated from its XRD and SAED 
patterns to verify the effect of the PEGylation on the crystal structure. The SAED 
pattern of PEGylated MGONCs-4 was presented together with its original MFNPs 
and MGONCs-4 SAED patterns in Figure 6-24. The diffraction rings in SAED 
patterns of MGONCs-4-PEG showed well-pronounced 4 characteristic diffraction 
rings for (200), (311), (331) and (440) planes for manganese ferrite that coincided 
with the rings from the SAED pattern of its original MFNPs-1 and MGONCs-4. This 
preliminary study showed that PEGylation has no significant effect towards MFNPs 
crystallinity. Unfortunately, further XRD analysis on MGONCs-4-PEG did reveal a 
very weak (insignificant) signal for further determination of the crystalline structure 
of the core MFNPs. This was due to the presence of PEG that decreased the relative 
peak intensity and the peak broadening due to small MFNPS-1 core size. 
In order to have clearer demonstration of the PEGylation effects towards the 
crystal structure of the manganese ferrite, ~18nm MFNPs were synthesized (denoted 
as MFNPs-4) through similar thermolysis of mixed metal-acetylacetonate precursors. 
The TEM image of MFNPs-4 was given in Figure 6-25a. Such large nanocrystals 
size was chosen in order to eliminate the peak broadening effect due to small 
crystallite size. Hydrophobic MFNPs-4 nanoparticles were then used to form 
MGONCs-10 (GO/MFNPs mass ratio = 1:2.42; 60 minutes sonication time). The 
TEM image of MFNPs-4 was given in Figure 6-25b. Subsequently, MGONCs-10 
was PEGylated with mPEG-NH2 (MW 5000) using similar carbodiimide chemistry 
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that was used to PEGylate MGONCs-4. The TEM image of MGONCS-10-PEG was 
given in Figure 6-25c. The TEM size distributions of MFNPs-4 (18.8 ± 2.2 nm) were 
quite closed with the MFNPs-4 embedded in MGONCs-10 (18.5 ± 2.9 nm). 
 
Figure 6 - 25: TEM images of (a) as-synthesized ~18 nm (MFNPs-4), (b) MGONCs-
10 (core = MFNPs-4; GO/MFNPs mass ratio = 1 : 2.42; 60 minutes sonication time). 
(c) PEGylated MGONCs-10 (MGONCs-10-PEG). TEM size distributions of ~18nm 
MFNPs-4: (a) as-synthesized (18.8 ± 2.2 nm) and (b) after formation of MGONCs-10  
(18.5 ± 2.9 nm). 
The XRD patterns of MFNPs-4, MGONCS-10 and MGONCs-10-PEG was 
compared in Figure 6-26. It was observed that the characteristic peak intensities 
decreased as MFNPs-4 undergo MGONCs formation and its subsequent PEGylation. 
Overall the characteristic peaks location as well as the relative peak intensities of 
MFNPs-4 was still maintained. All the XRD peaks in the wide angle 2θ range of 20o–
75
o
 of MFNPs-4, MGONCS-10 and MGONCs-10-PEG were indexed to (220), (311), 
(400), (422), (333) and (440) planes of the cubic spinel ferrite structure MnFe2O4. 
From Figure 6-26c, additional XRD peaks were observed at around 2θ of ~19.2o and 
~23.0
o
 (pointed by green arrow) for MGONCs-10-PEG samples. These peaks 
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indicated the presence of organic moieties PEG (from the crystallization of PEG 
which occurred during the freeze-drying process of MGONCs-10-PEG during XRD 
sample preparation), which confirmed the success of PEGylation indirectly. [42-44] 
Overall, the further XRD and SAED analysis revealed that the PEGylation through 
carbodiimide chemistry did not affect the overall MFNPs crystallinity. 
 
Figure 6 - 26: XRD patterns of (a) MFNPs-4, (b) MGONCs-10 and (c) MGONCs-10-
PEG (blue color line: GO, green color line: PEG and red color line: manganese 
ferrite). 
The as-synthesized MFNPs-4 was as interesting as other types of MGONCs 
samples. Due to its similar synthesis process, the hydrodynamic size of MGONCs-10 
(50.6 ± 0.3 nm) was comparable to MGONCs 7-9 (in the 50–60 nm range). The DLS 
size distribution of MGONCs-10 was given in Figure 6-26a. From the VSM 
experiment in Figure 6-26b, the MS value of MFNPs-4 (96.86 emu.g
-1
) dropped to 
approximately 24.82 emu.g
-1
 after the MGONCs formation. Similar to previous 
MGONCs samples, the drastic drop in the MS value (~74.4%) was due to the presence 
of approximately ~75.7% organic moieties as determined from the TGA analysis 
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(Figure 6-27c). The basic properties of all MGONCs sample presented in this thesis 
were summarized in Table 6-2. 
 
Figure 6 - 27: (a) Hydrodynamic size distribution of MGONCs-10. (b) Magnetic 
hysteresis loop profiles of MFNPs-4 (dotted line) and MGONCs-10 (solid line). (c) 
TGA results of MGONCs-10. 
6.3.6 Colloidal Stability and In-vitro Cell Cytoxicity of MGONCs-PEG 
In various in-vitro and in-vivo applications such as MRI and MFH, the water-
dispersible nanocomposites should neither disintegrate nor aggregate. The 
nanocomposites also should not induce any toxicity effect. For such reason, the 
colloidal stability and in-vitro cell cytotoxicity will be investigated in this section. 
 





C. (b). Average hydrodynamic size of MGONCs-4-PEG in water and 




C) for 5000 minutes. 
The colloidal stability of MGONCs-4-PEG sample was performed by the DLS 
experiment. The time-dependent hydrodynamic size plot against time presented in 
Figure 6-28a showed that MGONCs-4-PEG was very stable for prolonged period of 
time. The average hydrodynamic sizes of MGONCs-4-PEG samples in water at 25
o
C 








C after 4 days were 115.8 ± 0.8 nm, 
116.6 ± 0.7 nm, 129.9 ± 0.8 nm and 140.2 ± 0.9 nm respectively (Figure 6-28b). 
There was no significant variation in MGONCs-4-PEG hydrodynamic sizes even after 
4 days of incubation. Furthermore, all MGONCs samples were also stable when 
incubated with strong table-top magnet for few weeks. Unlike other various magnetic 
nanoparticles/graphene-based materials that have good response to external magnetic 
field by forming aggregation and attracted, MGONCs samples were found to have 
excellent colloidal stability, even in the presence of such strong magnetic field. [6-18] 
 
Figure 6 - 29: (a) Summary of GO, GO-g-PEG, MGONCs and MGONCs-PEG zeta-
potentials measured by Malvern Zetasizer Nano ZS. (b) Plot of zeta-potentials against 
various GO and MGONCs samples. 
On top of the hydrodynamic size study, SAED/XRD patterns analysis, zeta 
potential (ζ) analysis was also conducted to verify the surface charge, to estimate the 
colloidal stability as well as to understand the chemical interactions between the 
MGONCs building block components. The summary of the surface charges of various 
GO-based samples were given in Figure 6-29. Although GO was originally 
negatively charged (–42.9 ± 3.2 mV), MGONCs samples would be positively charged 
due to presence of excess oleylamine (from GO-g-OAM) that act as binder to host 
MFNPs. The zeta potentials of MGONCs sample were recorded in the range of 19.9 ± 
0.6 mV to 61.2 ± 1.7 mV. PEGylation would then significantly decrease the 
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MGONCs zeta-potential as PEG would act as an effective ‘spacer’ in ionic solution 
that prevents the ionic portion of the solution to interact closely with the positively 
charged amine (from oleylamine) and negatively charged carboxyls/hydroxyls (from 
GO). As an example, the zeta potential of MGONCs-4 decreased from 51.6 ± 3.6 mV 
to 17.3 ± 0.6 mV after PEGylation. Based on this results, the overall increment of 
MGONCs-4-PEG hydrodynamic size in PBS 1x can be attributed to the mild 
adsorption of the ionic charges pre-dominantly towards the positively charged 
oleylamine in MGONCs-4-PEG. 
 
Figure 6 - 30: In-vitro cell cytotoxicity: (a) MGONCs-4-PEG incubated with MCF-7 
cancer cells and (b) MGONCs-10-PEG incubated with NIH/3T3 fibroblast cells. 
 The cell viabilities of MGONCs nanocomposites were determined in two 
ways, (i) MGONCs-4-PEG were incubated with MCF-7 breast cancer cells and (ii) 
MGONCs-10-PEG  were incubated with NIH/3T3 mouse fibroblast cells at various 
iron concentration range (0.008 mM to 2.0 mM Fe). The cytotoxicity assay was 
performed after 12-24 hours of incubation with the respective MGONCs samples. 
From Figure 6-30a, MGONCs-4-PEG sample did not induce any notable cytotoxicity 
effect in MCF-7 cancer cells within the nanoparticles concentration of 0.03 mM Fe to 
2 mM Fe (equivalent to 1.8 to 116.7 µg.mL
-1
 Fe). Similarly, according to Figure 6-
30b, more than 95% of th NIH/3T3 fibroblast cells also remained viable after 
incubation with MGONCs-10-PEG sample at various iron concentration of 0.008 mM 
Fe to 2 mM Fe. These results suggested that the colloidally stable MGONCs 
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nanocomposite after PEGylation was suitable for various biomedical applications, 
such as magnetic hyperthermia agent and MR imaging contrast agent within the 
aforementioned nanoparticles concentration.  
Based on dilution sequences, 2 mM Fe of MGONCs sample (~160 µg.mL
-1
 
Fe) is equivalent to 300 µg.mL
-1
 nanoparticles. This was equivalent to at least 40 
µg.mL
-1
 of GO sheets. Hence the cell viability given in Figure 6-30 also indicated 
that GO sheet was compatible with both NIH/3T3 and MCF-7 cells up from 0.2 
µg.mL
-1
 to 40 µg.mL
-1
. Such good biocompatible of GO has also been reported 
previously for ultrasmall GO sheets as well as typical GO sheets obtained from 
Hummer’s method. [41, 45-46] 
Table 6 - 2: Summary of MGONCs initial precursor amount and basic properties. 

















MGONC-1 7.2 0.2 mL MFNPs-3 10 1 : 1.39 5 101.5 ± 1.3 19.02 0.126 
MGONC-2 4.125 0.2 mL MFNPs-3 10 1 : 2.42 5 90.2 ± 0.4 - 0.138 
MGONC-3 7.2 0.4 mL MFNPs-3 20 1 : 2.78 5 105.8 ± 1.5 30.52 0.135 
MGONC-4 4.125 0.2 mL MFNPs-1 10 1 : 2.42 12 81.2 ± 0.3 9.09 0129 
MGONC-5 4.125 0.2 mL MFNPs-2 10 1 : 2.42 12 89.7 ± 0.4 13.11 0.133 
MGONC-6 4.125 0.2 mL MFNPs-3 10 1 : 2.42 12 82.0 ± 0.5 15.70 0.143 
MGONC-7 4.125 0.2 mL MFNPs-1 10 1 : 2.42 60 56.8 ± 0.1 - 0.135 
MGONC-8 4.125 0.2 mL MFNPs-2 10 1 : 2.42 60 55.0 ± 0.6 - 0.131 
MGONC-9 4.125 0.2 mL MFNPs-3 10 1 : 2.42 60 56.2 ± 0.4 - 0.142 
MGONC-10 4.125 0.2 mL MFNPs-4 10 1 : 2.42 60 50.6 ± 0.3 24.82 0.154 
6.3.8 Magnetic Hyperthermia Study of MGONCs 
80–90 nm MGONCs Cluster Size: The heating effiency of the obtained water-
dispersible nanocomposites was assessed simply by exposing the MGONCs samples 
(various iron concentration: 0.1 to 0.3 mg Fe.mL
-1
) to AMF with different field 




 to 59.99 kA.m
-1
). The experimental set-up of the testing 
was illustrated in Chapter 2, Figure 2-2. All the measurements were conducted at 
frequency of 240 kHz. In the earlier investigations, MGONCs samples produced with 
12 minutes sonication time, i.e. MGONCs 4-6 (average hydrodynamic size was in the 
range of 80–90nm) and MGONCs-4-PEG samples were studied. Figure 6-31 showed 
the time-dependent temperature curves of MGONCs 4-6 samples as well as 
MGONCs-4-PEG sample (concentration was fixed at 0.1 mg Fe.mL
-1
.) respectively 
under exposure of AMF with different field amplitude. The calculated SAR values of 
MGONCs 4-6 samples as well as MGONCs-4-PEG were summarized in Figure 6-32. 
 
Figure 6 - 31: Time-dependent temperature curve of 1 mL of 0.1 mg Fe.mL
-1
: (a) 
MGONCs-4, (b) MGONCs-5, (c) MGONCs-6 and (d) MGONCs-4-PEG under 
exposure of AMF (41.98–59.99 kA.m-1) AC field at 240 kHz frequency. 
By comparing the MGONCs 4-6 heating profile, as the MFNPs core sizes in 
MGONCs increased from 6 to 14 nm, the time-dependent temperature curve showed 
faster heating rate. MGONCs-4, MGONCs-5 and MGONCs-6 required approximately 
460 seconds, 448 seconds and 433 seconds  to reach 42
o
C respectively (at 59.99 




 field). Due to the increase in the surface canting effect which deteriorated the 
magnetic properties (Table 6-2), the nano-size effect caused MGONCs-4 with 
smallest core size to be the weakest heating agent of all samples. This indicated that 
the heating capability of MGONCs samples was highly dependent on their magnetic 
property, as sample with higher MS value have faster relaxation time.  
 
Figure 6 - 32: SAR values summary of MGONCs 4-6 and MGONCs-4-PEG. 
The observed relationship was consistent with the analytical relationship 
between power dissipation and the loss component (susceptibility) of the magnetic 












SAR    …(8) 
where P is the mean volumetric power dissipation, ρ is the mass per unit volume, ϕ is 
the volume fraction of the nanoparticles in the respective solvent. According to the 
Debye model, P is related to the static susceptibility χ” and the magnetic field H0. The 
static susceptibility or the loss component takes in account the magnetic properties 
(i.e. MS value) as well as the the Langevin parameter ξ through the chord 
susceptibility χ0 as shown below: 













VM S    …(9) 
where ω is the frequency, τ is the relaxation time, V is the volume of nanoparticles 
and T is the temperature. By substituting in the chord susceptibility in equation (9) to 
SAR value equation (8), direct correlation between the SAR value and the MS value of 
the nanoparticles can be obtained. Moreover, when the nanoparticles are not 
monodisperse, the SAR value can be adjusted to the particle size distribution y(d), 





















dy    …(10) 
where d is the particle diameter and σ is the polydispersity index (PDI). Based on 
equation (9) and (10), the specific adsorption (SAR) values should be proportional the 
MS values and inversely proportional to the nanoparticles size distribution. [49-52] In 
the case of MGONCs 4-6 samples, the PDI values as given in Table 6-2 were within 
0.25. Hence MGONC 4-6 samples were considered to have narrow distribution and 
the PDI factor might not contribute significantly to the SAR values variation. [52] 
Therefore, MGONCs samples SAR values were expected to only be influenced by the 
MS values of the core MFNPs. 
 
Figure 6 - 33: Plot of SAR values measured at 59.99 kA.m
-1
 field and the heating 
time required to reach 42
o
C for  MGONCs 4-6 against the MGONCs MS value. 
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From Figure 6-33 and Figure 6-34, the field-dependent SAR values of 
MGONCs-6 (core: octahedral 14nm MFNPs-3) were higher than MGONCs-4 (core: 
spherical 6nm MFNPs-1). This was consistent with the earlier prediction that SAR 
values increased with the MS value. However, a significant drop in the field-dependent 
SAR values was observed from MGONCs-5. The discrepancy from the predicted 
trend from equations (8) and (9), can be ascribed to two reasons: (1) the variation in 
the initial MGONCs-5 heating profile curve as compared to MGONCs-4 and 
MGONCs-6 samples (time < 100 seconds) and (2) the difference in the morphology 
of the MFNPs core of MGONCs 4-6 samples. MGONCs-4 comprised of spherical 
and non-faceted MFNPs core. Meanwhile, MGONCs-5 and MGONCs-6 sample 
comprised of faceted MFNPs core. Thus, the PDI for individual faceted MFNPs core 
in MGONCs-5 and MGONCs-6 are greater than the PDI for individual spherical 
MFNPs core in MGONCs-4. This result was consistent when considering equation (9) 
and the published result by David et al. whereby faceted (more irregular) structures 
will have smaller SAR values than the spherical nanoparticles. [47] 
 
Figure 6 - 34: Field-dependent SAR values of 1 mL of MGONCs 4-6 and MGONCs-
4-PEG samples with 0.1 mg Fe.mL
-1
 concentration. 
PEGylation-Effect: By comparing the heat profile of MGONCs 4 and MGONCs-4-
PEG, the heating rate of MGONCs-4-PEG was relatively slower as compared to 
MGONCs-4. For instance, it required 605 seconds to reach 42
o
C at 59.99 kA.m
-1
 field 
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for MGONCs-4-PEG as compared to 460 seconds for MGONCs-4. The difference in 
the heating rate can be explained by the presence of the long-chain hydrophilic 
polyethylene glycol which significantly compromised the heat conduction. [48] The 
field-dependent SAR values given in Figure 6-34 showed that the calculated SAR 
value of MGONCs-4 was always greater than that of MGONCs-4-PEG. For instance, 
at 59.99 kA.m
-1
 AMF, the calculated SAR value for MGONCs-4 was 1541.66 W.g
-1
, 
approximately ~139.0% of the calculated SAR value for MGONCs-4-PEG at 1108.9 
W.g
-1
. This finding was in a good agreement with the previously reported surface 
coating effects in which the heating capability was hindered as the surface coating 
increases, due to the suppression of Brownian relaxation processes. [48,53] 
 
Figure 6 - 35: (a). Time-dependent temperature curve of MGONCs-4-PEG sample 
and (b) in-vitro cell cytotoxicity of MGONCs-4-PEG sample with MCF-7 breast 




) AC field at 240 
kHz frequency (0.05 mg Fe.mL
-1 
and 0.1 mg Fe.mL
-1
). 
In-vitro Demonstration: To assess the therapeutic potential, localized magnetic 
hyperthermia demonstration using MCF-7 breast cancer cells were carried out at 





) for different sample concentration, using MGONCs-
4-PEG sample. The cell viabilities of the treated MCF-7 cells were analyzed and 
compared with the cell viability of the cells grown without the presence of any AMF 
exposure and MGONCs nanocomposites. Since the presence of AMF induced a non-
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selective heating due to the autonomously generated Eddy current. As reported by 
Hergt and Dutz, the AMF amplitude (H) and the frequency (f) should fall below the 







). [54] Since the energy absorbed due to eddy currents is proportional to 
the exposure area (EEddy ~D
2
 where D is the coil diameter), such limit can be relaxed 






) due to the 
difference in the coil diameter used in the experiment. [54] At 240 kHz, both 24.35 
kA.m
-1
 and 43.35 kA.m
-1
 AMF field used in the hyperthermia demonstration were 
within the limit (0.59–1.04 x 1010 A.m-1s-1). 
 
Figure 6 - 36: (a). Time-dependent temperature curve of MGONCs 7–10 samples in 
water under exposure of AMF 59.99 kA.m
-1
 AC field at 240 kHz frequency (0.1 mg 
Fe.mL
-1
). (b) Plot of SAR values and the heating time required for reaching 42
o
C 
from room temperature against MGONCs 7–10 core nanoparticle sizes. 
MGONCs-4-PEG samples at 50 and 100 µg.mL
-1
 concentrations were 
subjected to 24.35 kA.m
-1
 and 43.35 kA.m
-1
 AMF field for 10 and 20 minutes 
respectively. The heating profiles were presented in Figure 6-35a. From Figure 6-
45b, at 10 minutes heating time, no significant cell-death were observed (blue bar) 
across all experiments. Meanwhile, at low concentration of MGONCs-4-PEG (50 




), negligible cell-death was observed regardless of the applied field. Only 
when incubated with higher MGONCs-4-PEG sample (100 µg.mL
-1
), 20.2% and 
74.5% cell-death were resulted after 20 minutes exposure to 24.35 kA.m
-1
 and 43.35 
kA.m
-1
 AMF field respectively. Therefore, higher MGONCs concentration with 
longer exposure time and higher AMF field were required in order to trigger 
significant MCF-7 cell-death. 
50–55 nm MGONCs Cluster Size: Further magnetic hyperthermia investigations on 
MGONCs samples prepared with longer sonication time (60 minutes) were carried 
out. The time-dependent temperature curve of MGONCs 7-10 were presented in 
Figure 6-36a. The average hydrodynamic size was around 50–55 nm with SAR 
values of 1626.0 W.g
-1
 for MGONCs-7 (6 nm MFNPs core), 1738.9 W.g
-1
 for 
MGONC-8 (11 nm MFNPs core), 1847.6 W.g
-1
 for MGONCs-9 (14 nm MFNPs core) 
and 1988.1 W.g
-1
 for MGONCs-10 (18 nm MFNPs core) at 59.99 kA.m
-1
 AMF 
exposure. The comparison of the MGONCs 7-10 SAR values with these 4 different 
superparamagnetic core sizes reiterated the trend of increasing SAR values with the 
core size (or magnetic property) predicted from the analytical relationship given in 
equations (8) and (9). Figure 6-36b also summarized the time required to reach 42
o
C 
for various MFNPs core size; the required time decreased as the core size increased. 
Table 6 - 3: SAR values summary of various MGONCs nanocomposites with 






80–90nm Cluster size  
60 Minutes 
Sonication 












6 nm MGONCs-4 1541.61 460 MGONCs-7 1626.06 573 
11 nm MGONCs-5 1231.68 448 MGONCs-8 1738.88 473 
14 nm MGONCs-6 1586.83 433 MGONCs-9 1847.56 454 
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When compared with the 80–90 nm MGONCs 4-6 nanocomposites from 
Figure 6-31, the SAR value of the MGONCs 7-10 formed with smaller 
hydrodynamic size 50–55 nm were much higher. In contrary, the required time to 
reach 42
o
C increased with the decrease of the cluster size. The SAR values and the 
required time to reach 42
o
C were summarized in Table 6-3. Since the SAR values 
were calculated from the initial heating profile, this implied that larger cluster size 
were less responsive to the applied AMF as compared to smaller cluster size. 
 
Figure 6 - 37: Time-dependent temperature curve of 1 mL of various MGONCs-10 
iron concentrations: (a) 0.1 mg Fe.mL
-1
, (b) 0.2 mg Fe.mL
-1
 and (c) 0.3 mg Fe.mL
-1
 
under the exposure of AMF (41.98–59.99 kA.m-1) AC field at 240 kHz frequency. (d) 
Plot of the required heating time of MGONCs-10 samples to reach 42
o
C against 
MGONCs iron concentrations. 
MGONCs Concentration-Effect: The concentration-effect towards the hyperthermic 
response of MGONCs-10 sample at various iron concentration (0.1, 0.2 and 0.3 mg 
Fe.mL
-1
) were investigated at various AMF with amplitude range of 41.98 – 59.99 
kA.m
-1
. The AMF exposure time-dependent temperature curve of MGONCs-10 at 
various iron concentrations presented in Figure 6.37a-c showed very responsive 
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hyperthermic responses. This could be attributed to MGONCs high magnetic 
susceptibility. The temperature increment rate systematically increased with the 
increase of the overall MGONCs concentration. From Figure 6-37d, the time 
required for MGONCs-10 to reach 42
o
C with 54.05 k.A.m
-1
 field from room 
temperature was 885, 714 and 588 seconds for 0.1, 0.2 and 0.3 mg.mL
-1
 concentration 
respectively. Meanwhile, at higher field of 59.99 kA.m
-1
, 455, 423 and 370 seconds 
were required for 0.1, 0.2 and 0.3 mg.mL
-1
 concentration respectively; almost half of 
the time required at 54.05 kA.m
-1
. At both lower fields of 41.98 kA.m
-1
 and 48.11 
kA.m
-1
, all three concentrations of MGONCs could not reach 42
o
C within 900 
seconds of heating.  
From the field-dependent SAR values plot given in Figure 6-38, the heating 
efficiency, respresented by its SAR value, increased with AMF amplitude as 
predicted. [47-49,55-58] The SAR value of MGONCs decreases significantly with the 
increase of the MGONCs concentration. The SAR values of MGONCs-10 samples at 
different MGONCs concentrations were summarized in Figure 6-39. Overall, 
increasing concentration from 0.1 mg Fe.mL
-1
 by 2- to 3-times did not reduce the 
heating time required to reach 42
o
C proportionally. This result suggested that the 
interactions occurred between the MGONCs within the solution hindered the effective 
heat dissipation during the relaxation process. Considering a hypothetical model 
whereby the hydrophobic oleic-acid coated MFNPs were directly decorated on GO 
sheets, the absence of high molecular weight organic/inorganic coating (e.g. 
amphiphilic polymer or silica coating) allowed a close interaction between the 
decorated MFNPs and the surroundings. With such configuration, the separation 
distance between MGONCs-10 within the solution played a critical role as it 
determined the resultant MGONCs dipole-dipole interactions (see Figure 6-40). This, 
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the increase in MGONCs concentration was associated with the increase in dipolar 
interactions which stabilized the MGONCs collectively against re-orientation towards 
the applied field. [57-59] Due to its nature, Brownian relaxation was less-dependent 
on the heating agent concentration and the dipolar interactions. However, the strong 
dipolar interaction prolonged Neel relaxation, while weak dipolar interactions 
promote faster Neel relaxation. [61] 
 
Figure 6 - 38: Field-dependent SAR values MGONCs-10 with various iron 
concentrations. 
 
Figure 6 - 39: Summary of MGONCs-10 SAR values at different MGONCs 
concentrations under various AMF exposures. 
Because of the dipolar interactions, when MGONCs concentration increased, 
it become more prominent in Figure 6-38 that SAR value became less-dependent on 
the applied field, particularly due to slower Neel relaxation.  When MGONCs samples 
were exposed to high frequency AMF (f > 100 kHz), Neel relaxation dominated the 
heat dissipation mechanism more than Brownian mechanism. Therefore, when the 
separation distance between MGONCs nanocomposites decreased due to increased 
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concentration, Neel relaxation was prolonged and the overall decrease in the effective 
mass-heating efficiency trend observed in Figure 6-38 can be explained. [50-51,57-
61] The concentration influence on SAR value was more prominent at lower field 
than higher field amplitude. At lower field of 41.98 kA.m
-1
, the SAR value of 0.3 mg 
Fe.mL
-1
 MGONCs-10 differed by only 5% as compared to the SAR value of 0.2 mg 
Fe.mL
-1
. While at higher field of 59.99 kA.m
-1
, the SAR value of 0.3 mg Fe.mL
-1
 
MGONCs-10 differed by approximately 25% as compared to the SAR value of 0.2 
mg Fe.mL
-1
. At higher AMF, the energy input to the MGONCs-10 system was 
sufficient to overcome the energy barrier for relaxation mechanism. 
 From the experimental result, it can be summarized briefly that the highest 
SAR value of 1988.1 W.g
-1
 was achieved at 59.99 kA.m
-1
 field with sample 
MGONCs-10, with concentration as low as 0.1 mg.mL
-1
. Afterall, due to its high MS 
values of MFNPs core, MGONCs have much better heating capabilitiy than any other 
type of oxide materials such as Fe3O4 and CoFe2O4 of similar particle size, even at 




Figure 6 - 40: Illustrations of (a) interparticle and (b) inter-composites interactions 
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6.3.9 MR Relaxivity of MGONCs Nanocomposites 
 
Figure 6 - 41: Plot of T2 relaxation time (1/T2) against iron concentrations for 
MGONCs samples at ~300K with different MFNPs core (6nm, 11nm, 14nm and 
18nm) with different hydrodynamic size, whereby the hydrodynamic size was 
determined by the sonication time (12 and 60 minutes). T2-weighted MR images of 
various MGONCs sample for different iron concentrations at ~300K. 
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Magnetic relaxivity studies on various MGONCs sample with different core 
sizes as well as hydrodynamic sizes (controlled by sonication time) was conducted. 
The T2 relaxation rates (1/T2) of various iron concentrations of MGONCs samples 
were presented in Figure 6-40. The T2-weighted phantom MR imaging demonstrated 
the concentration-dependent darkening (contrast enhancement) T2 effects as the metal 
concentration increases for all MGONCs samples. From the T2 relaxation rates plots, 
the gradient of best fitting line determined the relaxivity constants (r2) which 
described the increase of relaxation rate with respect to the iron concentration of 
MGONCs. With 12 minutes sonication time, the r2 relaxivities value of MGONCs 4-6 
samples with 6nm, 11nm and 14nm core MFNPs (Figure 6-40a-c) were calculated to 












. To complete the 
comparison chart, MGONCs containing ~18nm MFNPs was also synthesized (Figure 





 were obtained. Meanwhile, with 60 minutes sonication time, the r2 
relaxivities value MGONCs 7-10 samples with 6nm, 11nm, 14nm and 18nm core 


















With the presence of MGONCs, magnetic moments due to the magnetic field 
gradient generated by MFNPs samples embedded on GO sheets (under applied 
external magnetic field) interacted and caused microscopic field inhomogeneity. [62] 
Subsequently, this caused faster de-phasing process of water proton spins which 
eventually lead to acceleration of spin–spin relaxation time of neighboring water 
protons and shorten the T2 relaxation time. In general, the MRI r2 relaxivity values 
depend on the saturation magnetization as described by the equation below [63-65]: 











2     …(11) 
where a is a constant, dNP is the diameter of the nanoparticles, D is the diffusion 
coefficient, µ is the magnetic moment of the nanoparticles and γ is the gyromagnetic 
ratio of the water proton, CNP is the concentration of the nanoparticles and lastly 
J(ω,τD) is the spectral density function. Based on equation (11) above, an efficient T2 
contrast agents requires SPM to possess high magnetization values. Typically, the 
magnetic properties of nanoparticles were highly dependent on the nanoparticles core 
sizes. From the MR relaxivity results, MGONCs-6 (MS: 15.70 emu.g
-1
) and 
MGONCs-9 which comprised of larger MFNPs core size as compared to MGONCs-4 
(MS: 9.09 emu.g
-1
) and MGONCs-7, possessed much better magnetic properties in 
terms of its magnetization qualities. As the result, the faster T2-relaxation was 
observed for MGONCs-6 and MGONCs-9 as compared to MGONCs-4 and 
MGONCs-7. Such results were expected since according to equation (11), the r2 value 
should increase as MFNPs MS value increased. 
Moreover, by comparing the individual T2 relaxation of sample produced with 
12 and 60 minutes sonication time, the presence of controlled aggregation of MFNPs 
on GO layer, or commonly known as clustering effect was able to provide additional 
contrast enhancement effect to improve the T2 relaxivity as reported previously. 
[17,66-68] This trend was observed for each respective MFNPs core sizes, when their 
hydrodynamic size decreased, the clustering effect decreased and therefore their. Such 
controlled-clustering can be utilized to design and control the T2-weighted contrast 
effect. Overall, T2 relaxation rate as high as 40.2 s
-1
 and 57.7 s
-1
 can be achieved with 
MGONCs sample loaded with 14 nm and 18 nm MFNPs respectively (prepared with 
12 minutes sonication time), with concentration as low as 0.125 mM Fe. 
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Figure 6 - 42: (a) Plot of the transverse relaxivity values r2 against different MFNPs 
core size at different sonication time (different resultant hydrodynamic size). (b) Plot 
of T2 relaxation rate (1/T2) for GO-g-OAM (control) and water. The T2-weighted MR 
images of water and the control GO-g-OAM was included. 
From the transverse relaxivity r2 values plot against the MFNPs core sizes 
(Figure 6-42a), the hydrodynamic-size and MFNPs core size dependent relaxivity 
behavior were summarized. When the hydrodynamic size was sufficiently large as 
compared to the MFNPs core, i.e. in 80–90 nm range, the clustering effect still 
persisted even with the increase of MFNPs core size. When the hydrodynamic size 
was reduced to sufficiently low, i.e. in 50–55 nm range, only sample that was far 
smaller than the hydrodynamic size (sample MGONCs 7-9) could have higher loading 
and hence greater clustering effects. Beyond this size, the r2 relaxivity value 
decreased as observed from MGONCs-10 sample. From Figure 6-42b, the presence 
of GO-g-OAM on the water-soluble nanocomposites has insignificant effect towards 
the T2 relaxation time of the water proton. The T2-weighted images of the negative 
(water) and positive control (GO-g-OAM in water) indicated similar T2 darkening 
effect. Therefore, based on these control results, the T2 effect observed in Figure 6-41 
can be solely ascribed to the presence of MFNPs decorated on GO-g-OAM. 
In order to demonstrate the formability of water-soluble nanocomposites with 
other system (different morphology), iron oxide nanocubes (IONPs) were synthesized 
through the thermal decomposition of iron-oleate precursors in 1-octadecene solvent 
  - 221 - 
 
and oleic acid as surface capping agent. [21] From Figure 6-43a, the synthesized 
nanocubes sample was monodisperse with average size of 7.8 ± 0.6 nm. The 
hysteresis loop measured at room temperature (Figure 6-43d) showed that the 
hydrophobic IONPs still behaved superparamagnetic with MS value of 39.5 emu.g
-1
. 
Two water-soluble nanocomposites, namely FGONCs-1 and FGONCs-2 were 
fabricated with 5 and 30 minutes sonication time. The TEM images given in Figure 
6-43b,c indicated well dispersion of both FGONCs samples in water. Because of the 
prolonged sonication, the size distribution of FGONCs-2 indicated a smaller 
hydrodynamic size (58.3 ± 0.4 nm) as compared to FGONCs-1 (95.9 ± 1.6 nm). From 
the relaxation plot against the iron concentration given in Figure 6-43f, the r2 









 respectively. Due to smaller cluster size, FGONCs-2 sample was 
expected to have lower relaxivity as compared to FGONCs-1 sample. 
 
Figure 6 - 43: TEM images of: (a) as-synthesized ~8nm Fe3O4 nanocubes (IONPs) 
dispersed in CHCl3, water soluble IONPs/GO-g-OAM nanocomposites with (b) 5 
minutes and (b) 12 minutes sonication time. (d). Hysteresis loop of IONPs at ~300K 
(e). Hydrodynamic size distribution of FGONCs 1-2 in water. (f) Plot of FGONCs 
samples T2 relaxation rate (1/T2) against iron concentrations. 
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6.4 Summary 
In summary, hydrophobic MnFe2O4 magnetic nanoparticles nanocrystals were 
successfully synthesized and decorated on GO sheets using oleylamine as 
intermediary spacer, forming water soluble nanocomposites MGONCs. During the 
process, simple mini-emulsion and solvent evaporation process were employed. The 
loading and the hydrodynamic size of such nanocomposites were tailored, simply by 
varying GO and MFNPs ratio as well as sonication time during emulsion process. 
Afterall, nanocomposites with the size range down to approximately 50–60 nm were 
successfully fabricated. To improve the colloidal stability of the nanocomposites in 
physiological solutions, especially in phosphate buffered saline solution (PBS 1x), 
PEGylation was carried out through carbodiimide chemistry. The obtained PEGylated 
nanocomposites showed excellent colloidal stability, as well as suitable 
biocompatibility with both NIH/3T3 and MCF-7 cells with negligible toxicity. 
Heating through AMF exposure indicated that MGONCs samples were 
promising as efficient magnetic hyperthermia agents. At concentrations as low as 0.1 
mg Fe.mL
-1
 (under 59.99 kA.m
-1 
field and 240 kHz frequency), MGONCs could 
deliver up to 1847.6 W.g
-1
 and 1988.1 W.g
-1 
using MGONCs samples loaded with 14 
nm and 18 nm MFNPs (hydrodynamic size of 50–60 nm). For these two samples, 
approximately 450 seconds were sufficient for the system to reach 42
o
C. A simple in-
vitro demonstration conducted to determine the efficacy of using MGONCs loaded 
with 6 nm MFNPs to eradicate MFC-7 was also successful. Without the applied 
AMF, MFC-7 cells lived favourably with more than 100% cell viability. However, at 
43.36 kA.m
-1
 applied field for 20 minutes, 0.1 mg Fe.mL
-1
 MGONCs sample was able 
to eradicate MCF-7 cells, leaving only 25.5% viable cells. Separately, the T2-weighted 
MR studies revealed that MGONCs were effective as T2 contrast agents with potential 
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of tailoring the relaxivity through the hydrodynamic size. A T2 relaxivity value (r2), as 








 could be achieved with MGONCs 
loaded with 14 nm and 18 nm MFNPs (hydrodynamic size of 90–100 nm). From a 
simple comparison, it was clearly indicated that small hydrodynamic size was 
required for effective MFH agent to allow fast heat release to the surrounding. 
However, larger hydrodynamic size was required for effective MRI T2 contrast agent 
to allow higher localized magnetic perturbation to the system to induce faster 
relaxation of surrounding water protons. Hence, there was a need to balance the 
hydrodynamic size to obtain suitable hyperthermic response for MFH application as 
well as suitable relaxivity for MRI contrast agent. 
Besides its biocompatibility and colloidal stability, the current synthetic 
method demonstrated was also compatible with other types of hydrophobic 
nanoparticles system, as verified by decorating ~8 nm Fe3O4 iron oxide nanocubes on 
GO layer. Therefore the synthetic method was universal to synthesize water soluble 
nanocomposites for various biomedical applications.  
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In this thesis, the main objective to investigate and develop water-soluble 
functional superparamagnetic nanocomposites has been fulfilled. The subsequent 
investigations on biomedical application such as MRI T2 contrast agent, magnetic 
hyperthermia heating agents also showed very promising results. And when these 
nanocomposites were coupled with fluorescence agent, cellular imaging was enabled, 
allowing multimodality imaging. Four different strategies have been independently 
developed and investigated thoroughly. The summary of the advantages and 
disadvantages of each respective method were given in Table 7-1. The original 
hydrophobic nanoparticles properties were still retained even after water-
solubilization process. All the water-dispersible samples presented in this thesis 
showed outstanding colloidal and chemical stability with rather low (or negligible) 
cytotoxicity either with NIH/3T3 fibroblast cells or MCF-7 breast cancer cells.  
In Chapter 3, in-situ ligand modification through alkenoic ligand maleinization 
coupled with thermolysis process was successfully performed to obtain water-
dispersible nanocrystals. These nanocrystals were comparable with typically 
hydrophobic nanocrystals obtained from the thermolysis process. The maleinization 
reaction time was optimized to 3 hours. The crystallinity and the magnetic properties 
of the obtained water-dispersible nanocrystals were similar as compared to the typical 
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hydrophobic nanocrystals. Unlike typical ligand modification technique, the 
demonstrated method was non-destructive and did not impair the physical properties. 
Table 7 - 1: Summary of various water solubilization methods presented in this thesis. 
Water-Solubilization Method Advantages/Disadvantages 
1. Direct Transfer (Ligand Modification) 
 
 In-situ modification 
 Physical properties retained 
 Non-universal method 
 Specific to Alkenoic ligands 
 Biocompatible and Functionalizable 
2. Monodisperse Phase Transfer 
 
 Universal method 
 Physical properties retained 
 Single layer coating 
 High colloidal stability 
 Biocompatible and Functionalizable 
3. Nanoclusters Formation 
 
 Universal method (3-Dimensional system) 
 Multifunctional (cores tuning) 
 Tunable loading (controlled aggregation) 
 High colloidal stability 
 Biocompatible and Functionalizable 
4. Graphene Oxide Nanocomposites Formation 
 
 Universal method (2-Dimensional system) 
 Tunable loading and hydrodynamic size 
 Controlled aggregation 
 High colloidal stability 
 Biocompatible and Functionalizable 
In Chapter 4, amphiphilic brush copolymer PIMA-g-C12 was employed to host 
the hydrophobic SPM. Several parameters (hydrolyzing agent amount, polymer to 
SPM mass ratio and the initial SPM concentration) have been thoroughly investigated 
and optimized. By using the optimized parameters, the hydrodynamic size increment 
was no more than 33% as compared to the original hydrophobic nanoparticles after 
water solubilization. The HRTEM images verified the presence of single layer coating 
encapsulating individual hydrophobic nanoparticles. When fluoresceinamine dye was 
conjugated to PIMA-g-C12, in-vitro cellular bio-imaging demonstration using 
NIH/3T3 cells was enabled and the cellular uptake mechanism was studied.  
In Chapter 5, controlled collective encapsulation of hydrophobic nanoparticles 
using PEG-functionalized amphiphilic brush copolymer PMAO to form spherical 
nanoclusters was demonstrated. The loading of the nanoclusters can be simply tuned 
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by varying the nanoparticles core, nanoparticles sizes and the initial nanoparticles 
amount (mass ratio). By coupling magnetic nanoparticles with QDs, bi-functional 
nanoclusters sample with fluorescent and magnetic behaviors was obtained. The 
formation of the multifunctional nanoclusters has negligible effect on the overall 
properties of the nanoclusters. Such bi-functional nanoclusters sample was also 
successfully demonstrated for in-vitro cellular bio-imaging using NIH/3T3 cells.  
Table 7 - 2: MR relaxivity summary of various superparamagnetic Fe3O4 and 
MnFe2O4 sample (different core sizes) with different organic surface coating. 
 
In Chapter 6, two-dimensional GO sheets were successfully used to host 


















Surface Coating – Maleinized Oleic Acid (MOA) 
Spherical Fe3O4 (13 nm) 38.8 ± 2.1 nm 495.8 0.27 1814.9 
Surface Coating – Amphiphilic Brush Copolymer PIMA-g-C12 
Spherical Fe3O4 
(10 nm) 
18.5 ± 0.1 nm (NaOH) 
19.6 ± 0.3 nm (PBS 1x) 
38.1 0.42 89.9 
Octahedral MnFe2O4 
(18 nm) 
26.3 ± 0.1 nm (NaOH) 
30.1 ± 0.1 nm (PBS 1x) 
125.7 1.06 118.1 
Surface Coating – PEGylated Amphiphilic Brush Copolymer PMAO-g-PEG 
Spherical MnFe2O4  
(6 nm) 
104.7 ± 1.5 nm 246.0 0.98 251.1 
Octahedral MnFe2O4 
(11 nm) 
106.2 ± 1.1 nm 280.2 0.88 320.0 
Octahedral MnFe2O4 
(18 nm) 
82.5 ± 0.9 nm 238.7 0.25 937.0 
Octahedral MnFe2O4 
(11 nm) w/ AIZS QDs 
119.8 ± 1.0 nm 263.5 0.98 267.9 
Surface Coating – Oleylamine-modified Graphene Oxide GO-g-OAM 
Spherical MnFe2O4  
(6 nm) 
81.0 ± 0.3 nm 105.8 N/A N/A 
Octahedral MnFe2O4 
(11 nm) 
89.7 ± 0.4 nm 227.9 N/A N/A 
Octahedral MnFe2O4 
(14 nm) 
82.0 ± 0.5 nm 256.2 N/A N/A 
Octahedral MnFe2O4 
(18 nm) 
101.5 ± 1.3 nm 459.5 N/A N/A 
Spherical MnFe2O4  
(6 nm) 
56.8 ± 0.1 nm 71.5 1.28 55.8 
Octahedral MnFe2O4 
(11 nm) 
55.0 ± 0.6 nm 206.9 1.26 164.6 
Octahedral MnFe2O4 
(14 nm) 
56.2 ± 0.4 nm 230.7 1.28 180.2 
Octahedral MnFe2O4 
(18 nm) 
50.6 ± 0.3 nm 185.6 0.71 259.4 
Cubic Fe3O4 
(9 nm) 
95.9 ± 1.6 nm 105.2 0.01 14024 
Cubic Fe3O4 
(9 nm) 
58.3 ± 0.3 nm 79.2 0.15 514.1 
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magnetic nanocomposites. The loading and the hydrodynamic size of the resultant 
water-dispersible nanocomposites were tuned by varying GO and MFNPs ratio as 
well as sonication time. Nanocomposites with the size range down to approximately 
50–60 nm were successfully fabricated. Rather than forming encapsulated structure, 
the SEM, TEM and AFM analysis clearly suggested that MGONCs were composed of 
multiple MFNPs decorated on the surface of GO sheets. To improve the MGONCs 
colloidal stability in physiological solutions, PEG was functionalized onto the 
MGONCs surface through carbodiimide chemistry. The MGONCs nanocomposites 
were also investigated for its therapeutic potential through localized heating of MCF-
7 breast cancer cells. 
 
Figure 7 - 1: Plot of T2 relaxation time (1/T2) of various water-dispersible 
nanocomposites. (core: ~18nm octahedral MFNPs). 
MRI: All the MR relaxivity tests performed were summarized in Table 7-2. Samples 








 were obtained 
from 13 nm hMIONPs and MGONCs sample with 18 nm MFNPs core. High r2 value 
of hMIONPs can be ascribed to the uncontrolled IONPs mild aggregation due to the 
synthesis process. Meanwhile, high r2 value of MGONCs sample was attributed to the 
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 was obtained when single PIMA-g-C12 encapsulation was employed for 10 nm 
IONPs. Figure 7-1 summarized several note-worthy MR relaxivity results of the 
water-dispersible nanocomposites for comparison. When the hydrodynamic size of 
the system increased, more hydrophobic nanoparticles were incorporated and 
therefore the resultant T2 relaxation rate increased significantly. Such increase was 
due to the clustering effect enhancement which induced strong localized de-phasing. 
Table 7 - 3: SAR values summary of various superparamagnetic MnFe2O4 sample 
(different sizes) with different organic surface coating. 
 
Hyperthermia: The heating abilities of several water-soluble magnetic 
nanocomposites presented in this thesis were summarized in Table 7-3. In terms of 
the heating efficiency, Figure 7-2 compared the magnetic nanoclusters using PMAO-
g-PEG and the MGONCs samples that have been loaded with ~11nm MFNPs. From 
the comparison, the heating efficiency of 0.3 mg Fe.mL
-1
 MFNCs (75.9 ± 0.4 nm) 
Samples/  
Core Size  
Hydrodynamic 
Size (nm)  
Field  
(kA/m) 






Surface Coating – PEGylated Amphiphilic Brush Copolymer PMAO -g-PEG 
Octahedral MnFe 2O4 
(11 nm)  
0.3 mg Fe.mL -1 
75.9 ± 0.4 nm  
(High Loading)  
48.11 295.3 N/A 
59.99 540.7 627 
81.1 ± 1.2 nm  
(Low Loading)  
48.11 307.9 N/A 
59.99 468.5 557 
Surface Coating – Oleylamine -modified Graphene Oxide GO -g-OAM 
Spherical MnFe 2O4  
(6 nm) 0.1 mg Fe.mL -1 
81.0 ± 0.3 nm  59.99 1541.6 460 
Octahedral MnFe 2O4 
(11 nm)  0.1 mg Fe.mL -1 
89.7 ± 0.4 nm  59.99 1231.7 448 
Octahedral MnFe 2O4 
(14 nm)  0.1 mg Fe.mL -1 
82.0 ± 0.5 nm 59.99 1586.8 433 
Spherical MnFe 2O4  
(6 nm) 0.1 mg Fe.mL -1 
56.8 ± 0.1 nm  59.99 1626.0 573 
Octahedral MnFe 2O4 
(11 nm)  0.1 mg Fe.mL -1 
55.0 ± 0.6 nm  59.99 1738.9 473 
Octahedral MnFe 2O4 
(14 nm)  0.1 mg Fe.mL -1 
56.2 ± 0.4 nm  59.99 1847.6 454 
Octahedra l MnFe2O4 
(18 nm)  0.1 mg Fe.mL -1 
50.6 ± 0.3 nm  59.99 1988.1  453 
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was far below 0.1 mg Fe.mL
-1 
MGONCs (55.0 ± 0.5 nm) samples. The required time 
for MFNCs sample to reach 42
o
C (625 seconds) was much longer than the required 
time for MGONCs (535 seconds). These result demonstrated that two-dimensional 
structure based on oleylamine-modified GO materials allowed faster relaxation and 
heat release as compared to the three-dimensional structure (spherical polymer 
coating). The presence of “encapsulation” polymeric coating acted as heat barrier 
(low heat conductivity) which slowed down the heat release to the environment. 
 
Figure 7 - 2: Comparison of the time-dependent temperature curve of ~11nm MFNPs 
embedded inside PMAO-g-PEG nanoclusters and oleylamine-modified GO sheets. 
From simple hyperthermia and MRI results comparison, there was a need to 
optimize the water-solubilization method to obtain desired hydrodynamic size. On 
one side, increasing nanoparticles clustering through controlled aggregation allowed 
higher localized magnetic perturbation which induced faster relaxation of surrounding 
water protons. Hence, it will result in better and more effective MRI T2 contrast agent. 
However, to obtain an efficient MFH agent, small hydrodynamic size system which 
indicated minimal nanoparticles aggregation was demanded to allow fast heat release 
to the surrounding. Nanocomposites with large hydrodynamic size will be less 
responsive under AMF field exposure. Therefore, to obtain suitable both hyperthermic 
response for MFH application and relaxivity for MRI contrast agent, well-controlled 
water-solubilization essentially becomes very critical. 
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7.2 Recommendations for Future Work 
7.2.1 In-situ Maleinization Process 
 
Figure 7 - 3: Synthesis of maleinized unsaturated fatty acids: chemical structures. 
In Chapter 3, the direct coupling of maleinization into nanoparticles 
thermolysis synthesis was satisfactory in producing high quality water dispersible 
nanoparticles. The presence of hydrophobic unsaturated fatty acid ligand was required 
for both thermolysis and the in-situ maleinization process. Typical unsaturated fatty 
acid, i.e. oleic acid, has been employed to showcase the idea feasibility. In general, 
this work can be extended to different unsaturated fatty acids [1-2], e.g. undecylenic 
acid [3-5], linoleic acid [6] and poly-unsaturated fatty acids [7]. Figure 7-3 illustrated 
the possible maleinized fatty acids chemical structures. On top of in-situ maleinization 
process, it is also possible to use pre-synthesized maleinized-unsaturated fatty acids as 
the capping agent during thermolysis process. Considering linoleic or undecylenic 
acids have been reported previously as surfactants for magnetic nanocrystals synthesis 
[8-9], the synthesis using maleinized-ligands are highly possible. By using different 
maleinized-ligands and precursor/surfactant ratio, high quality and water dispersible 
magnetic nanocrystals with tunable size and morphology can be synthesized. 
7.2.2 Aggregation and Hyperthermia-induced Nanomagnetic Actuation 
 Typical hydrodynamic sizes of the superparamagnetic nanocomposites 
synthesized in Chapter 3–6 range from 30–100 nm [10-11, 12-15]. These 
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nanocomposites are smaller than the average cell size (10–100 µm) and comparatively 
similar to the macromolecules sizes (5–50 nm) [16]. Because of its comparable size 
with cell surface receptor and its nanomagnetism behavior, these nanocomposites can 
be potentially developed into nanomagnetic switch that controls the cell fate. 
Basically, there are two ways nanomagnetism can interact with cell surface receptor: 
(i) mechanical (translational) force and (ii) heat generation (hyperthermic response). 
Receptor Aggregation-induced Cellular Activation 
 
Figure 7 - 4: (a) Normal signal transduction: binding of multivalent ligands to the cell 
surface receptors. (b) Similar downstream signaling cascades can be induced by 
coupling functionalized SPM to surface receptors. Under external magnetic field, 
SPM magnetized and clustered, mimicking the cell surface receptors aggregation. 
In the biochemistry of cellular signaling and signal transduction, living cells 
are able to sense the surrounding through the cell surface receptor on membrane 
surface. There are various classes of receptors that activate the downstream signaling 
cascades when they are forced to cluster together as a response to multivalent ligand 
binding as illustrated in Figure 7-4a [17-19]. These include tyrosine kinase, cytokine, 
growth factor, tumor necrosis factor, T-cell and G-protein coupled receptors. Many 
theoretical studies concluded the naturally occurring receptor-clustering signaling 
mechanism is a thermodynamically favorable phenomenon [19-20]. In 2007 the 
concept of nanoscale magneto-activated cellular signaling was introduced to mimic 
the natural receptor clustering phenomenon. The mechanicals stimulation can be 
generated through the use of external magnetic field to magnetically induced 
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translation vectors (attractive forces). The changes induced by this mechanical 
stimulation will trigger false signaling mechanism and subsequently activate cellular 
activities (as shown in Figure 7-4b), such as differentiation, growth and death. In 
2008 Mannix et al. demonstrated the nanomagnetic actuation concept to activate the 
calcium ion channel signalling [21], while Lee et al. in 2009 demonstrated receptor-
mediated artificial triggering of cell growth in the pre-angiogenesis stage [22]. On the 
other hand, TNF receptor signaling activation is more promising, especially for cancer 
treatment. Its activation will lead to voluntary cellular apoptosis, triggered by the 
death receptors clustering (receptors oligomerization) [23-24]. 
 
Figure 7 - 5: (a) In-vitro study of the remote-controlled cellular apoptosis activation: 
experimental procedures. (b) Cell viabilities comparison of cells incubated with 
antibody-against TNF-R1 receptor functionalized WMFNPs: with and without the 
presence of external magnetic field. 
In a similar approach, SPM can be firstly attached to the antibody targeting the 
death receptor, TNF-R1. PIMA-g-C12-coated MNFPs (from Chapter 4) was highly 
suitable for such application due to its optimized hydrodynamic size and excellent 
colloidal stability. Based on such strategy, a simple preliminary in-vitro testing was 
carried out to induce the MCF-7 breast cancer cells apoptosis. The availability of the 
carboxylic acid functional groups on the surface, allows the biofunctionalization of 
WMFNPs with streptavidin through carbodiimide chemistry. Relying on the avidin-
biotin chemistry, biotinylated monoclonal antibody against TNF-R1 was then 
incubated with streptavidin conjugated WMFNPs to obtain functionalized WMFNPs. 
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MCF-7 cells were incubated with the functionalized WMFNPs, both with and without 
the presence of applied external magnetic field (Figure 7-5a). The cell viability was 
analyzed by colorimetric assays using CCK-8 and microplate reader.  
From the in-vitro study on the magnetic-field induced cellular apoptosis 
activation through receptor clustering, the qualitative ratio between the viable cells 
from different experiment conditions (with and without magnetic field) using 
functionalized WMFNPs was compared. Figure 7-5b indicated that the presence of 
both magnetic field and the targeting agent to bind to TNF-R1 receptor were 
essentially required to induce cellular apoptosis. Under applied magnetic field and at 
sufficiently high concentration (0.48 mM Fe), functionalized WMFNPs were able to 
induce more cellular death. A more detailed study on the signaling mechanism 
tracking such as caspase-8 cleavage and activation, as well as monitoring both 
intracellular and extracellular Ca
2+
 ion concentrations and flux can be performed.  
Hyperthermia-induced Insulin Secretion 
 
Figure 7 - 6: Strategy to harness magnetic hyperthermia for diabetic treatment. 
Alternatively, the hyperthermic response of nanocomposites containing SPM 
(as demonstrated in Chapter 5 and 6) can be utilized to induce alternate signaling 
mechanism. Generally, insulin prevents the use of body fat as the energy source. In a 
normal human body metabolism, insulin is secreted within the body proportionally to 
control the glucose levels in the blood. When the control of insulin level fails (under-
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secretion), diabetes mellitus would be resulted. In biochemistry, transient receptor 
potential resembling the vanilloid receptor channel (TRPV) is known as a calcium 
permeable ions channels. One of the sub-family receptor, TRPV2 is regulated by heat 
and highly expressed in pancreatic β-cells [25]. It was recognized that insulin 
secretion from pancreatic β-cells is the only efficient means to decrease blood glucose 
concentration and TRPV2 receptor has been reported to be involved in the insulin 
secretion [26]. Through a proper conjugation of magnetic nanocomposites with 
monoclonal antibody against TRPV2 receptor, the resultant functionalized 
nanocomposites can be attached to the membrane TRPV2 receptor of pancreas β-
cells. As illustrated in Figure 7-6, when AMF is applied, the heat dissipation from 
magnetic nanocomposites can cause a localized temperature increment beyond 42
o
C. 
Since TRPV2 is heat-activated, localized heating through hyperthermia mechanism 
will activate TRPV2 receptor which subsequently triggers the Ca
2+
 ions signalling and 
finally results in the insulin-secretion. Fortunately, AMF field can be applied 
remotely; therefore hyperthermia-induced cellular signalling for insulin production is 
very promising for diabetic patients rather than a conventional insulin delivery. 
7.2.3 Synthesis of Au-MFe2O4 (M = Fe, Mn) Heterostructures  
Besides the conventional multifunctional nanocomposites formation method 
using amphiphilic brush copolymers (presented in Chapter 5), it is possible to form 
multifunctional nanocomposites through the epitaxial nucleation and growth. Various 
multifunctional inorganic nanoparticles can be synthesized through the thermal 
decomposition method, for example, metallic/metal oxide nanocomposites such as Ag 
or Au with MnO, Fe3O4 and etc [27-29]. Of various types of nanocomposites, Au-
Fe3O4 heterostructures was of interest for biomedical applications. Typically, Au-
Fe3O4 heterostructures were synthesized through a complicated process, e.g. the use 
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of pre-synthesized iron-oleate precursors or pre-formed gold nanoparticles [30-31]. 
Alternatively, as shown below, simple thermolysis of iron-acetylacetonate and gold 
precursors can be employed to epitaxially grow Fe3O4 on Au nanoparticles [32-35].  
 
Figure 7 - 7: TEM images of Au-Fe3O4 nanoflower synthesized in: (a) 1-octadecene 
(b.p. ~320
o
C), (b) benzyl ether (b.p. ~295
o
C) and (c) phenyl ether (b.p. ~265
o
C). XRD 
pattern (d) and hysteresis loop profile (e) of Au-Fe3O4 nanoflower. 
The morphology of Au-Fe3O4 heterostructures synthesized at different solvent 
polarity conditions were characterized by TEM. Figure 7-7a-c depicted the TEM 
images of hydrophobic Au-Fe3O4 dispersed in CHCl3, synthesized with 1-octadecene, 
benzyl ether and phenyl ether. The resultant hetereostructures resembled flowers 
structure. The spatial arrangement of Fe3O4 on Au nanoparticles, represented by the 
number of Fe3O4 ‘petals’, can be adjusted by varying the solvent polarity. From 
Figure 7-7d, the Au-Fe3O4 heterostructures XRD pattern indicated the simultaneous 
presence of crystalline Au and magnetite structure. The hysteresis loop (Figure 7-7e) 
indicated that the heterostructures behaved superparamagnetically with MS value over 
40 emu.g
-1
. Conveniently, other metal dopant (e.g. manganese) can be introduced 
simply by using mixed-metal acetylacetonate precursors.  
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7.2.4 Ultrasmall Fe3O4/GO Nanocomposites as MRI T1 Contrast Agent 
 
Figure 7 - 8: TEM images of ultrasmall iron oxide SPM synthesized using (i) iron-
oleate precursors: (a) as-synthesized nanoparticles (USIONPs-O) and (b) after water 
solubilization using GO (FGONCs-O) and (ii) acetylacetonate precursors: (c) as-
synthesized nanoparticles (USIONPs-A) and (d) after water solubilization using GO 
(FGONCs-A). 
As discussed previously in Chapter 6, the water solubilization technique 
developed by using ultrasmall GO sheets was a universal tool to obtain various water-
dispersible nanocomposites. One of simple example was the use of such method to 
host semiconductor AIZS quantum dots reported by Yang et al. recently. [36] 
Similarly, other hydrophobic nanoparticles can be water-solubilized conveniently. 
Recently, the development of ultrasmall iron-oxide SPM (USIONPs) was of interest 
due to its potential as MRI T1 contrast agent. [36-39] The T1-contrast enhancement 
effect was in place due to the presence of ferric (Fe
3+
) ions with 5 unpaired electrons 
on the nanoparticles surface. As the size of the iron oxide SPM decreased, the surface 
canting effect occured, suppressing the magnetic properties due to the reduction the 
magnetic anisotropy volume and hence suppressing the T2-effect. [39] Because of 
this, T1-effect can be boosted and USIONPs was thus proposed as T1 contrast agent. 
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There were two reliable ways of fabricating ultrasmall iron oxide, i.e. thermolysis of 
iron-oleate precursors [39] and iron-acetylacetonate precursors [40]. Figure 7-8 
summarized the preliminary USIONPs results. USIONPs with 4.0 ± 0.6 nm (Figure 
7-8a) and 2.3 ± 0.3 nm (Figure 7-8c) were obtained when using iron-oleate and iron-
acetylacetonate precursors. After water solubilization with ultrasmall GO sheets, the 
average USIONPs TEM size did not vary significantly despite prolonged sonication 
time during the process (4.1 ± 0.5 nm and 2.2 ± 0.4 nm for FGONCs-O and FGONCs-
A). The hysteresis loop analysis of USIONPs-A (Figure 7-9a) revealed a relatively 
low MS value (8.85 emu.g
-1
). The FGONCs-O and FGONCs-A hydrodynamic size 
were relatively similar at 62.3 ± 1.4 nm and 63.1 ± 0.5 nm respectively.  
 
Figure 7 - 9: (a) Hysteresis loop profile of hydrophobic ~2.3 nm ultrasmall iron oxide 
nanoparticles synthesized using acetylacetonate precursors. (b) Hydrodynamic size 
distribution of FGONCs-A in water. (c) Plot of T2 and T1 relaxation time (1/T2 and 
1/T1) against iron concentrations for FGONCs-A samples at ~300K. 
The MR relaxivity test for FGONCs samples with smallest USIONPs, 









 however, was not improved despite the T2–
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effect suppression. Due to the ultrasmall size of USIONPs (< 3 nm), the system have 
to overcome larger energy barrier to break-down the O/W droplet during the emulsion 
process (as illustrated in Figure 5-20). Therefore, large hydrodynamic size FGONCs 
samples were obtained, suggesting more USIONPs per nanocomposites which 
hindered the water/USIONPs interaction required for T1-contrast agent. Further work 
on the optimization of the USIONPs loading can be done to improve the r1 relaxivity. 
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